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iA B S T R A C T
Stem cell therapy for ischaemic stroke is an emerging field in light of an increas-
ing number of patients surviving with permanent disability. Several allogenic
and autologous cells types are now in clinical trials with preliminary evidence
of safety. Some clinical studies have reported functional improvements in some
patients.
After initial safety evaluation in a Phase 1 study, the conditionally immor-
talised human neural stem cell line CTX0E03 is currently in a Phase 2 clinical
trial (PISCES-II). Previous pre-clinical studies conducted by ReNeuron Ltd,
showed evidence of functional recovery in the Bilateral Asymmetry test up
to 6 weeks following transplantation into rodent brain, 4 weeks after middle
cerebral artery occlusion.
Resting-state fMRI is increasingly used to investigate brain function in health
and disease, and may also act as a predictor of recovery due to known network
changes in the post-stroke recovery period. Resting-state methods have also
been applied to non-human primates and rodents which have been found to
have analogous resting-state networks to humans. The sensorimotor resting-
state network of rodents is impaired following experimental focal ischaemia of
the middle cerebral artery territory. However, the effects of stem cell implanta-
tion on brain functional networks has not previously been investigated.
Prior studies assessed sensorimotor function following sub-cortical implan-
tation of CTX0E03 cells in the rodent post-stroke brain but with no MRI
assessments of functional improvements. This thesis presents research on the
effect of sub-cortical implantation of CTX0E03 cells on the resting- state senso-
rimotor network and sensorimotor deficits in the rat following experimental
stroke, using protocols based on previous work with this cell line. The work in
this thesis identified functional tests of appropriate sensitivity for long-term
dysfunction suitable for this laboratory, and investigated non-invasive moni-
toring of physiological variables required to optimize BOLD signal stability
within a high-field MRI scanner.
ii
Following experimental stroke, rats demonstrated expected sensorimotor dys-
function and changes in the resting-state sensorimotor network. CTX0E03
cells did not improve post-stroke functional outcome (compared to previous
studies) and with no changes in resting-state sensorimotor network activity.
However, in control animals, we observed changes in functional networks due
to the stereotaxic procedure. This illustrates the sensitivity of resting-state
fMRI to stereotaxic procedures. We hypothesise that the damage caused by cell
or vehicle implantation may have prevented functional and network recovery
which has not been previously identified due to the application of different
functional tests.
The findings in this thesis represent one of few pre-clinical studies in resting-
state fMRI network changes post-stroke and the only to date applying this
technique to evaluate functional outcomes following a clinically applicable
human neural stem cell treatment for ischaemic stroke. It was found that injury
caused by stereotaxic injection should be taken into account when assessing
the effectiveness of treatment.
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I N T R O D U C T I O N
1.1 stroke
Stroke is a term used to describe a wide array of central nervous
system disorders associated with any cerebrovascular disorder
resulting in an acute clinical presentation. These include sub-
arachnoid and intracerebral haemorrhages, silent infarction, and
ischaemic infarction determined via evidence of ischaemic injury
within a vascular territory and with clinical symptoms lasting
for greater than 24 hours or until death (Sacco et al., 2013). With
high metabolic demands (requiring 15% of cardiac output) and
limited energy reserves, the brain is highly sensitive to persistent
perturbations in CBF (cerebral blood flow). As a consequence,
the affected area of the brain dies leading to permanent loss of
function with limited recovery.
1.1.1 Stroke subtypes & epidemiology
Stroke affects 15 million people worldwide (WHO). Cerebrovas-
cular disease accounts for 6.3% of the global Disability Adjusted
Life Years (DALYs) i.e. the total number of potential years lost by
premature death due to disease, totalling 9.35 millions of years
(Lopez et al., 2006). In the UK, stroke is believed to cost £3 billion
a year with over 4000 deaths in Scotland in 2014 (Scottish Stroke
Statistics, 2016) and a wider economic cost of £8 billion primarily
due to the effect of permanent post-stroke disability. Although
1
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the mortality rate from stroke has decreased by 39% in the last
10 years in Scotland (Scottish Stroke Statistics, 2016), over 50% of
stroke survivors are left permanently disabled, leading it to be
the greatest range of disability burden of any disease (Adamson
et al., 2004).
The two main forms of stroke are occlusive ischaemic (80% inci-
dence) or haemorrhagic (20% incidence), with each requiring its
own unique form of clinical management (Heiss, 2010). Haemor-
rhagic stroke is typically caused by amyloid angiopathy (Thanvi
and Robinson, 2006). Occlusive ischaemic stroke occurs when
an embolus (coagulated blood) occludes a cerebral vessel perma-
nently or transiently. Small vessel disease also causes ischaemic
stroke but is mechanistically less well understood. The artery
occluded determines the region of the brain affected and the
resultant symptoms.
1.1.2 Cerebral blood flow, autoregulation, and stroke
The brain’s dependence on a continuous supply of oxygen and
glucose has led to the evolution of mechanisms to ensure blood
supply is not perturbed. Autoregulation assures that across a range
of systemic mean arterial blood pressures, cerebral perfusion pres-
sure (CPP) is maintained. CPP is regulated by arteriolar diameter
to control flow and volume (Lassen, 1959) via a plethora of factors,
most importantly carbon dioxide, a potent vasodilator (Gibbs and
Gibbs, 1935; Meng and Gelb, 2015). Other factors include hydro-
gen ion concentrations and vascular smooth muscle responses via
sheer stress receptors (Lassen and Christensen, 1976). Many of
these contributors are the product of the metabolic demand of
the neurons. Indeed, coupling of the cerebral vasculature to the
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neurons helps to maintain adequate function (see Section 1.4.1).
Autoregulation can be summarised as a ratio between CBF and
CPP detailing the ranges at which it can be maintained (typically
60− 150 mmHg, Figure 1). Lower perfusion pressures will cause
vasodilation and vasoconstriction at high pressure within the
aforementioned limits. Out-with these limits, flow is no longer
pressure-independent and hypo-/hyper-perfusion will occur.
Human CBF is approximately 60ml/100g/min (Steiner and An-
drews, 2006) and 100ml/100g/min in the rat (Herna´ndez et al.,
1978). Autoregulation exists to protect the brain from ischaemic
damage as a consequence of systemic blood loss, traumatic injury,
haemorrhage or from high blood pressure which may limit oxy-
gen extraction. Ischaemic stroke can cause a loss of autoregulation
leading to hypoperfusion, contributing to stroke pathogenesis
(Dohmen et al., 2007).
Following occlusion of a cerebral artery, CBF reduces across the
vascular territory. In end-arteries, this reduction in perfusion is
the most severe, however this is partly determined by the collat-
eral vascular anatomy of the area where the converse may occur.
Instantaneous reduction in perfusion pressure soon causes dam-
age to the affected tissue (see below). The perfusion thresholds at
which particular forms of damage/perturbations occurs were ini-
tially determined in the baboon (Branston et al., 1974; Astrup et al.,
1977). Branston et al. showed that cortical evoked potentials on the
somatosensory cortex decreased as a function of blood flow (mea-
sured by the hydrogen clearance method (Pasztor et al., 1973)),
with complete failure of evoked responses at 15ml/100g/min. It
was later demonstrated the CBF threshold for failure of cortical
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Figure 1: Illustration of cerebral autoregulation as a ratio of CBF and CPP in
man. Autoregulation is pressure-independent along a range of approximately
60− 150mmHg (Plateau, B). CBF becomes pressure-dependent at the lower
limit (LL, A), upper limit (UL, C), and standard deviation (SD, SD). Image
adapted from Meng and Gelb (2015)
evoked potentials was less than that for the depolarisation of
neurons caused by the release of intracellular potassium (Astrup
et al., 1977). This confirmed earlier hypotheses of an ischaemic
‘penumbra’ whereby at a certain level of reduced CBF, neurons
are functionally inactive but are structurally uncompromised and
therefore potentially salvageable. Astrup et al. determined the
CBF threshold for the ischaemic penumbra to be between 10 and
17 ml/100g/min. Below this, cell death would occur rapidly
and irreversibly. Between normal CBF (50ml/100g/min) and the
upper limit for the ischaemic penumbra, the brain exists in a state
called benign oligaemia. Here, there is reduced CBF and CPP but
with no functional impairment due to increased oxygen extrac-
tion fraction (OEF, Lee et al. (2005)). Figure 2 illustrates the CBF
thresholds at which these various pathologies occur.
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Figure 2: The CBF thresholds of cellular impairment and death. Cell death
occurs below 10ml/100g/min; the penumbra at 10− 17ml/100g/min, and
benign oligaemia 18− 45 ml/100g/min. Image adapted from non-human
primate data from Astrup et al. (1977)
1.1.3 Acute ischaemic stroke pathophysiology
A severe reduction in cerebral blood flow following occlusion
of a cerebral blood vessel impedes the delivery of oxygen and
glucose to the local parenchyma known as the ischaemic core. As
a consequence, a cascade of pathological mechanisms, beginning
a few minutes after the reduction in perfusion come into play
eventually resulting in the death of the tissue. The time course of
the acute, and chronic, stroke pathological processes are detailed
in Figure 3.
The initial insult & excitotoxicity
The interruption in normal perfusion very quickly leads to a de-
pletion of limited ATP (adenosine triphosphate) reserves and a
concurrent rise in ADP (adenosine diphosphate) after 30 seconds
(Katsura et al., 1994). Unable to maintain membrane potentials
(via the failure of Na+/K+-ATPase), intracellular concentrations
of K+ fall and cell membranes depolarise, activating voltage-
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dependent Ca2+ channels, causing the release of glutamate into
the extracellular space. Increases in glutamate (with limited
re-uptake) activate ionotropic NMDA (N-methyl-D-aspartate),
AMPA (α-amino-3- hydroxyl-5-methyl-4-isoxazole-propionate),
kainate, and metabotropic glutamate receptors (mGLuR), (Beart
and O’Shea, 2007), initiating excitotoxic effects. The NMDA recep-
tor is permeable to Ca2+ and mGluR, causing release of Ca2+ from
endoplasmic reticulum (ER) stores via the IP3 (inositol triphos-
phate) pathways. Although the ER and mitochondria often act
as sinks for intracellular calcium, overloading leads to formation
of reactive oxygen species (via excessive nitric oxide production
increasing peroxynitrite levels) and activation of calcium depen-
dent proteins such as calpains and lipases; causing damage to cell
membranes. The increased influx of sodium (and chloride) ions
leads to passive influx of water into the cells causing a decline in
ADC (Apparent Diffusion Coefficient), resulting in DWI (Diffu-
sion Weighted Imaging) hyperintensities, following experimental
and human cerebral ischaemia (Schlaug et al., 1997; Lansberg
et al., 2001; Wegener et al., 2005). Gradually, several hours after
ischaemia, intravascular water shifts to the extracellular space
causing vasogenic oedema detected as T2 hyperintensities on MRI,
compromising perfusion, and increasing intra-cranial pressure
(ICP, von Kummer et al. (2015)).
Acute inflammation
As soon as oxidative stress occurs, reactive oxygen species (ROS)
activate the coagulation cascade (causing microvessel occlusions),
the proteolytic complement system (Napoli, 2001), and the release
of Interleukin-1α from the endothelium. Other pro-inflammatory
cytokines such as Nuclear Factor -κB (NF-κB), Interferon Regula-
tory Factor 1 (Irf-1), and Tumour Necrosis Factor-alpha (TNFα) are
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released by damaged cells (Iadecola and Anrather, 2011). Conse-
quently, endothlial expression of ICAM-1 (Intercellular Adhesion
Molecule-1), E-selectins, P-selectins, and Matrix metalloproteinase
(MMP) release, coupled with regulation of junctional proteins,
increase neutrophil and macrophage extravasation (Engelhardt
and Sorokin, 2009). Within the brain, microglia change their mor-
phology to active or phagocytic ameboid types within 4 hours
following ischaemia also contributing to the inflammatory process.
Splenomegaly is a well documented response to ischaemia with
increases in production of the aforementioned cytokines and C-C
motif ligands (such as CCL2, CCL3, and CXCL12) augmenting
the local immune response in the brain (Liu et al., 2015).
Peri-infarct depolarisations
Within the anoxic ischaemic core, neurones remain permanently
depolarised due to the loss of ATP and high extracellular con-
centrations of glutamate and potassium. Neurons within the
peri-infarct area have been shown to exhibit spontaneous depo-
larisations where a slow transient increase in extracellular K+ is
followed by rapid spike in concentrations, at a high energetic cost
(Nedergaard and Hansen, 1993; Fabricius et al., 2006). Mies and
Hossmann (1993) demonstrated that the frequency of peri-infarct
depolarisations in the rat correlated with an increase in infarct
volume of 13 mm3 per depolarisation.
Cell death
Both cell necrosis and apoptosis occur during ischaemic stroke.
The respective fates of cells depends on their location within
the ischaemic region. Cytotoxic oedema and plasma membrane
degradation cause cell necrosis, a concurrent release of calcium
from intracellular stores and an efflux of glutamate and intracel-
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lular debris into the extracellular space. Necrotic cell death con-
tributes to a positive feedback cycle of inflammation, cell damage,
and death (Martin et al., 1998). Histological hallmarks of necrosis
are cellular swelling, pyknosis, atypical organelle morphology,
lysis, and vacuolation of the neuropil. Within the peri-infarct
tissue, caspase dependent/independent apoptotic cell death dom-
inates, primarily due the reduced severity of the ischaemic insult
(Dirnagl et al., 1999). Mild ischaemic injury causes cytochrome-c
and caspase production from 6 hours post-insult and subsequent
cell death 24− 72 hours later (Endres et al., 1998). Apoptotic cells
are characterised by the condensation of chromatin and cellular
blebbing with maintained membrane integrity. The cell death
process and their removal by microglia and macrophages occur
within the first few hours following the ischaemic insult and
persist up to several weeks later.
1.1.4 Chronic ischaemic stroke pathophysiology
As well as focal damage at the site of compromised cerebral
perfusion, the ischaemic insult induces global changes in the brain
out-with the affected territory. The changes include diaschisis,
degradation of distal neural pathways (including the spinal cord),
and concurrent plastic compensatory changes (Figure 3).
Degeneration of neural pathways
Although ischaemic stroke affects a localised region of tissue
within a vascular territory, the neurons within that area which
synapse with others or - in the case of white matter tracts - transit
through to other regions of the brain, die or become functionally
compromised. Both the thalamus and substantia nigra have been
found to be atrophied several months post-stroke, with loss of
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Figure 3: Time-course of stroke induced damage from the initial insult to
several months later. Factors which contribute to the growth of the infarct are
in green; pathological events remote from the infarct are in blue, and plastic
responses in peach. Image adapted from Sist et al. (2012)
corticothalamic and thalamocortical pathways following MCA
occlusion (Fujie et al., 1990; Hara et al., 1993; Abe et al., 2003).
The ipsilesional thalamus has also been shown to have upregu-
lated NMDA, and downregulated GABA receptors, suggesting
a hyper-excitable state (Qu¨ et al., 1998). Beyond the thalamus,
post-stroke Wallerian degeneration of the cortical-spinal tract is
a well described phenomenon with damage to the sensorimotor
cortex inducing secondary damage to the corticospinal tract one-
month following injury (Weishaupt et al., 2010). Diffusion Tensor
Imaging (DTI) has shown a reduction in spinal cord fractional
anisotropy (FA) at 30 days post stroke which correlated with
deficits following motor assessments (Puig et al., 2010). Func-
tional unmasking describes the unveiling of pre-existing, latent
pathways has been found to occur within an hour post-stroke
(Sigler et al., 2009).
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Diaschisis
Diaschisis describes functional changes in areas of the brain re-
mote from the site of damage (Seitz et al., 1999). Derived from
the Greek roots of shocked throughout’, it is a symptom of the reac-
tion to the ischaemic insult. Acutely, oedema in large infarctions
causes swelling and compression of the contralateral hemisphere
including the compression of the vasculature (O’Brien et al., 1974;
Witte et al., 2000; Izumi et al., 2002), with compromised CBF
and metabolism (Lenzi et al., 1982; Celesia et al., 1984) as well
as impaired vascular reactivity to hypercapnia (Ka˚gstro¨m et al.,
1983; Dettmers et al., 1993). Electrophyisiological studies have
demonstrated that focal stroke caused impaired GABA transmis-
sion in the contralesional hemisphere and the peri-infarct region
(Buchkremer-Ratzmann and Witte, 1997) due to impaired transla-
tion (or post-translational modifications) of the GABAA receptor
(Neumann-Haefelin et al., 1999).
Plasticity and functional recovery
The mammalian cortex is a complex network of reciprocal com-
munications between functional areas. Although structural and
functional recovery in the injured brain is poor compared to other
organs, there is substantial evidence of an array of mechanisms
which aim to adapt to focal injury.
Focal damage to a region of the cortex has compounding effects
on the integration of the whole network. For example, lesioning
of the M1 motor cortex leads to a dissociation of M1 from the
whole somatosensory network, with impaired sensory and motor
function (Friel et al., 2005). And loss of areas adjacent to the
motor cortex causes deleterious changes in motor mapping (Ghar-
bawie et al., 2005). Although the brain is most often perceived as
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being organised into discrete functional areas, certain functions,
such as the memory engram, are believed to be widely diffuse
with multiple, adaptive pathways (Lashley, 1950; Bruce, 2001).
Diffuse connectivity has also been demonstrated between sensory
and motor areas of the cortex (Smits et al., 1991; Ferezou et al.,
2007) and may therefore contribute to post-stroke recovery via
functional unmasking.
plasticity in the peri-infarct region Early studies in the squir-
rel monkey demonstrated that partial destruction of the M1 region
causes remapping of digit representations in the surviving area
(Nudo et al., 1996). The same applied following deafferentation
subsequent to the removal of a digit (Merzenich et al., 1983). The
evidence from Nudo et al. suggested that the re-mapping process
is both an activity and competition based process. Soon after
stroke, the peri-infarct environment becomes a growth-promoting
region with increased expression in growth-associated genes such
as GAP-43, p21, and c-jun balanced by the expression of growth-
inhibing brevican (Carmichael et al., 2005). Stroemer et al. (1995)
showed that GAP-43 (an axonal protein found in growth cones,
indicative of sprouting) levels were increased in peri-infarct re-
gion up to 14 days post-cortical infarction. Synaptophysin (a
presynaptic terminal vesicle marker of synaptogenesis) expres-
sion increased 14− 60 days post-stroke in the peri-infarct and
contralesional cortex suggesting that synaptogenesis is part of
the long-term recovery mechanism. VEGF (Vascular Endothe-
lial Growth Factor), which has pro-angiogenic and neurotrophic
properties, has been found to be upregulated in the peri-infarct
region (Stowe et al., 2007). Neuroanatomical and in vivo optical
studies have demonstrated that excitatory dendritic spines are
capable of remodelling following brief periods of ischaemia, with
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a cessation of blebbing and re-extension of previously retracted
spines (Li and Murphy, 2008). In the long-term, dendritic spines
have increased turnover rates (Brown and Murphy, 2008) and
spine density is greater in regions far from the infarct due to the
increased level of perfusion as distance from the infarct increases
(Mostany et al., 2010).
The peri-infarct region has also been shown to exhibit a higher
baseline firing rate (Schiene et al., 1996) and increased incidence
of long-term potentiation (LTP) 7 days post-lesioning (Hagemann
et al., 1998). It’s likely that the degree of plastic recovery is de-
pendent on the balance between growth-promoting and growth-
inhibiting factors in association with the aforementioned competi-
tion, and the distance away from the ischaemic infarct.
outwith the peri-infarct region Post-stroke plastic mecha-
nisms are not confined to the peri-infarct region. Improved re-
covery from stroke-induced aphasia is associated with increased
activation in the contralateral Broca’s area (Thulborn et al., 1999).
However there is a balance between increased compensatory ac-
tivity of the contralateral hemisphere with activity in adjacent
regions of the ipsilesional hemisphere. Calautti et al. (2010) and
Ward et al. (2003b) found that BOLD signal activity confined to
the damaged hemisphere predicted a greater degree of recovery
compared to increased activity in the contralateral cortex, partic-
ularly so in the case of large infarctions. In the rat contralateral
M1 region, Hsu and Jones (2006) found increased MAP-2 and
NMDA receptor subunit one expression 24 days after lesioning of
the sensorimotor cortex. The density of both MAP-2 and NMDA
subunits was also associated with an improved performance in
the pellet reaching task, dependent on stroke volume. This sug-
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gested that lesion dependent compensatory mechanisms were
occuring in the contralateral hemisphere. Stroke volume depen-
dent effects on resting-state and stimulus-driven fMRI responses
in the rat have also been illustrated by vanMeer et al. (2010) &
Weber et al. (2006), (see Chapter 5 for more details). It’s therefore
logical to conclude that in the case of large infarcts, tissue of sim-
ilar function to that lost, i.e. if the whole vascular territory was
destroyed, would be found in regions with a different vascular
supply. This is in comparison to smaller infarcts where surviv-
ing peri-lesional tissue may have had a pre-existing functional
relationship to the tissue lost. Although recovery mechanisms
may restore behaviour to pre-stroke levels it’s unlikely that the
functionality is identical due to the loss of highly specific neurons,
depending on the region damaged. It is also important to note
that post-stroke recovery takes much longer in humans compared
to animals (Murphy et al., 2009).
1.1.5 Current clinical interventions
The symptoms of stroke can occur suddenly and include hemi-
paresis/hemiplegia, hemianopsia, and aphasia. Public campaigns
such as the ‘Act F.A.S.T’ by the NHS http://www.nhs.uk/actfast/
Pages/stroke.aspx are aimed to reduce the time taken for pa-
tients to reach hospital. Diagnosis of stroke is typically assisted by
non-contrast CT (Computer Tomography) or Diffusion-weighted
MRI. If ischaemic stroke is confirmed then patients are assessed
for blood vessel recanalisation via pharmaceutical thrombolysis or
thrombectomy. tPA (tissue-Plasminogen Activator) is a protease
which activates endogenous fibrinolytic plasmin. It is currently
recommended for use up to 4.5 hours from symptom onset (Saver
et al., 2009). The beneficial administration of tPA beyond 4 hours
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has been found to be negligible (Whiteley et al., 2016).
Thrombectomy is the mechanical removal of a thrombus via
an intravascular device to restore blood flow. If the throm-
bus can be identified by either CT or MRI angiography, then
the thrombus can be removed via an intravascular device as
per the recommendations in NICE guideline IPG548, https:
//www.nice.org.uk/guidance/ipg548 and (Goyal et al., 2016).
There is also substantial evidence to show that patient survival,
independence, and functionality are improved if the patient is
treated within a specialist acute stroke unit (Reviews, 2013).
Aside from thrombolysis or thrombectomy, another clinical treat-
ment for large strokes is decompressive hemicraniectomy to allow
for the herniation of the brain out of the skull, to avoid compres-
sion of healthy tissue (Lu et al., 2014). Methods of preventing re-
occurence include aspirin administration, control of hypertension,
high circulating cholesterol, and diabetes management where pos-
sible (Amarenco et al., 2004; Lawes et al., 2004; Ridker et al., 2005).
The functional deficits caused by stroke often improve and then
stabilise (Jørgensen et al., 1995). Physiotherapy and speech &
language therapy are often given with an aim to rehabilitate
post-stroke. Methods such as constraint-induced movement ther-
apy and electromyography biofeedback have shown some im-
provements when assessed systematically (Langhorne et al., 2009;
Corbetta et al., 2010; Langhorne et al., 2011; Pollock et al., 2014).
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1.1.6 Animal models of ischaemic stroke
Animal models are an invaluable resource for investigating the
organ-wide and systemic effects of a pathology and/or therapeu-
tic. In the case of stroke, they are essential for understanding the
structural and functional changes which occur following focal
injury. The middle cerebral artery (MCA) is the most commonly
occluded vessel in humans (Heiss, 2016), and this is reflected in
the in vivo models.
Rodent models of MCAO
Mice and rats are the most popular choice of species for pre-
clinical stroke research due to lower relative costs, similar cere-
brovasculature to man, the availability of co-morbid/genetically
modified models, well understood physiology, and greater ethi-
cal acceptance compared to non-human primates (Macrae, 2011).
Middle cerebral artery occlusion (MCAO) can be carried out by a
range of mechanical or pharmaceutical methods.
The most popular method of MCAO is the intraluminal filament
(ILF) method of mechanical occlusion (Koizumi et al., 1986a;
Longa et al., 1989). Typically, the common carotid artery and
its bifurcation is exposed and a nylon suture with a bulb at the
proximal end inserted through the internal carotid artery into
the Circle of Willis to the origin of the MCA. Occlusion can be
permanent or transient with its withdrawal after a prescribed
period of time simulating reperfusion. The ischaemic damage
caused is primarily in the striatum and often the sensorimotor
cortex (Figure 4). The method is popular due to the short proce-
dural duration allowing for high throughput, and the absence of
a need to perform a craniectomy. Occlusion can be confirmed by
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Laser Doppler Flowmetry with reasonable success however the
method still carries a large variance in infarct volume as well as
a risk of vessel rupture and intracerebral haemorrhage (Schmid-
Elsaesser et al., 1998). Oedematous swelling can cause death
within 48 hours in large infarcts due to compression of the bulbar
structures within the intact skull. In hypertensive rats, MCAO
methods ethods which involve craniectomy lead lower mortality
rates as the brain has space to expand, lowering intracranial pres-
sure (Ord et al., 2012).
Other mechanical methods of MCAO include permanent occlu-
sion of the MCA at proximal or distal locations via electrocoagu-
lation (Tamura et al., 1981), or injection of an autologous blood
clot (Kaneko et al., 1985). Electrocoagulation methods are more
favourable for controlling infarct volume (by determination of
which area of the MCA to occlude) and generation of favourable
amounts of penumbra (Macrae, 2011), but require greater surgical
skill and time.
Examples of pharmaceutical methods of MCAO are topical appli-
cation of endothelin onto the MCA (Macrae et al., 1993), stereo-
taxic injection of endothelin into the brain parnechyma (Sharkey
et al., 1993), intraluminal injection of thrombin (Orset et al., 2007),
and photochemical generation of free radicals (and thus clot gen-
eration) via photo-excitation of Rose Bengal (Watson et al., 1985).
The methods described above are an example of the wide array of
models available depending on the nature of the scientific ques-
tion poised. Disadvantages of rodent models include the lack of
white matter, the limited cognitive behaviours compared to hu-
mans, and the lissencephalic nature of their brains in comparison
to other mammals, including primates.
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Figure 4: The extent of ischaemic damage in the striatum and the cortex and
oedematous swelling of the infarcted hemisphere 48 hours following occlusion
of the MCA via the intraluminal filament method. Brain tissue has been
stained with TTC (2, 3, 5-triphenyltetrazolium chloride) which is
dehydrogenated to red formazan in living mitochondria. Dehydrogenation is
unable to occur in dead, infarcted tissue and as such, does not stain. Image
adapted from Farr and Trueman (2011).
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Non-human primates & other species
Non-human primates (NHPs) are phylogenetic cousins of humans.
Commonalities within the brain include similar vascular anatomy
(Fukuda and del Zoppo, 2003), greater white to grey matter ratio
compared to rodents, a gyrencephalic cortex, and similar network
structures. MCAO techniques have been applied to the marmoset
(Freret et al., 2008) and baboon (Branston et al., 1974) as well
as sheep (Wells et al., 2012), pigs (Sakoh et al., 2000), and cats
(Feustel et al., 1981). However, the use of larger animals has
greater housing and care costs. In particular, NHPs and cats
attract a greater degree of public ethical criticism. These issues
limit the volume of research in higher animals despite calls for
greater use of these species to improve translation of pre-clinical
therapeutic research to the clinic. There are still however caveats,
for example the failure of the free-radial trapping agent NXY-059
to show clinical efficacy despite pre-clinical trials in primates as
well as rodents (Shuaib et al., 2007).
1.1.7 Assessment of post-stroke disability in humans
Unilateral ischaemic stroke induces neurological deficits on the
contralateral side to damage. Ischaemic damage to the MCA
territory of the brain can present clinically as limb and/or facial
hemiparesis or hemiplegia, ataxia, aphasia, spatial neglect and
sensory loss (Symposium, 2016) with the majority of these symp-
toms successfully reproduced in rodent and primate models of
ischaemic stroke (Ginsberg, 1996).
Patient recovery, after surviving the initial insult, is a compli-
cated, non-linear process carried out by a variety of mechanisms
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including compensation to the disability and substitution via reor-
ganisation of surviving networks which requires patient-specific
rehabilitation programmes (Langhorne et al., 2011). One tech-
nique used to rehabilitate upper limb hemiparesis is Constraint
Induced Movement Therapy (CIMT, Grotta et al. (2004)), where
the ipsilesional, healthy forelimb is restrained to force use of the
hemiparetic limb. The EXCITE trial (Wolf et al., 2010) demon-
strated equal improvement in arm motor function when treated 3-
9 and 15-21 months post-stroke, with greater rate of improvement
in the former treatment group. However, systematic analyses
suggest that the reported benefits of such treatment is subject to
small-study bias (Corbetta et al., 2010).
Contralateral control of the body is also complemented by ipsi-
lateral pathways (Brus-Ramer et al., 2009). Some of the functions
lost can be spontaneously restored via compensation by related re-
gions of the affected network including the opposite hemisphere
(Biernaskie et al., 2005). However, this compensation by the oppo-
site hemisphere has been found to reduce the degree of activation
within surviving areas of the network which in turn is attributable
to poorer functional outcomes (Ward et al., 2003a).
Assessments of human disability
Various clinical measures exist to assess stroke-induced neuro-
logical deficits as well as the extent of the subsequent impair-
ment. The National Institutes of Health Stroke Scale (NIHSS,
http://www.nihstrokescale.org/) is a quantitative evaluation
of stroke-induced neurological deficit (Brott et al., 1989), which
has also been shown to be a good predictor of long and short-
term outcomes (Adams et al., 1999). The Barthel Index (BI), from
Mahoney and Barthel (1965), evaluates the degree of dependence
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a patient requires during day-to-day living for example clean-
ing, dressing, and climbing stairs. Such tests can be used as a
means of assessing the efficacy of rehabilitative treatments. The
Fugl-Meyer test (Fugl-Meyer et al., 1975) is a performance based
assessment of impairment evaluating motor function, balance,
joint mobility, and sensory function. Although comprehensive,
the test is lengthy, taking approximately 30 minutes.
The Action Research Arm Test (ARAT, Yozbatiran et al. (2008))
assesses a patient’s post-stroke hemiplegic limb function via their
ability to move their arm and grasp, grip, and pinch various
objects; providing an evaluation of their arm specific limitations
on daily activity. A two point improvement in ARAT test score
(moving a 25mm3 block) is currently being used as the primary
outcome measure in the PISCES-II trial (NCT02117635).
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1.2 stem cells
1.2.1 Stem cell biology
Mammalian stem cells are classified by: a lack of specialisation,
the ability to undergo mitotic division, and to differentiate into
other cell types (Gage, 2000). The diversity of daughter cells to
which they can differentiate depends on their position within a
well established hierarchy. This hierarchy and concordant nomen-
clature is shown in Figure 5.
A zygote is the only totipotent mammalian cell type, with the abil-
ity to differentiate into any other cell type following implantation
into the wall of a uterus. Upon development into a blastocyst, em-
bryonic stem cells have the capability to form an entire organism,
with the exception of the trophoblast cells of the placenta. As the
development process continues, cell types become restricted to
only those within a specific organ or tissue type, and following
further signalling inputs and developments, specialised adult
cells are generated. Within a mature organism, adult stem cells
persist for the repair and/or renewal of almost all adult tissues
with some restrictions. Recent technological advances have al-
lowed for adult fibroblasts to be de-differentiated into pluripotent
cells via the introduction of four ‘reprogramming’ genes: Oct4,
Soc2, c-myc, Klf-4 (Takahashi et al., 2007).
Following the identification, characterisation, and induction of
various stem cell sources, investigations have led towards assess-
ments of their therapeutic role in transplantation (from exogenous
or autologous sources) in the treatment of disease.
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1.2.2 Neural stem cells
Until relatively recently it was believed that the adult brain is
incapable of mitotic division. Indeed, the adult brain has a very
limited capability to repair following injury in comparison to the
dermis or the gastrointestinal tract. However, there exist two
niches within which neural progenitor cells (NPCs) reside: the
subventricular zone (SVZ), adjacent to the ependymal layer of the
lateral ventricles (Johansson et al., 1999), and the smaller subgran-
ular zone (SGZ) within the dentate gyrus of the hippocampus
(Altman and Das, 1965; Eriksson et al., 1998). Several studies
have also identified self renewing Glial Flibrillary Acidic Protein
(GFAP) positive cells in vitro and in vivo (Laywell et al., 1999;
Imura and Kornblum, 2003; Garcia et al., 2004). Subsequently, the
purpose and role of neural stem cells within the forebrain have
been investigated.
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Figure 5: Illustration of neural stem cell lineage beginning from the totipotent
zygote and the various stages of further specialisation with limitations to their
subsequent fate. Small arrows in reverse direction infer the de-differentiation
of cells to their parent type. Image adapted from Gage (2000).
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Fates of Subventricular and Subgranular NPCs
Neural precursor cells are subject to a huge variety of signalling
inputs during their growth, development, and integration to the
adult nervous system (Abrous et al., 2005). Developing cells
within the SGZ migrate only a short distance to the granular
cell layer above, forming glutamatergic synapses and projecting
axonal processes out to the CA3 neurons (Liu et al., 2003). SVZ
precursors have been identified in rodents, non-human primates,
and humans. In rodents these cells migrate towards the olfactory
bulb alongside blood vessels via a chemorepulsion mechanism
through what is known as the Rostral Migratory Stream (Lois
and Alvarez-Buylla (1994), Figure 6). Once at the olfactory bulb,
rodent SVZ precursors mostly differentiate into GABAergic gran-
ule cells, and integrate into the olfactory bulb circuitry (Belluzzi
et al., 2003). There is some evidence for the presence of neural
stem cells and a rostral migratory stream in non-human primates
(Kornack and Rakic, 2001) and also the human brain (Curtis et al.,
2007). However the studies in the latter remain controversial
(Sanai et al., 2007). Human studies have found that the number of
proliferative cells in the SVZ declines with age (Sanai et al., 2011),
and do not integrate into the human olfactory bulb (Bergmann
et al., 2012), but are found in the striatal areas adjacent to the SVZ
(Ernst et al., 2014). There is also some evidence for neurogenesis
in the cortex (Gould et al., 2001).
The biological requirement for neurogenesis in both the olfactory
bulb and the dentate gyrus is speculative. Suggestions include the
requirement for mammals to detect and process novel olfactory
stimuli and the consolidation of learning, and memory, respec-
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tively (Liu et al., 2003; Lazarini and Lledo, 2011).
Following brain injury, SVZ progenitor cells have been found to
proliferate and migrate ectopically in response to chemoattrac-
tants such as Reelin (Hack et al., 2002; Parent, 2003). In the case of
ischaemic stroke, neurogenesis has been found to increase in the
SVZ ipsilateral to the site of injury (Parent et al., 2002; Arvidsson
et al., 2002) and differentiate into cells initially positive for dou-
blecortin (an immature neural maker). These ectopic cells have
been found to migrate in chains, similar to the RMS, along blood
vessels (Thored et al., 2007). There is also some evidence that this
also occurs in human stroke with Ki-67 (proliferative marker) and
doublecortin positive cells identified (Jin et al., 2006).
Figure 6: Illustration of the Rostral Migratory Stream (RMS, green) in the
rodent brain. Normally, neuroblasts migrate along the RMS to the olfactory
bulb (OB). In reaction to brain injury, these neuroblasts have been reported to
migrate ectopically to the site of injury. Lesion (L), Cortex (Cx), Corpus
callosum (CC), Ventricle (V). Image adapted from Saha et al. (2012).
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1.2.3 The Therapeutic Potential of NPCs
With our limited capacity to treat neurodegenerative disease or to
restore function after focal ischaemic damage with conventional
pharmaceutical approaches, focus has turned to the potential role
of stem cells due to their capacity to differentiate into the various
cell types of the CNS. Current hypotheses define that stem cell
treatments for CNS would either strive to re-establish connectivity
via the replacement of damaged neurons, stimulating angiogen-
esis, or to provide additional trophic support for endogenous
recovery mechanisms (Kornblum, 2007).
Stem cells as a novel treatment for ischaemic stroke
Stem cells offer an alternative potential opportunity to regain
lost functionality (Lindvall and Kokaia, 2011; Sinden et al., 2012).
The post-stroke brain is by no means a static environment and
the pathological processes (described earlier) vary greatly from
the moment of insult to the subsequent weeks and months As
such, the optimal timing and dose to administer a stem cell ther-
apeutic remains unknown. Previous clinical trials have focused
on the use of autologous blood sourced mesenchymal stem cells
(MSCs), which differentiate into neurons and glia, delivered intra-
vascularly in the acute or sub-acute stages (Uccelli et al., 2008;
Lee et al., 2010; Honmou et al., 2011). However, there is some
controversy with this method as Detante et al. (2009) showed that
technecium labelled human MSCs did not cross into the brain
one week after MCAO.
Other investigations have focused on the chronic post-stroke pe-
riod (da Fonseca et al., 2010; Bhasin et al., 2011). At this stage,
the majority of dead tissue has been removed with the infarct
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replaced by a CSF filled cyst, inflammation is reduced, and sur-
viving tissue plasticity mechanisms are under way. Implantation
of stem cells at this stage may therefore enhance the plastic com-
pensatory approaches. Using neural stem cells (which have a
more direct lineage to CNS cells compared to MSCs) seems a
rational choice. However, this provides unique challenges in the
sourcing and administration of such cells whereas autologous
mesenchymal stem cells are far easier to isolate. Despite these
challenges, both neural and mesenchymal stem cells are currently
in clinical trials.
Steinberg et al. (2016) recently published the results of a Phase
1/2a clinical trial of allogenic bone marrow mesenchymal stem
cells transfected with a Notch1 intracellular domain, which has a
role in stem cell differentiation into neurons and glia (Lundkvist
and Lendahl, 2001; Dezawa et al., 2004). The study demonstrated
that intracerebral implantation of the cell line into the peri-infarct
area, on average 22 months post stroke, lead to a mean decrease in
NIHSS scores of 2 and a mean increase in the Fugl-Meyer motor
function of 11.4% with no serious adverse effects of transplan-
tation. However caution in interpretation is advised due to the
uncontrolled study design which was also not powered to detect
improvements in clinical scores.
1.2.4 The neural stem cell line CTX0E03
The CTX0E03 cell line is a neural stem cell line currently under
clinical investigation as a treatment to improve functional disabil-
ity in the chronic post-stroke phase (See Chapter 5). CTX0E03
(CTX) cells are a conditionally immortalised human neural stem
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cell line manufactured in an automated environment to a clinical
grade by ReNeuron Ltd.
Cell line generation and immortalisation
The CTX cell line was derived from cortical tissue of a single first
trimester foetus (Bioscience Resources, USA) in compliance with
ethical and legal guidelines (Pollock et al., 2006).
The function of a protein of choice can be controlled by its fusion
to the hormone binding domain of a steroid hormone receptor
(Picard, 1993). The oestrogen receptor (ER) is a steroid hormone
of high interest for control of expression due to the relative ease in
obtaining its ligand, 17β-estradiol, and the absence of endogenous
ER in many tissues (Littlewood et al., 1995). However, due to the
presence of oestrogen in many culture serums and the weak ago-
nism of media component phenol red (Berthois et al., 1986), the
ER, in its unadulterated form, is undesirable. A mutant murine
ER (E525R) has no binding specificity with 17β-estradiol but has
partial agonist activity with the anti-oestrogen drug metabolite,
4-hydroxytamoxifen (4OHT) (Danielian et al., 1993). The E525R
mutant ERs expression is strictly dependent on the presence of
4OHT (Littlewood et al., 1995) and as such makes an ideal target
for controlling protein function.
Conditional immortalisation was achieved via controlled expres-
sion of the c-myc protein. As an oncogene, c-myc is involved
in cellular proliferation and apoptosis (Cerni, 2000). With con-
cerns that the long-term maintenance of embryonic and primary
stem cell lines can lead to genetic instability and tumourgenicity,
a c-mycERTAM transgene was transfected via a retroviral vector.
Clonal division of the neural stem cells was therefore permitted
1.2 stem cells 29
in the presence of 4-hydroxytamoxifen in culture until a time of
requirement whereby a 4-OHT free media can be used to silence
the transgene and initiate differentiation (Stevanato et al. (2009),
Figure 7). The integration site of the c-mycERTAM transgene at a
non-coding region of Chromosome 13, ensured the stability of
the cell line up to 45 passages with a stable karyotype.
Figure 7: Diagram illustrating the dependence of CTX cell mitotic division
with the conditional expression of c-Myc on agonism of the E525R receptor by
4-hydroxytamoxifen. Top, agonism of the E525R receptor with
4-hydroxytamoxifen in culture media permits clonal division of the CTX cells.
Bottom, the absence of 4-hydroxytamoxifen from culture media induces
differentiation and maturation of CTX cells.
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CTX0E03 cell line characteristics in vitro and in vivo
Characterisation studies in vitro have found that CTX cells have
the following phenotypes as described in Pollock et al. (2006) and
Hicks et al. (2013). The human cells were identified in the post-
stroke rodent brain by staining for the Human nuclear antigen
(HuNuc, Figure 8).
i Neuron and astrocytic cell types. Following the removal of 4-
OHT from the cell culture media the cells ceased clonal di-
vision and underwent differentiation to β-III tubilin, Olig-2
(oligodendrocyte), and GFAP (Glial Fibrillary Associated Pro-
tein, astrocyte) positive cells, (Figure 9).
ii Pro-Angiogenic CTX cells have been found to highly express
VEGFA (Vascular endothelial growth factor A), EGF (Epider-
mal Growth Factor), TGFβ1 (Tumour Growth Factor Beta-1),
HIF-1α (Hypoxia Inducible Factor 1-alpha), and other pro-
angiogenic growth factors. CTX-cells showed co-staining in
co-culture with HUVEC (Human Umbilical Vein Endothelial)
cells and association with smooth muscle actin in vivo (Figure
10), suggesting that CTX cells may play a role in angiogeneis
via direct interaction with vascular cells or via the release of
pro-angiogenic factors.
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Figure 8: Confocal micrograph of HuNuc positive cells (green) in the
ipsilateral striatum 5 weeks post-transplant. Image adapted from Pollock et al.
(2006), scale bar not provided in publication.
Figure 9: In vitro immunocytochemistry of CTX0E03 cell neural and astrocyte
differentiation. Left: CTX-cells in culture in growth media with 4-OHT. Right:
CTX-cells 7 days after removal of growth factors and 4-OHT. Stains: Hoesht
nuclear (blue), βIII-tubulin (green), and GFAP (red). Image adapted from
Pollock et al. (2006).
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Figure 10: In vitro and in vivo immunocytochemistry of angiogenic properties
of CTX0E03 cells. Left: HUVEC - CTX cell co-culture with HUVEC;
von-Willebrand factor (purple); CTX cell human specific nestin (green). Right:
CTX0E03 cells (red) in proximity to smooth muscle actin (green) highlited by
white boxes. Images adapted from Hicks et al. (2013).
CTX0E03 effects and the post stroke brain
All published studies which have investigated the effect of CTX-
cells in the post-stroke brain have done so with implantation at
4 weeks following focal cerebral ischaemia in Sprague Dawley
rats (Pollock et al., 2006; Stroemer et al., 2009; Smith et al., 2012).
Improvements in sensorimotor function of treatment groups have
been assessed via the Bilateral Asymmetry (details in Chapter 3),
and Rotameter tests.
The cell line has been shown to be safe in rodents up to 3 months
post-transplantation; exhibiting positive dose-dependent efficacy
up to doses of 450000 cells when implanted into the peri-lesional
caudate nucleus (Stroemer et al., 2009).
CTX cell transplants increased the number of von Willebrand
Factor positive cells at the peri-lesional implantation site at seven
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days (Figure 10, Hicks et al. (2013)) and three months post-
implantation (Stroemer et al., 2009). In vivo, CTX cells have
been shown to differentiate into CD62 (endothelial marker) and
Olig-2 positive cells (Figure 11); and caused up-regulation of en-
dogenous & MAP-2 (Microtubule associatated protein), a mature
neural marker (Stroemer et al., 2009).
The PISCES Clinical Trials
CTX cells are currently in a Phase II clinical trial (PISCES-II,
NCT02117635) to determine whether an intracerebral dose of
20 million cells into the ipsilesional hemisphere recovers loss of
function of the paretic arm 4 weeks following ischaemic stroke.
The Phase I PISCES trial demonstrated no serious effects of CTX-
cell transplantation (more details in Chapter 5).
Figure 11: Confocal images of immunocytochemistry staining of 3 month
post-MCAO rat brain sections. Left: CTX cell (HuNuc, green) co-staining with
endothelial CD31 (red) cells showing as yellow. Right: CTX cell (HuNuc,
green) co-staining with Olig-2 (red) cells, showing as yellow. Images adapted
from Stroemer et al. (2009)
.
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1.3 magnetic resonance imaging
1.3.1 Magnetic resonance theory
Nuclear Magnetic Resonance (NMR) is the phenomenon whereby
nuclei (that possess spin) align with an external magnetic field,
and precess, creating a net magnetisation (M0). The precessional
frequency (ω) of a nucleus within an external magnetic field (of
strength B0) is given in Equation 1, determined by a nucleus
dependent constant known as the gyromagnetic ratio, γ.
ω = γB0 (1)
Protons excited by a radio-frequency (RF), or excitation pulse, of
matching Larmor frequency i.e. on resonance frequency, tilts the
net magnetization from along the B0 axis (or z-axis) into the xy-
plane, by inducing phase coherence among the nuclei. The time
constants of the recovery back to equilibrium are known as T1
and T2 relaxation times respectively. T1 is spin-lattice relaxation
time, and T2 is spin-spin relaxation time. T2 is dependent on
the interactions between spins. The measured signal decays
over time due to the dephasing of the spins, caused by the local
interactions of the spins as well as inhomogeneities in the external
magnetic field. This decay is known as Free Induction Decay
(FID). The rate of FID is given by T2∗ which is always less than T2.
Images acquired with T2∗ weighting are more likely to include
susceptibility artefacts. They typically occur where there are
caused ferrous depositions such as haemorrhages and air in the
sinuses and ear canals.
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Repetition time (TR) & Echo Time (TE)
The repetition time (TR) is the time interval between excitation
pulses and will dictate the magnitude of the received signal and
affect image contrast. Longitudinal magnetisation (Mz) at time
TR compared to the original magnetisation (M0) is determined
by their respective T1 values (Equation: 2)
Mz = M0(1− e
−TR
T1 ) (2)
The rate of decay of the T2∗ signal is described in Equation 3.
It can be seen that the time at which the signal is measured i.e.
Echo Time (TE), will affect image contrast due to the T2 values of
different tissues.
e
−TE
T2
∗ (3)
Tissue composition, the determination of T1 and T2
Different tissues have different chemical compositions and struc-
tural components. As such, the behaviour of proton spins within
each of these varies.
Fat protons are within large triglyceride structures surrounded
by electroneutral carbon atoms compared to the more exposed
protons of water molecules. As such, fat protons resonate at a
lower frequency, realigning with B0 faster, leading to lower T1.
Water has a long T2 due to the rapid rotation of the molecules
across a wide range of frequencies whereas protons in solid struc-
tures such as muscle or bone have more restricted rotations and
as such, shorter T2 values.
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Different tissues have differing T1 recovery, and T2 or T2∗ decay
times, and as such, the overall signal measured is a result of the
density of protons in the sample. By varying the TR and TE,
images with differing tissue contrast can be made. For example,
by applying short TRs and short TEs, the T2 relaxation effects
are minimised and therefore allows for differentiation of struc-
tures based on their T1 values. Longer TEs and TRs reduce T1
relaxation effects and allow for T2 or T∗2 contrast. F
1.3.2 Application of MR theory to imaging
Application of magnetic field gradients (thus differing the Larmor
frequencies of the protons within an object) allows for spatial
localisation. MRI was developed by Lauterbur, who named it
zeugmatography. Further technological advances eventually led
to the development of modern-day Magnetic Resonance Imaging
(MRI).
MRI is based on the application of magnetic field gradients across
a subject placed within the static field (therefore with differing
Larmor frequencies across the subject) to derive the spatial infor-
mation of the received signal. There are usually three primary
gradients, applied in three orthogonal dimensions:
slice-select gradient (z axis): By transmitting RF pulses of
bandwidths with a centre frequency matching the Larmor fre-
quency, spins are excited only within this region; determining the
slice position. The slice thickness is determined by the bandwidth
of the RF pulse and the strength of the slice selection gradient.
The remaining two gradients determine the spatial localisation
within the slice.
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frequency-encoding gradient (x axis): During detection of
the echo, following excitation, applying a gradient along the x-
axis, protons will precess at different frequencies. As such, the
rate of change of phase is proportional to the position along the
x-axis.
phase-encoding gradient (y axis): The gradient applied for a
short time along this axis between pulse and acquisition causes
the transverse magnetisation to precess at different rates. Once
turned off, the spins precess at the same rate, but with phase-
offset proportional to their position along the y-axis.
The field of view (FOV) of an image is the spatial extent over
which MR data are collected. The data within the FOV are di-
vided into elements known as voxels. The size of the FOV and
the voxels determines the image resolution.
The raw data acquired are digitally converted measurements for
an echo from a given volume or slice. The raw data are stored as
an array of complex numbers along the readout direction. Raw
data matrices are generated with each row corresponding to the
value of the phase-encoding gradient the was applied. Each point,
the echo signal amplitude, can therefore be described as kx, ky for
the time that the respective gradient is active. This is known as
k-space, measured in s−1. The central part of the matrix contains
data acquired at low amplitude phase-encoding gradients and
are mostly responsible for image contrast. The outer areas of the
matrix are data acquired at high or low amplitude gradients and
so generate high frequencies (see Equation 1), providing edge
definition. To generate the image matrix, the complex data are
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Fourier-transformed in both dimensions.
The Signal-to-noise ratio (SNR) of MRI data is determined by
several variables including: hardware properties, proton density,
voxel volume, receiver bandwidth, T1, T2, flip angle, TE, TR to
name a few. Optimisation of these variables will improve SNR,
and thus image quality.
Pulse sequences describe the manner in which RF pulses and
gradients are applied which in turn determines the signal mea-
sured and the resultant images. Diverse sequences have been
developed which permit investigations into various macro and
micro-structural properties of tissues but also the metabolic and
functional behaviours within all organs including the brain.
spin-echo sequences A Spin-Echo (SE) sequence applies a 90◦
excitation pulse, flipping the magnetisation vector into the or-
thogonal plane. Due to the T2∗ effect, spins begin to dephase.
Application of a 180◦ pulse will cause the spins the precess in the
opposite direction, and to become in phase again. Spin re-phasing
eliminates B0 effects resulting in a T2 weighted echo (Hahn, 1950).
The TR and TE of the spin echo sequence will determine the
contrast of the image as described above.
gradient-echo sequences Gradient echo/Gradient recalled
echo (GRE) sequences were developed to decrease scan time.
A short TR and small flip angle (less than 90◦) are used with an
echo generated via gradient reversal. The TE used and thuse
the resultant signal will determine the amount of T2∗ weighting.
However because of this, GRE images are confounded by a lower
SNR compared to SE sequences with similar parameters.
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echo-planar imaging Echo-planar imaging (EPI) sequences
are very rapid acquisitions whereby k-space is filled following a
single RF pulse by rapid switching of the frequency and phase-
encoding gradients. Multi-shot EPI uses multiple excitations to
fill k-space, increasing acquisition time but reducing susceptibility
artefacts. EPI image contrast is determined by the TE when the
phase encoding gradient is zero.
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1.4 the bold signal
Although now one of the staple methods to investigate brain
function during activation and rest, the Blood Oxygenation Level
Dependent (BOLD) signal is a reflection of a complex integration
of cerebral blood flow, blood volume, and metabolic events in
response to neuronal activation. Since the first identification of
the BOLD signal 26 years ago (Ogawa, Lee, Nayak and Glynn,
1990), functional imaging studies have dominated the neuro-
science and psychology literature. BOLD data are often presented
as ‘activated’ voxels overlaid on anatomical maps to reflect spatio-
temporal signal changes of statistical significance.
1.4.1 Flow-metabolism coupling
The mammalian brain is highly metabolically active, consum-
ing 20% of the body’s energy at rest (Mangia et al., 2008). The
majority of ATP use is devoted to glutamate cycling and maintain-
ing the cellular ionic gradients required for signal propagation
and synaptic transmission. Functional hyperaemia is the phe-
nomenon of the increase in blood flow in response to neuronal
activation. The mechanisms by which functional hyperaemia is
induced are multifaceted, further complicated by the varying dis-
tributions of energy consumption throughout different regions of
the brain. Energy use within the cerebral cortex is distributed be-
tween synaptic transmission, housekeeping (non-signalling tasks),
action potentials, and maintaining resting potentials estimated
at 44, 25, 16, and 15 percent respectively (Howarth et al., 2012).
Flow-metabolism coupling evolved to ensure active neurons and
glia receive adequate blood supply to maintain normal function.
We are now aware of a multitude of molecular signals which
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work in concert to direct flow at the macro- and microscopic level
to ensure that active regions are supplied with sufficient oxygen
and glucose to function. These include glutamate, lactate, oxygen,
arachdonic acid metabolites, and adenosine (Attwell et al., 2010).
As a result, we are also beginning to unpick potential mechanisms
by which flow-metabolism coupling dysfunction may occur, con-
tributing to disease onset or pathology.
Prior to the early 1980s, it was conventionally believed that the
blood flow response to neural activity was driven by metabolic
demand in a linear fashion (Roy and Sherrington, 1890). However,
measurements of cerebral blood flow (CBF), and oxygen extrac-
tion fraction (OEF) via Positron Emission Tomography (PET)
imaging, using 15O labelled water and molecular oxygen respec-
tively, showed that the blood flow response to somatosensory
stimulation exceeded metabolic rate by nearly 6-fold (Fox and
Raichle, 1986). Although initially controversial, see Fox (2012), the
term functional hyperaemia was termed to describe how activity at
the cellular level within the brain is coupled with disproportion-
ate increase in local blood flow.
The brain has a relatively constant oxygen extraction fraction
(OEF) of 40% from the blood at rest (Gusnard and Raichle, 2001).
During activation however, feed-forward mechanisms increase
CBF to anticipate the increased demand for oxygen and glucose.
For example, stimulation of the human V1 area resulted in a 15%
increase in energy demand with a 60% increase in CBF (Lin et al.,
2010). Consequently, functional hyperaemia causes a reduction in
the OEF; the fundamental basis of the BOLD signal. For increasing
metabolic demand, the oxygen gradient between blood and the
tissues must be increased either by increasing capillary pO2 or
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decreasing mitochrondial pO2. Therefore CBF is a determinant of
tissue oxygen tension. However, even at a microscopic level, the
interstitial pO2 is not uniform (Leithner and Royl, 2014) and many
models fail to consider the impact this has on local OEF and flow
responses during activation. Hypotheses, such as the capillary
transit time heterogeneity (CTH) hypothesis (Rasmussen et al.,
2014) aim to provide a conceptual expansion of existing models.
1.4.2 Functional hyperaemia & Identification of the BOLD signal
Deoxyhaemoglobin is paramagnetic (Pauling and Coryell, 1936)
and the susceptibility (the degree of magnetisation) of blood
changes as a linear function of oxygenation (Weisskoff and Ki-
ihne, 1992). As such, deoxygenated blood has a greater suscepti-
bility compared to its oxygenated counterpart causing local field
inhomogeneities within erythrocytes, the lumen contents, and
surrounding tissues; shortening the net T∗2 in the voxel. One
may initially believe that as a result of neural activity, the T2
signal would decrease further as oxygen is extracted. However, as
described above, functional hyperaemia causes a surplus of oxy-
genated blood to be delivered to the region of activation thereby
decreasing the concentration of paramagnetic deoxyhaemoglobin
within the vessel lumen.
The contrast changes within the vessels of the hyper-/hypoxic ro-
dent brain were first identified via a gradient echo pulse sequence
at 7T (Ogawa, Lee, Nayak and Glynn (1990), Figure 12). Com-
parisons between contrast during carbon monoxide inhalation
(which has negligible contrast effects) and hypoxia, inferred that
the contrast changes were generated by susceptibility differences
between vessel deoxyhaemaglobin and the surrounding tissues.
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This seminal paper spurred the hypothesis that MRI could be
utilised to investigate activity in the brain.
Figure 12: GRE image of an anoxic rat brain (ventilated on 100% N2) at 7T
(117x117x500µm). High levels of deoxyhaemoglobin within blood vessels
caused increase in magnetic susceptibility and reduced T∗2 as shown by the
contrast of the cortical vessels. Image adapted from Ogawa, Lee, Kay and
Tank (1990).
1.4.3 Neurophysiological contributors to the BOLD signal & the haemodynamic
response
Logothetis et al. (2001) were the first to demonstrate the neural
basis behind the BOLD signal. Using simultaneous fMRI and
intra-cortical electrophysiology, it was shown that increases in
the Local Field Potential magnitude (LFP, up to 300µm from the
electrode) were highly correlated with the haemodynamic re-
sponse with some contribution of Multi Unit Action potentials
(MUAs). The cortical BOLD signal represents regional inputs
and processing in the voxel as well as excitatory and inhibitory
interneurons. Excitatory inputs are either intrinsic signals from
within the cortex or thalamocortical afferents to pyramidal cells
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whereas inhibitory connections are short and local, possibly tun-
ing the projecting neural outputs (Logothetis, 2003).
The temporal dynamics of the BOLD responses are typified by
three phases (Figure 13): first a pre-stimulus dip, believed to be
due to a short increase in deoxyhaemoglobin due to metabolic
demands prior to hyperaemia (Hu and Yacoub, 2012). The second,
positive response is the signal change to the functional increases
in CBF and CBV which occurs 2-4 seconds post-stimulus. This is
followed by the ‘post stimulus undershoot’, (van Zijl et al., 2012).
The resultant BOLD signal changes as a consequence of functional
hyperaemia is typically weak, within 1-2% (greater at higher field
strengths). As such, a substantial degree of image pre- and post-
processing is required to detect changes in brain activity (see
Section 1.4.6 below). To fit within the statistical models used in
fMRI analysis, the data are often fitted to a haemodynamic response
function (hrf).
Figure 13: The temporal profile of the BOLD response. The response is
characterised by an initial dip in the BOLD signal followed by a signal
increase caused by the hyperaemic response. Lastly, the post-stimulus
undershoot. Image adapted from Hu and Yacoub (2012).
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The hrf assumes that the BOLD response following neural activa-
tion acts in a linear time-invariant relationship. There are various
methods to model the hrf (Ashby, 2011). Data are often fitted to a
function which models the hrf (Boynton et al., 1996). As shown in
Figure 14, this function models the lag in peak response following
the stimulus with a peak at approximately six seconds and a slow
decay over a 20 second period. However, this function does not
accommodate for the differences in the hrf seen throughout the
brain (Aguirre et al., 1998), such as the delayed response seen in
the prefrontal cortex (Schacter et al., 1997). As such, the model
risks introducing bias in the task-based paradigms increasing the
risk of false detection of activation (Ashby, 2011).
To make hrf models more flexible, canonical forms were gener-
ated with several variables which can be estimated (Boynton et al.,
1996). Non-linear models were also generated since the BOLD
response is not linear (Buxton and Frank, 1997). However, linear-
ity holds without any substantial introduction of errors (Ashby,
2011). Non-linear methods have since been developed, however
many require considerable computational power (Friston et al.,
2000).
Applications of spin-echo BOLD and gradient-echo BOLD imaging
Most BOLD experiments are conducted using a GRE-EPI se-
quence. However, the signal is often mis-localised due to the
draining of deoxyhaemoglobin rich blood into pial vessels and
surface veins (Disbrow et al., 2000). Spin-echo (SE) sequences, as
described earlier, eliminate T∗2 decay and can improve the spatial
specificity of the BOLD signal to the parenchyma (Goense et al.
(2007), Figure 15).
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Figure 14: Mathematical model of the haemodynamic response function h(t),
based on (Boynton et al., 1996) often used to model the BOLD response.
Figure generated from MATLAB code provided in Ashby (2011).
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Figure 15: Spin echo (left) and Gradient echo (right) fMRI activation maps
from the Macaque V1 acquired at 4.7T (SE 333x326µm planar; GE 333x250µm
planar; both 2mm slice thickness). In the SE images, V1 activation is confined
to the grey matter in Layer IV. GE-EPI activation showed maximal activation
at the surface, illustrating GE-EPI sensitivities to the veins. Figure modified
from Goense et al. (2007).
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1.4.4 BOLD imaging in animals
A large number of functional imaging studies have been con-
ducted in non-human primates (Logothetis et al., 1999; Disbrow
et al., 2000; Goense et al., 2008). They are a preferable model for
fMRI investigations compared to rodents due to their larger brain
size, greater grey-to-white matter ratio, more homologous brain
structure to humans, and their ability to be trained for conscious
experiments for long periods of time. However, due to cost and
low public approval, their use is limited to a few specialised cen-
tres. As a result, functional imaging studies in rats have increased
in popularity. Although it is possible to train rats to remain still
within an MRI scanner (Liang et al., 2015), anaesthesia or sedation
is preferred with various compounds trialled, each with their own
strengths and caveats for BOLD imaging (detailed in Chapter 4).
1.4.5 The BOLD signal in the resting brain
Great focus has been applied to understanding the mechanisms
underpinning the intrinsic activity of the resting brain. PET, and
later BOLD imaging, where the subject was invited to remain
at ‘rest’ during imaging, showed that brain activity occupied a
specific network known as the Default Mode Network (DMN,
Raichle et al. (2001)) whose activity reduced during task driven
activations. Resting BOLD fluctuations in bandwidths previously
considered as noise (< 0.1 Hz) were first identified by Biswal
(Biswal et al., 1995) across the human sensorimotor network.
Additional resting cortical networks have subsequently been iden-
tified (Lowe et al., 1998; Hampson et al., 2002).
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There are differing views on the neural basis of resting state
BOLD imaging. Leopold et al. (2003) identified low frequency
fluctuations in the local field power in the macaque visual cor-
tex with high coherence between electrodes over 20mm apart.
He et al. (2006) showed, using electrocorticography in humans,
that slow cortical potentials (SCPs) - a combination of infra-slow
fluctuations (ISFs) and δ frequency band of LFPs correlated with
spontaneous BOLD fluctuations in several states. Scho¨lvinck et al.
(2010) demonstrated in the macaque that Local Field Potentials
correlated with global cortical BOLD oscillations. The haemody-
namic response correlated with frequencies in the gamma band
(40-80 Hz) with a characteristic 6 second lag. There were also
correlations with lower frequencies (2-15 Hz) with no lag. LFP-
BOLD coupling was lower in variance and more strongly coupled
when the monkey’s eyes were closed.
Resting BOLD studies in rats
Rats have also been shown to possess resting state networks
(Pawela et al., 2008) including the DMN (Lu et al., 2012) indicating
conservation of this phenomenon across mammals even under
light anaesthesia or sedation. Indeed, the rodent sensorimotor
resting state network shows strong homology with neuroanatomy
as seen in Figure 16.
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Figure 16: Illustration of the rodent sensorimotor network based on
histological studies. Abbreviations: corpus callosum (CC), Primary/Secondary
Motor area (M1/2), Primary/Secondary Sensory area (S1/2), caudate
putamen (CP), globus pallidus (GP), sensorimotor thalamus (SMT),
ventro-lateral thalamic nucleus (VL), ventral-posterior thalamic nucleus (VP),
posterior thalamic nucleus (PO), Figure modified from Pawela et al. (2008).
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1.4.6 BOLD data Pre-processing
Pre-processing of raw-functional data is an essential component
of all functional MRI data analysis. In statistical terms, noise is
the variability that does not fit the model, so by managing the
variance through several pre-processing steps, the power of the
data are increased.
motion correction: Motion shifts the spatial distribution of
voxels leading to mismatches between TRs. Most correction
methods use rigid body registration, which corrects for motion
along three translational dimensions and three rotations. Using
one volume as the standard, images from each TR are transformed
to match it as closely as possible (Friston et al., 1995).
coregistration: Registration of functional data directly to an
anatomical template carries the risk of registration being purely
resolved by localisation with the edges of the brain, rather than
including structures within the brain, due to the poor contrast
of the EPI data set (Poldrack et al., 2011). Coregistration to a
well recognised anatomical atlas with distinct structural delin-
eations improves the spatial localisation of the regions of the brain
involved in resting-state networks. The most popular coregistra-
tion method (also known as rigid-body transformation) is based
on mutual information which aims to maximise the association
between grouped voxel intensities (Collignon et al., 1995).
spatial smoothing : Spatial smoothing replaces a voxel value at
each TR by a weighted average of its neighbours by the full weight
at half maximum (FWHM) kernel. As such, high frequency noise
over small areas is removed and by doing so, increases the SNR.
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The data also become more normally distributed and therefore
more rigorously fit to the statistical tests used in functional MRI
analyses (Ashby, 2011).
temporal filtering: Temporal filtering smooths voxel data
across the time series, removing either high frequency noise (low
pass filter), or low frequency noise (high-pass filter).
field-mapping and distortion correction : Echo planar imag-
ing (EPI) is highly susceptible to geometric distortion due to B0
inhomogenieties caused by sources such as the air within the
ear canals, haemorrhages within the parenchyma, or implanted
devices. These sources of susceptibility cause the greatest dis-
tortion in the phase direction due to the smaller bandwidth. As
such, inhomogeneities cause shifts in voxel position, altering the
shape of the brain. Distortion (often dissimilar between sub-
jects) complicates EPI image intra-subject co-registration as well
as co-registration to standard atlases. Field-mapping is a direct
measurement of the inhomogeneities within a subject and is cal-
culated by acquiring two 3D gradient echo images at different
echo-times, calculating the phase difference between them, and
dividing it by the difference in TE. From the phase, magnitude (a
FLASH counterpart of the phase image), and functional volumes,
a voxel displacement map (VDM) is calculated and the EPI vol-
ume subsequently unwarped (Jezzard and Balaban, 1995).
The pre-processing methods described above are analogous be-
tween human and non-human data sets. In the case of anaes-
thetised rodents, motion correction is not usually required, be-
cause the animal is unconscious and secured via ear and tooth
bars.
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1.4.7 The Applications of BOLD imaging
It is of no surprise that functional imaging has gained in popu-
larity due to its ability to infer neural activity non-invasively. As
such, the neuroimaging field in relation to cognition and disease
has exploded in the last two decades (Bandettini, 2012). Resting
state BOLD studies have often focused on the purpose of the
Default Mode Network and its changes in disease states (Buck-
ner and JR, 2008). Physical damage to the brain in the form of
ischaemia, traumatic injury, or tumourigenesis all affect brain
structure, and function as a consequence with resultant changes
in functional networks (Honey and Sporns, 2008).
The effect of ischaemic stroke on the BOLD signal and functional
networks has been extensively investigated. It’s been found that
ischaemic stroke causes a decline in the magnitude of the BOLD
signal in the contralateral hemisphere following a finger tapping
task (Pineiro et al., 2002). Findings such as these are unsurpris-
ing. Post-stroke responses such as the ‘no reflow’ phenomenon
(Ames et al., 1968), impaired vascular responses to stimuli such
as hypercapnia (Ka˚gstro¨m et al., 1983), and the sustained con-
striction of capillary pericytes (Hamilton et al., 2010; Hall et al.,
2014) all affect neurovascular coupling and the BOLD signal as
a consequence. The loss of neurons, gliosis, loss of long range
fibres, and subsequent cyst formation (detailed earlier) all have
a direct consequence on neuroanatomy and function. However
the adult brain is capable of some degree of plasticity which has
been identified in both rats (Weber et al., 2008; vanMeer et al.,
2010; van Meer et al., 2012) and in humans (Ward et al., 2003a,b;
Dancause, 2006).
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There is a general consensus that in the early stages of infarction,
increased activity in the contralateral hemisphere (e.g. increased
digit representation) is attributable to loss of horizontal callosal
projections causing a reduction in interneuron inhibition (Dan-
cause, 2006). The degree of involvement of the contralesional
cortex in the post-stroke brain is believed to predict functional
outcome (Weiller et al., 1993; Pineiro et al., 2001; Dijkhuizen et al.,
2003; Ward et al., 2003b) with increasing involvement indicative
of poor recovery.
However, the heterogeneity of infarct size, location and functional
consequences following stroke make determining if there exists a
typical response of the brain to injury, incredibly challenging.
1.4.8 Summary
Therapies for ischaemic stroke are currently mechanical or phar-
maeutical recannalisation, preventing recurrence, or adaptive
measures to cope with the subsequent disability. Stem cell treat-
ments may provide a new means of limiting ischaemic injury, or
improving disability in the chronic stages of the disease. CTX0E03
cells have previously shown to improve motor function following
middle cerebral artery occlusion in rodent models (Stroemer et al.,
2009; Smith et al., 2012). After Phase I evaluation suggested the
cell line to be safe in human patients (Kalladka et al., 2016) the cell
line is now in a Phase 2 clinical trial. Magnetic resonance imaging
is a relatively safe means of investigating brain structure and func-
tion in both humans and pre-clinical models. Resting state fMRI
is now a popular method to assess brain connectivity without
the need for a stimulus. As the mechanisms of CTX-cell induced
functional improvement are yet to be determined, resting-state
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fMRI may provide a means to assess how the brain responds to
stem cell transplantation. As there has yet to be a published study
on resting state network changes following a stem cell therapy for
stroke and few studies on the longitudinal changes in rat brain
connectivity post stroke, this thesis will present novel data in this
field.
1.5 hypotheses 56
1.5 hypotheses
The hypotheses in this thesis are:
• The functional assessments chosen will be of suitable sensi-
tivity to detect long-term post-stroke dysfunction.
• Non-invasive monitoring of end-tidal carbon dioxide, and
other variables, will be achievable within a high-field MRI
scanner.
• Intracerebral transplantation of CTX0E03 cells into the peri-
infarct region will generate sensorimotor functional improve-
ments (as seen previously) with concordant changes in the
post-stroke resting-state network.
1.6 aims
The aims of the experiments in this thesis are thus as follows:
• To assess a range of behavioural tests suitable for the detec-
tion of long-term post-stroke sensorimotor dysfunction.
• The development of an anaesthesia and physiological mon-
itoring protocol suitable for longitudinal fMRI studies and
rodents.
• Investigating the effect of a neural stem cell therapy for is-
chaemic stroke on resting-state fMRI networks and functional
outcome.
2
M E T H O D S
2.1 legislation and welfare
All procedures involving animals were performed under the An-
imals (Scientific Procedures Act), 1986, under UK Home Office
Project Licence, 60/4449, (‘Pre-clinical stroke and experimental
MRI’, Prof I.M.Macrae, University of Glasgow). Stem cell han-
dling and transplantation was approved by the University of Glas-
gow Genetically Modified Organisms Safety Committee (GMSC)
under reference number GM223/INP/MM 1. Materials brought
into the Biological Services Veterinary Research Facility were
approved following Risk Assessment by the Biological Services
Safety and Records Officer, in file under serial number 380. All
procedures were performed by Tristan Hollyer (PIL: 60/13076)
unless stated otherwise.
The animals used in all experiments were adult male out-bred
Sprague Dawley strain of laboratory rat (Rattus norvegicus). An-
imals were housed in maximum groups of 4 under a 12 hour
light/dark cycle (7am/7pm, local time) in identical plexiglass
containers with sawdust, nesting material, and a cardboard cylin-
der. Access to water and food pellets was ad libitum during
licensed procedures unless stated otherwise. In all surgical pro-
cedures, body temperature was monitored and maintained at
37± 0.5 ◦C using a rectal probe coupled to a homeothermic heat
blanket (Harvard Apparatus).
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2.2 surgical practice
2.2.1 Aseptic technique
Aseptic technique was followed for all surgical procedures as
defined in the Project Licence ‘Background Information on Pro-
gramme of Work & Local Appendices’ and are summarised below.
Equipment, operator, and the surgical bench
The surgical bench, cork-board, and surrounding area were disin-
fected using 70% ethanol. Sterile drapes were then placed over
the bench and cork-board with autoclaved surgical instruments
and swabs placed on them. Non-thermostable items such as
the Doccol intraluminal filaments were sterilised by immersion
in a cold sterilant (Medistel R©) for a minimum of 30 min and
then rinsed with sterile saline. In between surgeries, tools were
scrubbed in Decon R©90, rinsed with water, and the tips resterilised
by placement in a hot-bead steriliser for a minimum of 15 seconds
(Germinator 500, Cell Point Scientific), or placed in a bench-top
autoclave. Prior to surgery, the operator scrubbed and washed
their hands, nails, and wrists via a standard hand washing pro-
cedure using 4% chlorhexidine digluconate hand scrub (Hydrex,
Ecolab). Sterile gloves and clean scrubs and gown were worn for
all procedures.
Preparation of the animal
The surgical site of the anaesthetised rat was clipped of hair
in a location distant from the surgical area. The skin was then
disinfected using a swab soaked with 0.5% w/v Chlorhexidine
digluconate in 70% w/v ethanol solution (Hydrex R©Clear, Ecolab).
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Pre-operative analgesia was then administered as described in
Section 2.2.2.
2.2.2 Analgesia
Ropivacaine (10mg/ml), (Naropin, GSK), was used as a line-block
analgesic (1-2mg/kg) for recovery procedures including stereo-
taxic implantation (Section 5.3.5) and transient Middle Cerebral
Artery Occlusion (Section 2.3.1). Naropin was administered sub-
cutaneously onto the prepared surgical site in the anaesthetised
animal prior to incision.
2.2.3 Anaesthesia
For all surgical procedures, rats were transferred from their hous-
ing cages in the VRF to the surgical suites within the Wellcome
Surgical Institute or the Glasgow Experimental MRI Centre (GEM-
RIC). Following recording of body weight, the animals were
anaesthetised in an anaesthetic chamber (Baxter Healthcare Ltd,
UK) with 5% isoflurane in a mixture of oxygen and nitrous ox-
ide at 30% and 70% respectively; delivered at a rate of 1 l/min.
Anaesthesia was maintained either via a nose-cone (0.5 l/min)
or via endotracheal intubation (Section 2.3.2) with 2-3% isoflu-
rane at the same oxygen-nitrous oxide gaseous mixture. Depth
of anaesthesia was confirmed by the absence of any withdrawal
reflexes to pinching of the ventral aspect of the hindpaw, typically
absent within 4-5 min from the start of anaesthesia. This reflex
was assessed frequently throughout all surgical procedures. If a
withdrawal reflex was present, surgery was halted temporarily
and delivered isoflurane levels increased to a level suitable to
inhibit this reflex.
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2.3 surgical procedures
Surgical procedures were undertaken either in the Wellcome
Surgical Institute or the GEMRIC theatre suites.
2.3.1 Transient Middle Cerebral Artery Occlusion
Transient middle cerebral artery occlusion (tMCAO) was per-
formed via the intraluminal filament method, first described in
Koizumi et al. (1986b) and reviewed in (Macrae, 1992, 2011), as
shown in Figure 17. Viewing through a bench-top microscope
(Wild/Leica M650), an incision was made down the midline of
the prepared ventral neck using an #11 scalpel blade and the un-
derlying fascia and the left ventral region adjacent to the trachea
exposed. The masseter, omohyoid and cleidomastoid muscles
were dissected apart to expose the common carotid artery (CCA).
Two 4-0 stutures were placed around the CCA approximately
10 mm apart; the tie most distal from the heart approximately
5mm from the bifurcation of the CCA to the external carotid
artery (ECA) and internal carotid artery (ICA). This tie was loose
compared to the more proximal tie which was secured around
the vessel permanently. Loose ties of 4-0 silk suture threads were
placed around the ECA between the branches of the occipital and
ascending pharyngeal arteries and also the occipital (OA) and
Internal carotid (IC) arteries. A 4-0 silk thread was sometimes
used to isolate the pterygopalatine artery (PtA) at its bifurcation
from the ICA. The purpose of these ties was to occlude retrograde
blood flow and manipulate the vasculature to provide the best
visual field for insertion of the intraluminal filament. Ties were
placed under tension and manipulated using Halsted Mosquito
forceps. Using micro-scissors, an incision was made between the
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two ties on the CCA and an intraluminal filament (purchased
from Doccol Corp., MA) of appropriate size, (see Table 1) was
carefully inserted through the CCA and ICA to the origin of the
MCA. This was confirmed by the filament encountering resis-
tance at an insertion length approximately 22 mm from incision
site. Once the filament was inserted correctly, the distal CCA and
ICA ties were secured to retain the filament; all other ties were
removed.
Sham MCAO
Sham MCAO procedures were performed to account for the af-
fect of the surgery on functional performance. As according to
Stroemer et al. (2009), sham surgery was performed by repeating
the exact procedure as described above with the exception of the
complete insertion. In this case, the filament was only inserted
to the bifurcation of the internal carotid artery and the ptery-
gopalatine artery (approximately 8mm) and withdrawn after the
equivalent occlusion time.
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Figure 17: Illustration of intraluminal occlusion of the left middle cerebral
artery when viewed inferiorly. The intraluminal filament was inserted distal to
the bifurcation of the CCA and guided up through the ICA to the origin of the
MCA. Dashed loops represent loose ligatures; solid loops represent
permanent ligatures around the vessels.
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Animal Weight (g) Coat diameter (mm) Suture USP no. Coat Length (mm)
280-330 0.37, 0.39 4-0, 5-0 3-4, 4-5, 5-6
330- 400 0.41 4-0, 3-0 3-4, 4-5, 5-6
Table 1: Recommended intraluminal filament dimensions for MCAO as
recommended by, and purchased from Doccol
In situ recovery for confirmation of correct placement of the intraluminal filament.
As described in Stroemer et al. (2009); to confirm that the intralu-
minal filament had successfully reduced blood flow to the middle
cerebral artery territory of the affected hemisphere, the incision
was temporarily closed using Michel clips and the animal recov-
ered from anaesthesia with the intraluminal filament in situ. At 60
minutes following insertion of the filament, three tests sensitive
to ischaemic damage within the MCA territory were conducted:
• Tail lifting/contralateral forelimb test: the rat was lifted
by the base of its tail. Successful occlusion of the MCA
in an animal would lead to contralateral forelimb flexion,
contralateral body twisting, or hemiparesis.
• Circling test: lifted by the base of its tail with the forepaws
remaining in contact with the surface, an animal with a
successful MCA occlusion would tightly circle.
• Vibrissae evoked forelimb placement test: brushing the vib-
rissae over a raised surface initiated a step-up reflex of the
corresponding forelimb. Successful MCA occlusion removed
this reflex on the side contralateral to the ischaemic insult.
This procedure also allowed for the overlapping surgeries to
maximise throughput and reduce time under anaesthesia.
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Post-MCAO Surgical Care
The standard post-operative care procedure (Section 2.4) was
followed with the following exceptions to dietary monitoring.
As detailed in Modo et al. (2000), rats were provided with three
softened dietary pellets for the first 24 hours after surgery. Food
intake and defecation were monitored on a scale of 0 to +3 with 0
being no food eaten or defecation to +3 being all food eaten with
obvious signs of urination and defecation for the first 72 hours.
For the first 48 hours following surgery, 2.0 ml of 0.9% saline were
given subcutaneously twice a day to prevent dehydration and aid
recovery. Additional supportive fluids - either 0.9% saline or 2
ml 50% glucose:saline solution (Baxter Healthcare Ltd) or food
enriched with Complan (Heinz) - were given on a discretionary
basis. Recovery progress was recorded on ReNeuron form 023-
V03 ‘Post-Operative Record Sheet Following MCAO’.
2.3.2 Endotracheal intubation
For procedures where endotracheal intubation was required, intu-
bation equipment was made using a 16G IV cannula (AniCathTM,
Millpledge). A stylus was made by removing the bevel of the nee-
dle using wire cutters and creating an acute bend at the midpoint;
the cannula itself comprised the endotracheal tube, as shown in
Figure 18.
The animal was first deeply anaesthetised, described in Section
2.2.3, before being transferred to the surgical bench. Placed
supine, a loop of 2-0 suture thread attached to a corkboard by a
19 gauge needle was placed around the rat’s upper incisors. Once
secure, the board and the rat were raised up to a vertical angle
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(75-90 degrees) so that the rat was hanging from its incisors with
its mouth partially open. A fibre optic light was positioned on to
the dorsal aspect of the neck to help illuminate the larynx and
the upper trachea; the tongue moved aside using forceps and the
oral cavity dried with a cotton bud.
The endotracheal tube, supported by the stylus was then care-
fully placed through the throat and into the trachaea, the stylus
removed, and the tube connected to an Ugobasile volume-driven
ventilator (Harvard Bioscience). Correct placement was confirmed
by a synchronisation of lung inflation with the ventilator. If this
was not the case, the intubation tubing was likely to be in the
oesophagus, and as such, the tube was removed and reinserted.
Once correctly inserted, the intubation tube was secured by a
small suture made in the lip and depth of anaesthesia assessed.
Ventilation parameters were typically set to 60-70 breaths/min
with an inspired/expired volume of 2.5-3.5 ml with gasesous
mixtures described above in Section 2.2.3.
Endotracheal intubation is a preferred method of anaesthesia de-
livery for certain procedures as by controlling the volume and rate
of inhaled gases precisely, the suppressive effects of isoflurane on
respiration are limited and physiological parameters (e.g. arterial
pCO2 and pO2) can be more accurately controlled. Care was
taken to avoid trauma to the palette and larynx and the animal
reanaesthetised if reaction to laryngeal stimulation was observed.
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Figure 18: Photograph of the modifications made to the IV cannula
(AniCathTM, Millpledge) to create the endotracheal tube (top) and stylet
(bottom). Scale bar: 20 mm.
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2.3.3 Arterial and venous cannulation
Both arterial and venous cannulations followed the same proce-
dure with the respective blood vessel. As such, the procedure
in this section will refer to both the femoral artery and vein as
‘the vessel’. The leg was secured and the inguinal region shaved
and disinfected as described in Section 2.2.1. Following incision,
the components of the femoral sheath (vein, artery, and nerve)
were dissected apart (with care taken to avoid trauma to the
femoral nerve) and two 4-0 silk suture threads placed around
the vessel and tied at proximal and distal ends of the exposed
vessel. An arteriotomy directed towards the proximal aspect of
the vessel was made and a 0.93 mm internal diameter PE-tubing
catheter (connected to a 1 ml syringe containing heparinised
saline (1000units/ml) was inserted into the lumen. Once secured,
the catheter was flushed with heparinised saline and connected
to a transducer with blood pressure and heart rate recorded in
real-time using Biopac acquisition software. At regular intervals,
blood samples were taken (75− 100µl) and analysed for pH, oxy-
gen and carbon dioxide partial pressures (pO2, pCO2) and %O2
saturation using a clinical blood gas analyser (RAPIDLabTM248
System, Siemens).
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2.4 recovery & post-operative care
Post-operative care followed a standard procedure unless stated other-
wise.
Immediately after surgery, 2.0 ml of 0.9% saline was given sub-
cutaneously and the time of recovery from anaesthesia recorded.
The animal was then transferred to a cage lined with AD pads
and placed in a designated recovery room. Softened food pellets
provided in a small plastic weighing boat on the floor of the cage.
For the remainder of the recovery period, cages were cleaned and
animals weighed daily, with a mash of softened pellets supple-
mented with Complan (Nutricia) given in addition to dry pellets
ad libitum until pre-operative body weight was regained. As dic-
tated in the Project Licence, if body weight dropped to below 25%
of pre-operative weight the Named Animal Care and Welfare Offi-
cer (NACWO) or Named Veterinary Officer (NVO) were notified
immediately and the animal’s future in the study determined on
an individual basis.
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2.5 behavioural procedures
2.5.1 Habituation to Handling
Following delivery to the Veterinary Research Facility (VRF), and
prior to formal assessments, the rats were acclimatised for seven
days in the assessment to become accustomed to the handing
and restraint methods applied in the behavioural assessments.
Familiarisation to human interaction and handling helped to
reduce anxiety and stress in the animals, which in turn, permitted
more reliable data acquisition.
2.5.2 Transient Global Neurological Assessments
A ten-point scoring system, adapted from Modo et al. (2000),
provided an acute assessment of global neurological sequelae
following MCAO/Sham surgery. The assessment included the
following tests described here, as if performed by a neurologically
impaired animal.
• Grasping: By placing a bar under both forelimbs, in line with
the animal, the animal fails to grasp the bar simultaneously
with both forepaws.
• Placing reaction: The animal was placed on the edge of a
platform or table where one side of the body is alongside the
edge. When pulling each limb gently in turn off the edge,
the animal fails to spontaneously replace the displaced limb
back on to the platform.
• Visual placing: When lowering it slowly down towards the
edge of the cage keeping its forelimbs free, the animal does
not reach both forelimbs towards the cage.
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• Righting reflex placed in a supine position, the animal would
not spontaneously right itself.
• Horizontal bar test: By placing the animals forelimbs on to
a bar approximately 30 cm above the surface, the animal is
unable to hang on for a maximum of 3 seconds.
• Spontaneous mobility: When placing the animal on an open
surface in a familiar environment it fails to move and explore
the surroundings within 10 seconds of placement.
• Circling: Following focal cerebral ischaemia, circling be-
haviour was exhibited in the direction of the contralesional
hemisphere either spontaneously, or when its hindlimbs are
raised up by lifting from the base of the tail.
These tests were binary in their nature; a score of 1 confirming
a deficit and a score of 0 confirming its absence. The remaining
three points of the test were evaluated by the ‘Tail Lifting Test’;
a modification from the Bederson scale. The test evaluated the
extent of dysfunction induced by MCAO, scored from 0 to 3 by
the following criteria:
• 0 - no apparent dysfunction
• 1 - flexion of the contralateral forelimb
• 2 - body twisting to the contralateral side of damage
• 3 - hemiparesis
Such acute assessments are suitable for determining the extent
of post-surgical impairment as well as an indicator of the degree
of dysfunction generated by the stroke. They are not, however,
deemed adequate in identifying permanent neurological dysfunc-
tion due to the tendency for rodents to spontaneously recover
(Modo et al., 2000).
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2.5.3 Behavioural Assessments
The identification of assessments suitable to evaluate long-term
sensorimotor dysfunction caused by experimental stroke is de-
scribed in Chapter 3.
2.5.4 Statistical analysis of behavioural data
As described in Matthews et al. (1990), the application of a two-
sample statistical test at each time-point in data acquired serially
is statistically incorrect: the data points are not independent of
one another in temporal and subject terms. As such, Matthews
and colleagues suggest the use of summary measures of repeated
measurements data, in particular, the ‘Area under the curve’
(AUC) measure. An AUC value provides a summary of each
animal’s sensorimotor function (depending on the test). The
mean results from each group can then be compared with relative
ease using an appropriate t-test/ANOVA or their non-parametric
equivalent.
All behavioural data results for each animal were summarised by
an individual AUC value and group comparisons made accord-
ingly on GraphPad Prism 6 software.
2.6 perfusion fixation
Transcardial perfusion fixation was performed for future histolog-
ical analysis of CTX cell, control groups, and pilot tissue. Animals
were first deeply anaesthetised (described in Section 2.2.3) and
then maintained on 3% isoflurane via a face mask. The thoracic
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cavity was opened by an incision at the xiphoid process of the
sternum, the diaphragm incised, and the ribs cut at their postero-
lateral aspect using blunt dissection scissors. The ribcage was
then retracted superiorly to provide full access to the cavity. The
heart was held loosely with Halsted Mosquito forceps, a cannula
derived from a blunt 16G needle was inserted through the apex
of the heart into the aorta. During insertion of the cannula, hep-
arinised saline (10 ml/l) was running through it at a pressure
of 80− 100 mmHg. Once positioned correctly, the right atrium
was incised using sharp micro-dissecting scissors for complete
circulatory exsanguination. Once the saline perfusate was clear of
blood (approximately 200-300 ml), 4% paraformaldehyde (PAM)
was perfused at the same pressure stated above. Satisfactory
fixation was confirmed by spontaneous limb movements followed
by the onset of tissue rigour after 200-300 ml of PAM perfusion.
2.6.1 Post-perfusion tissue preparation & paraffin embedding
Following perfusion fixation (Section 2.6), the carcass was de-
capitated and the head immersed in 4% PAM for a minimum
of 24 hours to limit dark neuron artifacts (Cammermeyer, 1961;
Jortner, 2006). Following immersion, the brain was removed
and immersed in 4% PAM indefinitely until batch embedding.
The embedding procedure was preceded by immersion on 70%
ethanol for 24 hours and then processed by the protocol detailed
in Table 2.
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Step Reagents Duration(min)
1 70% Ethanol 60
2 95% Ethanol 60
3 95% Ethanol 60
4 100% Ethanol 60
5 100% Ethanol 60
6 100% Ethanol 60
7 Xylene 60
8 Xylene 60
9 Xylene 60
10 Paraffin 60
11 Paraffin 60
12 Paraffin 60
Table 2: Steps of the automated embedding process.
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2.7 magnetic resonance imaging
A standard protocol was followed for preparing the animal for
non-functional magnetic resonance imaging. All imaging exper-
iments were carried out on a Bruker Biospec 7T/30cm system
with a BGA12 integrated 400mT/m gradient (ID) system with in-
tegrated ‘FASTMAP’ shimming. Details of the scanning protocols
used are in the respective study chapters.
2.7.1 Standard preparation for Magnetic Resonance Imaging
Animals were anaesthetised (as described in Section(2.2.3) and
maintained via a facemask or endotracheal intubation (Section
2.3.2). The animal was placed prone within an MR compatible
Perspex cradle (Bruker Biospin) and the head secured using ear
and tooth bars. Body temperature was monitored via a rectal
probe and maintained at 37 ◦C via a closed-circuit heated water
system (Cole-Parmer Polystat R©) on the surface of the cradle and
by a blanket placed over the dorsal surface of the body. Respi-
ration rate was monitored using a pressure sensor (GrasebyTM)
placed on the base of the cradle. All physiological parameters
were monitored and recorded using a Biopac MP150 Acquisition
System and AcqKnowledge software.
A four channel phased-array surface coil was secured level over
the dorsal aspect of the head and the cradle then placed within
the bore of the magnet. Positioning and alignment of the animal
within the bore was verified by pilot scans.
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Animals were required to be positioned within the cradle and the
magnet as reproducibly as possible to ensure that the inter and
intra-subject data sets were as uniform as possible. This was done
by marking on the cradle its appropriate depth within the bore
and making sure that the animal’s head was as level as possible.
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3.1 introduction
3.1.1 The Rodent Somatosensory Cortex
The mammalian cerebral cortex is a highly organised, layered
structure, with layers varying in function and specificity in the
processing of information input, output, and signalling between
associated cortical areas and sub-cortical structures (Felleman and
Essen, 1991). Each layer is unique in its cytoarchitecture, energet-
ics, connectivity and vascular supply (Patel, 1983) and each differs
in its responses to its respective inputs (Dunn et al., 2005). Layer
IV, the major input-layer, has denser microvasculature, is the most
metabolically active, and appears to be responsible for initiating
the haemodynamic response, with hyperaemia propagating up
towards the surface layers (Tian et al., 2010).
The rodent neocortex shares the same anatomical hallmarks
and nomenclature attributable to most other mammals. The
somatosensory representation of the body is embossed within
the S1 region, with a large proportion dedicated to the Vibris-
sae (Figure 19). Other major subdivisions of S1 are the forelimb
(S1FL) and hindlimb (S1HL) areas. S1 has some partial overlap
with the motor cortex with reciprocal communications to/from
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the thalamic Ventroposterial lateral (VPL) and Ventroposterior
medial (VPM) nuceli terminating in Layer IV (Donoghue et al.,
1979). The sensory representation of the whole body is further
replicated in S2 latero-caudal to S1.
Figure 19: The Rodent Somatosensory Cortical Topography. The topography
of the rodent S1 is dominated primarily by the vibrissae Barrel Cortex (blue).
Barrel Cortex cortical connectivity exists between the contralateral Barrel field
and the ipsilateral S2 and M1. Figure adapted from Petersen (2007).
The Vibrissae and the Barrel Cortex
The rodent vibrissae (whiskers) are an essential component of the
animal’s sensory system (Figure 20). Touch and object localisation
is determined by contact of rhythmic whisking of the vibrissae
in combination with freely ranging head and body movement
(Kleinfeld et al., 2006). A large azimuthal plane is covered by
anterior-posterior whisking and superior-inferior planes covered
by dorso-ventral whisks (Bermejo et al., 2002).
Stimulation of the vibrissae causes depolarisation in sensory
neurons of the infraorbital branch of the trigeminal nerve via
mechanogated ion channels (Petersen, 2007). The sensory neu-
rones form glutaminergic synapses within trigeminal nuclei ’bar-
relettes’ in the brain stem which in turn project to their respective
3.1 introduction 78
barreloids in the VPM (Veinante and Descheˆnes, 1999). VPM
neurons project to their discrete somoatotomic location in Layer
IV of the Barrel Cortex.
The Barrel Cortex is the sensory subfield of S1 where each large
vibrissa is somatopically mapped by individual neuronal func-
tional representations (Woolsey and der Loos, 1970), Figure 20B.
Processing of inputs from the vibrissae can be small and involve
discrete populations of neurons, or wide ranging, demonstrating
the wide range and plasticity of these cortical responses to dif-
fering stimuli (Frostig, 2006). Integration of the vibrissae system
occurs through several nested feedback loops:
• the brainstem (including whisking rhythm generation, (Nguyen
and Kleinfeld, 2005).
• via thalamic nuclei VPM to S1 and S2; a paraleminiscal
pathway through the posterior medial nucleus to the superior
colliculus, M1, S1 and S2; and a direct leminiscal pathway
from the VPM to the Barrel Cortex.
• corticocortical projections with thalamocortical mediation.
Extensive labelling studies have shown that relay cells of the tha-
lamic central lateral nucleus have projection to the striatum and
both S1 and M1 vibrissae areas (Descheˆnes et al., 1996). Overlap-
ping inputs from these areas to the dorso-lateral striatum provide
evidence for an integrative role of the basal ganglia.
Cortical processing of signals from Barrel Cortex are both unilat-
eral and bilateral. Corticocortical connections exist via glutamin-
ergic neurons. Unilaterally there are projections to S2 and M1
with some callosal connectivity (Petreanu et al., 2007).
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Figure 20: The Rodent Barrel Cortex. (A) Stimulation of a vibrissa causes
excitatory input into the trigeminal ganglia (1), the VPM (2) and consequently
to the Barrel Cortex (3). (B) Vibrissae have specific somatotopic maps on the
contralateral cortex. Figure adapted from Petersen (2007).
Short periods of intraluminal MCAO induce damage primar-
ily to the striatum. As such, corticothalamic inputs through the
dorsol-lateral striatum are most often damaged by MCAO. Longer
occlusion times will often involve infarction of the cortex. The
resulting sensorimotor deficits detail the complexities of the sen-
soirmotor system neural circuity and its vulnerabilities to damage.
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3.1.2 Rodent skilled forelimb use
Skilled forelimb use (reaching, grasping, and manipulation) is a
homologous function across many species, apparently emerging
in the early stages of tetrapod evolution (Iwaniuk and Whishaw,
2000).
The skilled reaching movement occurs in several stages driven
firstly by upper arm positioning and abduction to pronate the
palm followed by supination at the wrist to present food to the
mouth (Whishaw and Pellis, 1990). The individual digits of
the forehand make a series of complex movements during the
reaching task including flexion, reaching, and ‘arpeggio’ grasping
motions (Whishaw and Gorny, 1994). The movement is coordi-
nated via a synergy of several pathways including the cortical
spinal, rubrospinal, tectospinal, and reticulospinal tracts (Iwaniuk
and Whishaw, 2000). Within the forebrain, comprehensive lesion-
ing studies have shown that the caudate-putamen, motor cortex,
and the substantia nigra all share a role in skilled forelimb use
(Whishaw et al., 1986).
Although the motor cortex (M1) is typically spared during MCAO
due to anterior cerebral artery supply, motor function is often
impaired due to damage of subcortical structures with circuits
linked to M1 leading to changes in the forelimb representation in
the cortex (Gharbawie et al., 2005).
3.1.3 Assessing Post stroke disability in rodent models
The neurological deficit induced by focal cerebral ischaemia can
be broadly divivded into two categories: transient global deficits,
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and long term sensorimotor or cognitive deficits (Modo et al.,
2000). The former (assessed by tests such as the Bederson score,
see earlier) provides a useful means to confirm the acute onset
of stroke induced deficits and the presence of oedema. How-
ever, it has been demonstrated that rodents will spontaneously
recover and/or compensate with the unimpaired limb to mask
these deficits (Caleo, 2015).
Functional tests aim to detect the asymmetry induced by uni-
lateral ischaemic brain damage with a primary focus on motor
function and sensory neglect (Schaar et al., 2010). These include:
the Staircase test (Montoya et al., 1991), the ‘Vermicelli Handling
Test (Allred et al., 2008), The Cylinder Test Schallert et al. (2000),
The Bilateral Asymmetry Test (Schallert and Whishaw, 1984), The
Vibrissae Evoked Forelimb Reaching Test (Brooks, 1933) and The
Corners Test (Zhang et al., 2002).
With the overall aim of most candidate treatments being to restore
functions lost due to stroke, it is essential to select assessments ca-
pable of demonstrating the persistent deficits caused by ischaemic
stroke, with no susceptibility to adaptation or masking and with
limited user bias (Schallert, 2006). In the case of CTX0E03 cell
transplantation into the chronic post-stroke brain, tests must be
sensitive enough to detect long-term disabilities but to a sufficient
degree to detect subtle functional improvements.
3.2 aims 82
3.2 aims
The aims of the experiments in this chapter were to identify sen-
sorimotor assessments of suitable sensitivity to detect long-term
functional deficits caused by middle cerebral artery occlusion.
The selection of several appropriate tests was essential to investi-
gate, in future longitudinal assessments, the potential functional
improvements following CTX0E03 treatment.
3.3 methods
The strain, sex, age, habituation, handing, MCAO, post-operative
care, and global neurological scoring procedures are described
previously in the Methods chapter.
3.3.1 Functional assessments of post-stroke sensorimotor dysfunction
Sensitive assessments capable of detecting permanent sensorimo-
tor dysfunction following focal cerebral ischaemia were essential
for detecting predicted functional improvements subsequent to
CTX0E03 transplantation. Various tests were piloted to evaluate
their sensitivity and specificity to such deficits.
the corners test. As described in Zhang et al. (2002), the Cor-
ners Test assesses the ability of a rodent to spontaneously rear
up and turn to exit a 90◦ corner. This reflex is initiated when the
vibrissae on each side are simultaneously stimulated by contact
with the sides of the wall and involves a combination of vibrissae
sensation, forelimb and postural functions (Barth et al., 1990). A
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neurologically healthy rodent will have a turning preference of
40-60 % towards a particular side (Figure 21). Following focal
striatal damage by left MCAO, rats exhibit a turning bias to the
left.
A section of cardboard (approximately 50x100 cm) was folded
centrally to create a 90 degree angle. Each rat was introduced to
the corner ten times and the direction of exit recorded, with at
least a 60 second interval between assessments. The percentage
of turns to the left was calculated. Rats were tested prior to,
and following MCAO. Any animal with a preferential turning
bias (greater than 60% in either direction) prior to surgery was
excluded. Some rats became intolerant in the latter half of the
experimental period resulting in fewer than ten assessments being
made. The percentage of turns to the left was calculated from the
maximum number of successfully completed trials.
Figure 21: Photograph of a rat performing the Corners Test. Animals which
had undergone left MCAO exhibited a turning preference towards the
ipsilateral (A) over the contralateral (B) side of damage.
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the bilateral asymmetry (sticky label) test. Focal injury of
the cortex or striatum can result in tactile extinction and sensory
neglect; a deficit whereby simultaneous bilateral stimulation gen-
erates an absence in sensation to the contralateral stimulus locus
until the ipsilateral stimulus is removed. When the neglect is only
partially resolved, it is known as obscuration (Benton and Levin,
1972; Abramsky et al., 1971). The Bilateral Asymmetry Test (or
Sticky Label Test) is a popular test for assessing tactile extinction
and sensory neglect and was utilised in previous assessments
of sensorimotor recovery following CTX0E03 transplantation fol-
lowing experimental stroke (Stroemer et al., 2009; Smith et al.,
2012). It was therefore apt that this test was trialled to determine
whether similar results were achievable in our laboratory envi-
ronment.
The rats were scruffed and 14 mm diameter circular adhesive
labels (Ivy Stationary) were attached to the ventral aspect of
both forepaws (Figure 22). The paws where then pressed gen-
tly between the handler’s fingers simultaneously to remove any
placement bias and the animal placed into a testing box. The
rats then attempt to remove the labels with their tongue or teeth.
Performance was recorded using a digital video camera (Pana-
sonic HX-WA20) with the paw of first contact and the times of
label contact and removal noted. The maximum recording time
was defined as 180 seconds. Failure to either contact or remove
the labels within the allotted time was given the maximum time
of 180 seconds. The video data were analysed and the time to
remove the label (removal time), defined as length of time taken
following first contact to successfully remove the label.
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Figure 22: Photograph of a rat being prepared for the Bilateral Asymmetry
(Sticky Label) test. The animals were held by the scruff of the neck; 14mm
diameter labels applied to the ventral surface of each forepaw and the paws
pressed simultaneously before recording responses.
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staircase (paw reaching) test. The staircase test evaluates the
skilled reaching, grasping, and retrieving abilities of rats or mice.
Designed by Montoya et al. (1991), diet restricted animals were
presented bilaterally with 3 sugar pellets (TestDiet, MO) per step,
on a series of descending stairs (7 in total). The pellets were only
accessible from a narrow, enclosed plinth, allowing for indepen-
dent assessment of each forelimb (see Figure 23). Diet restriction
of animals was necessary to motivate them to perform the test
during training and testing. Ischaemic damage to the MCA terri-
tory affects both sensory and motor pathways including damage
to the corticospinal tract, affecting forelimb function. Advice from
Dr Rebecca Trueman, (University of Nottingham) was sought in
the design of this assessment.
Following the published diet restriction protocol in Farr and True-
man (2011), approximately 8-10 dietary chow pellets (10-13 g) per
animal were provided on the floor of the cages each day. This
caused a reduction to, and maintenance of body weight to 85-90%
of their starting weight and was sufficient to motivate the animals
to perform. Each animal’s weight was recorded three times a
week. If their weight dropped below 85% of starting weight, they
were separated from their cage mates for 24-48 hours and fed
additional diet to allow their weight to improve, before being
returned to their group housing. Small amounts of sugar pellets
were also provided before the training period to reduce any neo-
phobia.
Diet restriction was introduced 5-7 days prior to training. During
the training phase, each step of both staircases was filled to capac-
ity with sugar pellets. The rats were then placed in the apparatus
for 15 minutes. This allowed them to become familiar with the
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testing environment and the pellet retrieval task. The training
was conducted twice a day over a 5 day period. The number of
pellets retrieved was not recorded during the training phase.
Following training, baseline performance values were acquired
over 5 consecutive days with the baseline number of pellets con-
sidered to be the median number of pellets retrieved from each
step (max 3). Animals which failed to successfully retrieve any
pellets due to an inability to habituate to the testing environment
were excluded from the study. Following acquisition of base-
line data, the animals were returned to an ad libitum diet until
surgery. Once animals had regained their pre-surgery weight,
diet-restriction was re-initiated for the remainder of the experi-
mental period.
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Figure 23: Photograph of an adult rat performing The Staircase Test. Rats are
only able to obtain sugar pellets from each side with the respective forelimb.
Image adapted from Farr and Trueman (2011).
the vibrissae evoked forelimb (whiskers) test. This test as-
sessed the reflex which occurs when the vibrissae are brushed
upwards along a surface (Brooks, 1933). Animals were held with
the hind limbs supported and the forelimb contralateral to the
testing side, restricted. The animal’s vibrissae were then brushed
upwards along the end of a bench. In a naı¨ve/sham animal,
the forelimb ipsilateral to the stimulated vibrissae reached up to
make contact with the bench surface (Figure 24). As mentioned
previously, intraluminal MCAO generates primarily a striatal
infarction. As such, neurons from the VPM to the Barrel cortex
are vulnerable to damage. The vibrissae evoked forelimb test is
therefore an assessment of striatal damage. Left MCAO leads to a
failed response to right whisker stimulation. Animals were tested
on each side three times with successful performance marked
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as ‘0’ and a failed response as ‘1’. Results were presented as ‘%
failed responses’.
Figure 24: Photograph of an adult rat performing Vibrissae Evoked Forelimb
(Whiskers) Test. A neurologically healthy rodent would place the forelimb
ipsilateral to the stimulated vibrissae up onto a surface. Image adapted from
Farr and Trueman (2011).
the adjusting steps test. Forelimb akinesia following MCAO
was assessed using a modified version of the adjusting steps test
used in (Olsson et al., 1995; Mine et al., 2013), (Figure 25). The
animal was supported with one right forelimb free and its hind
limbs restrained. The free forepaw was moved in a forehand
and backhand direction with the number of bracing steps/hops
made over a 0.9 m distance over 5 seconds counted. The test was
conducted twice in both directions and the median value in each
direction evaluated as a measure of the overall performance.
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Figure 25: Photograph of an adult rat performing the Adjusting Steps Test.
The free forepaw was dragged 0.9 m along a surface in the direction of the
forehand (F) and the backhand (B) over a duration of 5 seconds. A
neurologically healthy rodent’s limb would undertake a series of steps/hops
whereas a focal ischaemic infarction negated this reflex.
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3.3.2 Histology
For assessments of the ischaemic infarct, brain were removed and
stained using Haematoxylin and Eosin (H &E). Haematoxylin
and eosin stain cellular nuclei and cytoplasm, respectively. Brains
were extracted from euthanized rats 7 days post-stroke, fresh
frozen in isopentane at −40◦C for 10min and then mounted and
embedded for tissue sectioning (20µm) on a cryostat at −19◦C.
Sections were collected at 8 stereotaxic levels (relative to bregma
rostral-caudally) representing the regions of the forebrain sup-
plied by the middle cerebral artery (Figure 26). The sections were
then stained with H&E, mounted with DPX and covered with
glass coverslips. Images of the sections were taken using a Micro
Nikkon 55mm camera using MCID software (Figure 27).
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Figure 26: Illustration of the eight coronal levels of the relative to Bregma
(mm) based on (Konig and Klippel, 1963) used by Osborne et al. (1987) to
illustrate regions of forebrain vulnerable to infarction following middle
cerebral artery occlusion.
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Figure 27: Determination of the infarct 7 days post-MCAO from MCID
photographs. The ischaemic infarct was measured from photographs of the
relevant slides (right). The distribution of the infarct is shaded in red on
coronal plates from the Paxinos and Watson (2006) atlas (left).
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3.3.3 Study design
The sensitivity of functional assessments was assessed at three
time periods post-MCAO in series. Animals were randomly
assigned to MCAO or Sham surgery.
acute to sub-acute (7 days): 70 min transient MCAO (tMCAO)
was conducted (as described earlier), followed by daily global
neurological and vibrissae reflex assessments, functional assess-
ments on days -1, 2 and 7. Brains were removed and infarct
volumes were quantified from haematoxylin and eosin (H&E)
stained sections at stereotaxic ‘levels’ of the MCAO territory de-
fined in Osborne et al. (1987). n = 5 and 8 for Sham and MCAO
groups respectively, unless otherwise stated.
sub-acute to chronic (21 days): 70 min tMCAO with func-
tional assessments on days -1, 2, 7, 14, and 21. Infarct volumes
were quantified from T2 weighted RARE MR images acquired on
day 7 post-MCAO. n = 7 and 16 for Sham and MCAO groups
respectively.
chronic (12 weeks): 90 min tMCAO with assessments on day
−1 and at weekly intervals. Infarct volumes were quantified from
T2 weighted RARE MR images acquired between 4 and 8 weeks
post-MCAO. n = 10 in both Sham and MCAO groups.
MRI imaging
Animals were prepared and positioned as previously described.
T2weighted RARE (Rapid imaging with Refocused Echoes) imag-
ing was used for high resolution anatomical imaging for delin-
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eation of the ischaemic infarct (TR=600ms, TE=46.62ms; planar
resolution of 100µm; 16 slices of 750µm thickness). Following
imaging, the animal was removed and recovered in its home cage.
3.3.4 Statistical analysis
All data are presented as mean ± standard deviation or me-
dian ± interquartile range, as an appropriate means of display-
ing the distributution of the data. To ascertain at which time
post-stroke functional assessments were no longer sensitive to
sensorimotor dysfunction, Sham and MCAO groups, and their
respective time points were compared via One-way ANOVA or
the non-parametric equivalent Kruskal-Wallace test with the rel-
evant correction for multiple comparisons. Corner, Adjusting
Steps, Bilateral Assymetry tests at 7 days were assessed with
thr Kruskal-Wallace test and with One-way ANOVA at 21 days
to assess at which time point the test lost sensitivity. For tests
conducted daily and the 12 week study, the summary measure of
area under the curve (AUC) was evaluated for each animal and
the group means compared Matthews et al. (1990). Conventional
statistical measures such as Student’s t-test/ANOVA are unsuit-
able for serial data sets as they do not take into account the likely
correlation and dependence between time points. AUC and other
summary measures use the individual subject as the ’basic unit’
(Matthews et al., 1990) and use the results of the whole data time
series to summarise the individual responses. The individual
responses can then be pooled according to treatment groups and
the means compared by conventional measures.
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3.4 results
3.4.1 Assessments sensitive up to 7 days post-MCAO
Acute and sub-acute post-stroke global neurological and func-
tional deficits were assessed in 8 and 5 male SD rats following 70
min and Sham tMCAO, respectively. Global neurological score
was assessed daily. Functional assessments were conducted in a
main cohort of rats on days -1, 2 and 7 pre/post-surgery. These
included:
• The Corners test.
• The Adjusting Steps test trialled in a sub-cohort of two Sham
and five tMCAO animals.
• The Bilateral Asymmetry Test / Sticky Label Test (BAT), tri-
alled in a sub-cohort of two Sham and five tMCAO animals.
• The Whiskers Test: assessed daily in a sub-cohort of two
Sham animals and all eight tMCAO animals.
Fresh-frozen, H&E stained, 20µm sections of tissue were manually
delineated from optical MCID images. The mean infarct volume
was 130± 94mm3, (Figure 28). There were no abnormalities in
the Sham animals.
Transient MCAO produced global neurological deficits which
persisted over 7 days following 70min tMCAO (p< 0.0001, Figure
29).
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Figure 28: Infarct volumes quantified from H&E sections taken across the
MCA territory following 70min tMCAO. Mean volume: 130± 94mm3 (mean
±SD).
Figure 29: Daily Global Neurological Scores following Sham () or 70min
tMCAO (•). 70min tMCAO caused distinct neurological impairment
throughout the experimental period (p< 0.0001); Unpaired t-test of Group
AUC values. Sham (n= 5), tMCAO (n= 8) Data presented as Median ±
Interquartile range.
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In the Corners test, all rats which underwent tMCAO exhibited
an increased turning bias towards the ipsilateral side of damage
when exiting a 90 degree corner (p< 0.01, Figure 30). Sham ani-
mals showed no change in turning bias (p> 0.05).
Figure 30: The percentage of turns to the ipsilesional side (left) at days −1, 2
and 7 following Sham (blue) or 70min MCAO (red) during the Corners Test.
There were no pre-stroke differences (p> 0.05). 70min tMCAO caused distinct
neurological impairment with persistent turning to the left compared to Sham
animals at the same time points (*, p< 0.05) and compared to baseline values
(**p< 0.01); Kruskal-Wallace with Dunn’s multiple comparisons test. Data
presented as Box &Whiskers plot with minima and maxima and individual
data points superimposed in green. Sham (n= 5), tMCAO (n= 8).
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The number of adjusting steps/hops taken when the right (con-
tralesional/affected) and left (ipsilesional/unaffected) forelimb
was dragged laterally and medially from the body across a surface
for a distance of 0.9m. No significant changes in lateral stepping
actions were found 2 and 7 days post tMCAO with either fore-
limbs (p> 0.05, Figure 31). 7 days post tMCAO, there was a
significant decline in the number of medial adjusting steps in the
right forelimb only (Figure 32).
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Figure 31: The number of adjusting steps made when the left (top) and right
(bottom) forelimbs are dragged lateral from the midline on days -1, 2 and 7
following Sham (black) or 70min tMCAO procedure (red). There was no effect
of tMCAO on lateral stepping movements of either forelimb at any time point
(p> 0.05); Kruskal-Wallace with Dunn’s multiple comparisons test. Data
presented as Box & Whiskers plot with minima and maxima and individual
data points superimposed in green. Vertical dashed line represents MCAO at
day zero. Sham (n= 2), MCAO (n= 5).
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Figure 32: The number of adjusting steps made when the left (top) and right
(bottom) forelimbs are dragged medial from the midline on days -1, 2 and 7
following Sham (black) or 70min left tMCAO procedure (red). There was no
effect of MCAO on medial stepping movements of the left (ipsilesional)
forelimb. MCAO caused a reduction in the number of steps made with the
contralesional (right) forelimb at 7 days compared to baseline (p< 0.05);
Kruskal-Wallace with Dunn’s multiple comparisons test. Data presented as
Box & Whiskers plot with minima and maxima and individual data points
superimposed in green. Vertical dashed line represents MCAO at day zero.
Sham (n= 2), MCAO (n= 5).
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The Vibrissae Evoked Forelimb / Whiskers test was trialled daily
post-stroke and sham procedure (Figure 33). There was no effect
of left tMCAO on forelimb raising reflexes on the ipsilesional side
compared to Sham-operated controls (p> 0.05). Contralesional
right forelimb raising was permanently impaired by MCAO in
comparison to Sham-operated controls.
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Figure 33: The percentage failed forelimb placing reflexes following upward
vibrissae stimulation of the ipsilesional side (left, top) and contralesional side
(right bottom) at days 1 to 7 following Sham (•) or 70min left tMCAO
procedure () procedure. There was no effect of MCAO on reflex ability on
the ispilesional side. 70min MCAO caused distinct neurological impairment
of the contralesional forelimb reflex compared to Sham animals at the same
time points (***, p= 0.002), Unpaired t-test of AUC values. Sham (n= 2),
MCAO (n= 8).
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Stroke induced sensory neglect and tactile extinction was trialled
by the Bilateral Asymmetry Test (Figure 34). The time taken to
remove the label from the ipsilesional (left) and contralesional
(right) forepaws were measured. There were no differences in
any assessments of the MCAO group (p> 0.05).
Figure 34: The time taken for removal of the adhesive label from the ipsi- and
contra-lesional forepaw in the bilateral asymmetry test. There was no
statistically significant effect of MCAO on the removal times from the ipsi-
and contra-lesional forelimb however, there was a clear trend for an increased
removal time on the contralesional forepaw (p> 0.05, Kruskal-Wallace).
MCAO Contralesional (), MCAO Ipsilesional (), Sham Contralesional (N),
Sham Ipsilesional (N). Vertical dashed line represents MCAO at day zero.
Sham (n= 2), MCAO (n= 4).
All functional assessments showed evidence or trends for sen-
sitivity to unilateral sensorimotor dysfunction in the acute and
sub-acute post-stroke period. The small number of sham control
animals and absence of pre-surgical measurement of the vibrissae
reflexes warrant further investigation, with a larger number of
animals and an extension of the study period out to the early
chronic phase of post-stroke pathology. As such, all tests were
examined for sensitivity to post-stroke dysfunction up to 21 days.
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3.4.2 Assessments sensitive up to 21 days post-MCAO
With the Corners, Adjusting Steps, Whiskers and Bilateral Asym-
metry assessments showing evidence for sensitivity to post-stroke
dysfunction in the first seven days post-insult, all were assessed
for sensitivity out to 21 days. It also provided an opportunity to
continue to develop surgical skills.
T2 weighted RARE MRI was carried out 7-12 days post-stroke to
provide quantification of the infarct. The mean infarct volume
was 107± 82mm3 (Figure 35), with no statistical difference com-
pared to the 7 day study above (p> 0.05, two-tailed unpaired
t-test). It can be seen that the infarct volumes are biomodal in
their distribution with some large strokes involving cortical areas.
Figure 35: Infarct volumes quantified by manual delineation of T2
hyperintensities from RARE images acquired 7-12 days following 70 min
tMCAO. Mean volume: 107± 82mm3 (mean ±SD).
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In the Corners test, all rats which underwent tMCAO exhibited
an increased turning bias towards the ipsilateral side of damage
from days 2 to 14 post-stroke compared to sham controls and
baseline, (Figure 36). The inter-quartile range and median stroke-
induced turning biases increased over this period and at 21 days
there was no difference between stroke and sham animals. Sham
animals showed no change in turning bias from days −1 to 21,
(p> 0.05).
Figure 36: The percentage of turns to the ipsilesional side (left) at days -1, 2, 7,
14 and 21 following Sham (blue) or 70min tMCAO (red) during the Corners
Test. There were no pre-surgical differences and no change in Sham animal
performance. 70min tMCAO caused distinct turning bias compared to
baseline. Compared to Sham animals at the same time-points, tMCAO
animals showed left-turning bias up to 14 days post-occlusion (####,
p< 0.0001; ##, p< 0.01; #, p< 0.05; ns, p> 0.05) and compared to pre-MCAO
values (****, p< 0.0001; ***, p< 0.001; **, p< 0.01; ns, p> 0.05);
Kruskal-Wallace test with Dunn’s correction for multiple comparisons. Data
presented as Box &Whiskers plot with minima and maxima. Vertical dashed
line represents MCAO at day zero. Sham (n= 7), tMCAO (n= 16).
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The lateral and medial adjusting steps of the right forelimb were
counted on days -1, 2, 7, 14 and 21 post-MCAO or Sham surgery.
Lateral steps were only impaired on days 2 and 7 compared to
both the Sham group and baseline values and compared to base-
line on day 14 only (p> 0.05, Figure 37). There were no significant
changes in lateral stepping actions at 21 days post tMCAO com-
pared to sham and baseline (p> 0.05). Medial stepping motions
(Figure 38), were permanently impaired compared to baseline
values (p> 0.0001) and to the Sham group (p< 0.01, Days 2, 7,
and 14; p< 0.05, Day 21). There were no significant changes in
Sham group performances across timepoints (p> 0.05).
Figure 37: The number of adjusting steps made when the right forelimb is
dragged lateral from the midline on days -1, 2, 7, 14, and 21 following Sham
(blue) or 70min left tMCAO procedure (red). tMCAO impaired lateral
stepping movements up to day 7 compared to Sham controls.
(#, p< 0.05; ns, p> 0.05) and up to 14 days compared to baseline
measurements (****, p< 0.0001; ***, p< 0.001; ns, p> 0.05); Kruskal-Wallace
test with Dunn’s correction for multiple comparisons. Data presented as Box
&Whiskers plot with minima and maxima. Vertical dashed line represents
tMCAO at day zero. Sham (n= 7), tMCAO (n= 16).
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Figure 38: The number of adjusting steps made when the right forelimb is
dragged medial from the midline on days -1, 2, 7, 14 and 21 following Sham
(blue) or 70min left tMCAO procedure (red). MCAO impaired medial
stepping motions compared to Sham controls (##, p< 0.01; #, p< 0.05; ns,
p> 0.05) and consistently compared to baseline (****, p< 0.0001; ns, p> 0.05).
Kruskal-Wallace test with Dunn’s correction for multiple comparisons. Data
presented as Box &Whiskers plot with minima and maxima. Vertical dashed
line represents MCAO at day zero. Sham (n= 7), MCAO (n= 16).
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The sensitivity of the Vibrissae evoked forelimb / Whiskers test
to stroke-induced dysfunction on both ipsilesional and contrale-
sional hemispheres was trialled on days -1, 2, 7, 14 and 21 post-
stroke and sham procedure (Figure 39). There was no effect of
left tMCAO on forelimb raising reflexes on the ipsilesional side
compared to Sham-operated controls (p> 0.05). However, it can
be seen by the large variability in the results that some animals
did have a failed ipsilesional forelimb raising response but it was
not statistically significant. Contralesional right forelimb raising
was impaired by tMCAO in comparison to Sham-operated con-
trols at all time points with no evidence of spontaneous recovery
(p> 0.05).
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Figure 39: The percentage failed forelimb placing reflexes following upward
vibrissae stimulation of the ipsilesional side (left, top) and contralesional side
(right bottom) at days −1, 2, 7, 14 and 21 following Sham (blue) or 70min
tMCAO (red) procedure. There was no effect of tMCAO on reflex ability on
the ispilesional side (ns, p> 0.05). 70min tMCAO caused neurological
impairment of the contralesional forelimb reflex compared to Sham animals at
the same time points (****, p< 0.0001) and compared to baseline values;
One-way ANOVA with Bonferroni’s correction for multiple comparisons.
Data presented as mean±SD. Vertical dashed line represents tMCAO at day
zero. Sham (n= 3), MCAO (n= 11).
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The sensitivity of the bilateral asymmetry test to detect sub-acute
to early-chronic dysfunction was trialled days -1, 2, 7, 14 and 21
post-stroke and sham surgery (Figure 40). Sham surgery had no
effect on label removal times (p> 0.05). The time to remove labels
from both contralesional and ipsilesional forepaws was signifi-
cantly impaired by stroke at Day 2 only (p< 0.0001 & p< 0.01
respectively) compared to Sham groups and baseline. At all other
post-stroke time-points there were no differences in removal times
compared to sham-surgery controls and baseline times (p> 0.05).
Figure 40: The time taken for removal of the adhesive label from the ipsi- and
contra-lesional forepaw in the bilateral asymmetry test at days -1, 2, 7, 14 and
21 post-tMCAO or Sham procedure. 70min tMCAO increased label removal
times on both ipsilesional and contralesional forepaws 2 days post-surgery
compared to baseline and Sham equivalents (****, p< 0.0001; **, p< 0.01).
There were no differences between baseline or sham removal times at any
other timepoints. tMCAO Contralesional (), tMCAO Ipsilesional (), Sham
Contralesional (N), Sham Ipsilesional (N). Data presented as mean±SD.
Vertical dashed line represents tMCAO at day zero. Sham (n= 7), tMCAO
(n= 16).
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There was a loss of sensitivity to detect a deficit in the Corners
and Bilateral Asymmetry tests compared to Sham controls by
days 21 and 7, respectively. They were henceforth excluded from
future use. The Whiskers and medial Adjusting Steps tests con-
tinued to show evidence for sensitivity to unilateral sensorimotor
dysfunction in the sub-acute to early-chronic post-stroke period.
The larger n-numbers, pre-stroke data, and sham controls for all
tests increased the statistical power of these results.
The Whiskers and Medial Adjusting steps tests were selected as
tests for sensitivity in the long-term chronic post-stroke period
up to +12 weeks following MCAO.
3.4.3 Assessments sensitive up to 12 weeks post-MCAO
Due to the binary nature of the Whiskers test scoring and risks
of handler bias in The Adjusting Steps test; The Staircase test
(Montoya et al., 1991) was also trialled for use, due to previous
evidence of its sensitivity to long-term disability and limited user
bias (Trueman et al., 2011; Farr and Trueman, 2011).
Previous studies found the onset of post-CTX cell improvements
from 6-8 weeks following transplant with assessments continuing
up to 12 weeks post-transplant (Stroemer et al., 2009; Smith et al.,
2012). Therefore finding assessments with continued sensitivity to
post-stroke dysfunction up to 3 months following the ischaemic
insult was essential before conducting a longitudinal study in-
volving CTX0E03 cell transplantation.
Following a series of failed strokes in earlier pilot work, the
MCA occlusion time was increased to 90 min for this study. The
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Whiskers and Adjusting Steps tests were carried out 1 week prior
to, and weekly after stroke surgery. The Staircase test was carried
out 1 week prior, and fortnightly post-stroke surgery.
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All infarct volumes in this study were of small volume (23.5±
21mm3) occupying the caudate putamen only (Figure 41). Possi-
ble reasons for this are discussed below.
Figure 41: Infarct volumes quantified by manual delineation of T2
hyperintensities from RARE images acquired 4-10 weeks following 90 min
MCAO. Due to an administrative error, one animal did not undergo imaging.
Mean volume: 23.5± 21mm3 (mean ±SD).
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Following the success of the Adjusting Steps test to demonstrate
stroke induced forelimb akinesia up to 21 days following the is-
chaemic insult, its robustness was assessed over a 12 week period
following MCAO/Sham procedure (Figure 42). Sham animals
demonstrated no change in right forehand stepping function fol-
lowing surgery. Animals which underwent 90 min left tMCAO
demonstrated immediate dysfunction followed by a mean recov-
ery of stepping function to 40% to baseline performance (+56%
compared to performance at week 1). Comparisons of mean
group AUC values showed that left tMCAO induced persistent
deficits in medial stepping actions compared to sham surgery
only (p< 0.0001), with no effect on lateral stepping (p> 0.05),
(Figure 42).
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Figure 42: The number of adjusting steps made when the right forelimb is
dragged lateral (top) and medial (bottom) from the midline following Sham
(•) or 90min left tMCAO procedure () measured at -1 week prior to surgery
and weekly intervals thereafter. There was no effect of tMCAO on lateral
stepping movement (p> 0.05). Medial steps were permanently impaired by
left tMCAO (****, p< 0.0001) with a mean recovery of 40% by week 12. Data
presented as mean ±SD, group mean AUC comparisons via unpaired t-test.
Sham (n= 10), MCAO (n= 10).
3.4 results 117
From earlier Whiskers Test experiments it was found that left
MCAO will lead to a failed forelimb response to right whisker
stimulation. Although shown to be highly sensitive in earlier
assessments, we assessed this reflex deficit up to 12 weeks post-
MCAO. Left MCAO induced deficit of right vibrissae evoked
forelimb raising function was persistent and permanent with very
little evidence of spontaneous functional recovery (Figures 43)
compared to Sham controls (p< 0.0001) even in cases of small
infarctions (Figure 41). There was no permanent effect on left
forelimb raising (p< 0.05).
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Figure 43: The percentage failed homotopic forelimb placing reflexes
following upward vibrissae stimulation of the ipsilesional side (left, top) and
contralesional side (right, bottom). Sham (•) or 90min left tMCAO animals ()
were tested at -1 week prior to surgery and fortnightly intervals thereafter.
There was no effect of tMCAO on reflex ability on the ipsilesional side
(p> 0.05). 90min tMCAO caused permanent neurological impairment of the
contralesional forelimb reflex compared to Sham animals points with no
recovery (****, p< 0.0001). Group mean AUC values compared by two-tailed
unpaired t-test. Data presented as mean ±SD. Sham (n= 10), MCAO (n= 10).
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With the requirement for a robust sensorimotor test with sufficient
sensitivity to detect long-term stroke-induced deficits, the Stair-
case test was piloted over a period of 12 weeks following 90min
left tMCAO (Figure 44). Diet-restricted animals were trained
to retrieve sugar pellets from a 7-step bilateral staircase (3 per
step), accessible with the homotopic forelimb only. Sham animals
demonstrated no change in their ability to retrieve pellets using
the right forepaw following surgery. Animals which underwent
90 min left tMCAO demonstrated immediate dysfunction fol-
lowed by a limited recovery to 50% to baseline (20% compared to
performance at week +2) in right forelimb pellet retrieval. Long-
term sensitivity of the Staircase test was evaluated by calculated
individual animal AUC values and comparing group means. Both
tests showed that left MCAO induced persistent deficits in right
forelimb pellet retrieval compared to sham surgery (p< 0.0001).
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Figure 44: The number of pellets retrieved with the ipsilesional (left, top) and
contralesional (right, bottom) forelimbs following Sham (•) or 90min left
tMCAO procedure () measured at -1 week prior to stroke surgery and
fortnightly intervals thereafter. There was no effect of tMCAO on left forelimb
retrieval ability (p> 0.05). 90min tMCAO caused a sustained deficit in pellet
retrieval ability with the right forelimb (****, p< 0.0001) with a mean recovery
of function of 20% by week 12 compared to week 2. Group mean AUC
comparisons via two-tailed unpaired t-test. Data presented as mean ±SD.
Sham (n= 10), MCAO (n= 10).
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3.5 discussion
Identification of assessments appropriate for long-term stroke-
induced deficits was an essential task before undertaking a longi-
tudinal study with CTX0E03 cell treatment and MRI. Tests had
to be able to expose dysfunction consistently, and repeatedly as
well as being able to detect any beneficial, or indeed detrimental,
effect of the stem cell implantation.
In this chapter, the Bilateral Asymmetry Test (BAT), Corners,
Adjusting Steps, Vibrissae evoked forelimb raising, and later the
Staircase tests were assessed for sensitivity to tMCAO-induced
sensorimotor function. The BAT and Corners test were no longer
sensitive to sensorimotor dysfunction by 21 days post-stroke. The
remaining tests, as well as the Staircase test, were shown to be
suitable up to 84 days post-stroke.
7 & 21 day assessments
The global neurological scoring system, based on Modo et al.
(2000) and Bederson et al. (1986), was assessed daily (Figure 29).
There was a peak global deficit at Day 2 post-stroke. Scores
then plateaued at Days 6 and 7, a finding consistent with pre-
vious investigations (Modo et al., 2003). However, such assess-
ments are known to lose sensitivity in the later post-stroke phases
(Schaar et al., 2010) as the acute pathology resolves and masking
behaviour (in the rat) ensues. Modifications of the scales are
present, often with greater maximum scores to limit the ceiling
effect (Emma Reid, personal communication). Compared to Sham
controls, this battery of tests provides a useful means of acutely
determining whether tMCAO has been successful or not and the
overall welfare of the animal. Animals with consistently high
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impairments are unlikely to survive in the long-term and should
be euthanised on welfare grounds.
The Corners test, showed tMCAO-induced left turning bias up to
14 days post-ischaemia (Figures 30 & 36). Boue¨t et al. (2007) had
similar findings in the mouse with a loss in sensitivity by Day 24
compared to the previous assessment at Day 8 in comparison to
Sham controls suggesting a role of spontaneous recovery. These
results contrast with Shen et al. (2006) and Zhang et al. (2002) who
showed turning biases up to 28 and 90 days in the post-stroke rat
and mouse respectively. In both of these studies, tMCAO animals
had mean infarct volumes of approximately 35% of total brain
volume, similar to data presented in this thesis. It is likely that
differences in results are due to the subjective nature of the as-
sessment, whereby animal subjects often require encouragement
to perform and often adapted to the testing environment and as
such was discontinued from further investigations.
The Bilateral Asymmetry test is a popular sensory motor assess-
ment of MCAO-induced dysfunction due to its ability to evaluate
tactile extinction and obscuration (Schallert and Whishaw, 1984)
with various modifications to assess the magnitude of sensory
dysfunction (Soleman et al., 2012). There are multiple ways of
analysing the data gathered from such experiments including,
the latency between removal and contact time between forepaws,
the time taken to remove, and the time taken to detect the la-
bel. The test has proven popular in rodent stroke studies (Modo
et al., 2000; Virley et al., 2000; Freret et al., 2006; Stroemer et al.,
2009; Smith et al., 2012; Soleman et al., 2012). There are however,
variations on methodology including the use of a bracelet of ad-
hesive tape around the wrist rather than a circular label on the
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dorsal aspect of the paw (Stroemer et al., 2009). This makes the
task more challenging for an impaired rodent as well as more
time consuming. Such methods are likely to make the BAT more
sensitive to dysfunction; often a circular label on the forepaw is
relatively easy for an animal to remove. It was found in this study
that the bilateral asymmetry test was not sensitive to sensorimo-
tor dysfunction beyond 7 days post-MCAO, contrary to other
published research (Figures 34 & 40). The method of MCAO
used in the majority of the studies referenced earlier was the ILF
method similar to this thesis however Soleman et al. (2012) used
the parenchymal endothelin-1 model in aged rats. As well as
differences in stimulus used, analysis of the BAT is often up to as-
sessor interpretation and as such leaves it open to bias, especially
when the animal makes multiple attempts to remove the label,
and animal habituation is likely. The lack of apparent sensitivity
of the Bilateral Asymmetry test and high risk of user bias led to
the cessation of any further investigation of this test beyond 21
days post-stroke.
Counting the number of adjusted steps has been shown to be a
marker of long term dysfunction. Previous studies showed that
MCAO leads to a decline in the number of adjusting steps made
by the forepaw in a lateral direction to the midline (Vendrame
et al., 2004; Mine et al., 2013). In the above experiments, follow-
ingt MCAO there was no change in the number of lateral steps
after 14 days and in-fact a consistent decrease in the number of
medial adjusting steps (Figures 31, 32, 37 & 38).
The Vibrissae evoked forelimb (Whiskers) test is sensitive to stri-
atal, as well as cortical damage (see above). It was found that
this assessment is highly sensitive to MCAO-induced damage
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with consistent, failed reflexes at all time points for the respec-
tive investigations (Figures 33, 39, & 43), even in the case of
small infarctions (Figure 41). The noted deficits on the ipsile-
sional side were unexpected (Figure 39) and were likely to be
an effect of the surgery, in rare cases, or complacency due to the
animal becoming habituated to the task. When taken out to 12
weeks post-stroke (Figure 43), the variance in atypical ipsilesional
forelimb placement declines over a 6 week period, suggesting
recovery of impairment. The test has previously been shown to
be indicative of sub-cortical damage, and capable of detecting
rehabilitation following experimental treatments (Barth and Stan-
field, 1990; Schallert et al., 2000; Stroemer et al., 2009). Due to
its high sensitivity and the ease of which the test is conducted
(with little chance of bias, due to its binary scoring) and its use
in previous CTX-cell studies (Stroemer et al., 2009) the test was a
good candidate for use in the future longitudinal imaging study.
12 week assessments
In this series of experiments, animals in the tMCAO group had
small mean infarcts of 23.5mm3 involving the striatum only (Fig-
ure 41) likely due to partial occlusion of the MCA or high collat-
eral flow. Despite this, sensorimotor deficits were detectable and
persistent. This may be due to the susceptibility of white matter
to ischaemic damage (Pantoni et al., 1996; Goldberg and Ransom,
2003) and as such, important neuroanatomical white matter struc-
tures such as the internal capsule and anterior commissure within
the subcortical MCA territory. These neuroanatomical structures
as well as regions of the caudate putamen all contain white matter
tracts involved in inter- and intra-hemispheric communication
and even a small lesion is likely to cause sensorimotor defects.
Indeed, it has been shown that small focal lesions induced by
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intracranial administration of endothelin-1 can lead to structural
and functional deficits (Frost et al., 2006; Lecrux et al., 2008). It
is therefore feasible that antero- and retero-grade degradation
of sensorimotor pathways can occur without evidence of a T2
weighted lesion being apparent on imaging.
Compromised dexterity is often the most long-lasting deficit re-
ported by patients (Boue¨t et al., 2007) so use of a test which
assesses dexterity, such as the Staircase test is a clear choice when
evaluating the theraputic potential of any treatment. The Stair-
case test, Adjusting Steps, and whiskers test were all assessed for
sensitivity up to 12 weeks post-MCAO.
All three behavioural tests showed adequate sensitivity in de-
tecting long term sensorimotor deficits up to 12 weeks following
focal cerebral ischaemia induced via the intraluminal filament
model (Figures , 42, 43, & 44). The small volumes of sub-cortical
damage lead to partial recovery in staircase and adjusting steps
performance by 20% and 56% respectively. However, spontaneous
recovery can be expected (Schallert et al., 2000; Rossini et al.,
2003; Schaar et al., 2010). In a casual observation, some animals
with the larger infarcts often showed the least degree of recovery
although this was not always consistent. There was no overall re-
gain of forelimb placing function following vibrissae stimulation.
The results indicate that these three functional assessments are
suitable for investigating recovery of function following intrac-
erebral implantation of CTX0E03 cells. Functional recovery has
previously been shown in the vibrissae evoked forelimb test at 12
weeks following implantation of CTX cells (Stroemer et al., 2009).
The other two tests have previously been published in investiga-
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tions of cellular therapeutics for stroke and other neurological
disorders (Olsson et al., 1995; Do¨bro¨ssy and Dunnett, 2005) but
not for the CTX line for treatment of chronic ischaemic stroke.
The hypothesis to be tested is that the cell treatment group of
animals will show partial recovery in performance over a simi-
lar time course to that of previous studies; approximately from
5-8 weeks following transplantation (Stroemer et al., 2009; Smith
et al., 2012). By using three sensorimotor tests in combination
with multi-modal MRI, effects of the stroke and/or stem cell
therapeutic have a good chance of being identified.
4
E S TA B L I S H I N G N O N - I N VA S I V E
P H Y S I O L O G I C A L M O N I T O R I N G F O R
F U N C T I O N A L I M A G I N G U N D E R
M E D E T O M I D I N E S E D AT I O N W I T H
I S O F L U R A N E
4.1 introduction
Functional imaging studies are often met with various technical
and physiological challenges (see Introduction Chapter). Due to
the sensitivity of the BOLD signal to arterial pCO2 and other phys-
iological variables (Logothetis et al., 1999), it was essential that all
physiological variables were monitored and kept within range to
ensure robust, and reliable data were acquired. It was therefore
necessary that before undertaking a longitudinal functional imag-
ing study, confidence was needed that systemic physiological
variables, most crucially, arterial pCO2, could be monitored and
adjusted repeatedly and non-invasively. Previous studies have
used urethane, ketamine-xylazine mixtures or α-chloralose with
or without conjunctive administration of pancuronium bromide
for the detection of resting-state or stimulus specific BOLD signal
changes (Williams et al., 2010). However, these compounds are
unsuitable for serial imaging studies due to the requirement for
intravenous delivery, muscle paralysis, and the risk of seizures
and generally poor, or no recovery (Lukasik and Gillies, 2003).
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The longitudinal nature of the planned CTX-cell study (Chapter
5) required methods to non-invasively monitor physiological pa-
rameters. The aims of the experiments outlined in this chapter
were therefore to develop and optimise an anaesthesia protocol,
using the veterinary pharamceutical medetomidine, for in vivo
functional imaging based on well established protocols by We-
ber et al. (2006) and Lu et al. (2012). There was also an aim to
establish non-invasive monitoring of end-tidal (ET)-CO2, heart
rate, and SpO2 whilst maintaining appropriate physiological con-
trol during mechanical ventilation. Both of these were to ensure
the reliable acquisition of resting-state fMRI data in future studies.
An End Tidal (ET) Capnograph and an MRI compatible pulse
oximeter (Nonin) were investigated as non-invasive means of
evaluating ET CO2, heart rate, and SpO2 respectively. Compar-
isons were made between conventional invasive measurements
and non-invasive ones made with the trial equipment.
4.1.1 Physiology and Pharmacology of Medetomidine
The alpha-2 adrenoreceptor (α2 receptors) agonist, medetomidine,
is a well documented drug of choice for in vivo functional imaging
(Weber et al., 2006; Lu et al., 2012). An understanding of its
mechanism of action provides an insight into its suitability and
an appreciation for the side-effects which accompany its use.
Alpha-2 adrenoreceptors in the central nervous system
α2 adreoreceptors are a Gi/o subtype of the adrenergic G-protein
coupled receptors (GPCR), (Bylund, 1988; Alexander et al., 2008),
whose primary mechanism of action is via the inhibition of adeny-
lyl cyclase with subsequent reduction in cAMP levels within cells.
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In situ hybridisation studies have identified the location of all
three of the α2 receptor sub-types (A, B and C) in various struc-
tures within the brain (Scheinin et al., 1994), making them clear
targets of interest for neuropharmacological intervention. In the
study mentioned above, α2A receptors were found to be highly
localised to the locus coeruleus (LC) in the hindbrain. The LC
contains the highest density of noradrenergic neurones in the
brain with projections throughout the CNS. Its primary purpose
is the promotion of wakefulness via projections to other nuclei re-
sponsible for alertness (Samuels and Szabadi, 2008), inhibition of
regions involved in REM sleep (Hou et al., 2002), and the cerebral
cortex (Jones and Yang, 1985). The release of noradrenaline from
LC neurones is co-regulated with µ-opioid receptors (Nakai et al.,
2002). It is therefore unsurprising that the LC has been a region of
interest for pharmacological intervention either via targeting neu-
ronal autoreceptors (surface receptors of the transmitting neuron)
altering synaptic behaviour, or by acting on LC target neurones.
Effects of Alpha-2A agonism & the Requirement for Physiological Control under
Medetomidine Sedation
Agonism of α2 receptors with clonidine or medetomidine gen-
erates sedative effects (Buerkle and Yaksh, 1998; Savola et al.,
1986; Hedenqvist et al., 2000). Although not often used in human
medicine, medetomidine and its enantiomer, dexmedetomidine,
are frequently used as pre-operative sedatives in veterinary prac-
tice and pre-clinical research (Sinclair, 2003). Hypotension is a
marked effect of centrally acting α2 agoinsts with subcutaneous,
intravenous or intramuscular administration demonstrating res-
piratory depression and bradycardia in out-bred strains of rats.
The hypotensive, respiratory, and bradycardic effects of alpha-2
agonists in vivo require careful monitoring so as to ensure phys-
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iological parameters do not deviate towards deleterious ranges,
even under appropriate dosing. This is of particular importance
for blood pressure, and arterial pCO2. Cerebral vasculature has
a limited capacity for autoregulation out with a systemic blood
pressure range of 70-160 mmHg (Herna´ndez et al., 1978) and
CO2 has a pronounced vasodilatory effect on arterioles at partial
pressures above 45 mmHg (Kety and Schmidt, 1948). There is
no evidence of medetomidine causing marked changes to the
BOLD signal related to neural activity compared to α-chloralose
or ketamine-xylazine mixtures in the default mode or sensorimo-
tor networks (Magnuson et al., 2010; Lu et al., 2012). However,
as the BOLD signal is highly sensitive it was important to de-
velop an optimal range of parameters, under a suitable means
of ventilation, by which all relevant physiological variables were
monitored and controlled within adequate ranges.
4.1.2 End Tidal Capnography
Carbon dioxide, a potent cerebral vasodilator, is an important
variable to maintain within a range of 35-45mmHg in arterial
blood. Arterial blood gas (ABG) measurements for arterial partial
pressures of CO2 (paCO2) are accurate but invasive and discrete.
Due to limitations in the amount of blood that can be withdrawn
for longitudinal studies, capnography is a suitable alternative as
it is a non-invasive and continuous means of ascertaining physio-
logical paCO2.
The structure of carbon dioxide lends itself to optical measure-
ments in the infrared (IR) spectrum with an absorption at 4.3µm.
Therefore, the concentration of carbon dioxide in a sample of
gas can be calculated by comparing the IR intensity prior to, and
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Figure 45: Model capnogram from (Thawley and Waddell, 2013) in normal
physiological scenarios divided into four phases. I, exhalation of dead space
gas; II, exhalation of a mixture of dead space and alveolar gases; III,
exhalation of alveolar gases (the end of which is the End Tidal value); and IV,
inspiration. P a CO2 in mmHg.
following passage through the sample. CO2 is typically measured
as % or mmHg. The standard waveform for a normal capnogram
is detailed in Figure 45.
There are two main methods of capnography for artificially venti-
lated animals. These are defined in terms of the position of the
sensor to the ventilation pathway: Side-stream, and main-stream.
A main-stream device measures pCO2 directly from the airway
with no time delay. Side-stream analysis samples expired air from
the ventilation tubing, causing a time delay with peak End-tidal
CO2 (ET-CO2) readings out of phase with the breathing rate. The
time delay can be exacerbated by the length of the sampling line.
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4.2 methods
4.2.1 Experimental animals
Naı¨ve, male Sprague-Dawley rats weighing 315-420g were used
in this pilot study. Experiments were carried out with the animal
in the MRI cradle on the bench-top, simulating the scenario of
the animal being in the scanner bore. All experiments were
non-recovery.
4.2.2 Anaesthesia protocol
The medetomidine administration protocol published in Lu et al.
(2012), in turn based on Weber et al. (2006), was chosen as it was
shown to be robust and reproducible.
Rats were initially anaesthetised according to the standard proto-
col described in Section 2.2.3 with the exception of using medical
air instead of nitrous oxide. The animals were then intubated and
cannulated (Sections 2.3.3 and 2.3.2), and transferred to the cradle
and maintained under 2% isoflurane by mechanical ventilation
at 1 l/min of medical air, supplemented with O2 at 24-27% of
inhalation volume measured using an oxygen sensor (Viamed,
UK).
Stock solutions of medetomidine (Domitor, Orion Pharma) and
reversal drug, atipamezole (Antisedan, Orion Pharma), were sup-
plied at 1 mg/ml and 5 mg/ml respectively and stored at room
temperature. The animals were weighed and aliquots of the stock
solutions were diluted in saline to 100 µg/kg/ml and at 100
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µg/kg, respectively.
A syringe containing 10 ml of the medetomdine solution was
mounted onto a syringe pump (Fresenius Kabi, Injectomat MC
Agilia R©) and connected to a cannula inserted into the subcuta-
neous space of the shaved flank. A 0.5 ml bolus dose of medeto-
midine was administered subcutaneously and isoflurane levels
gradually reduced to, and maintained at 1%. 15 minutes fol-
lowing the bolus, the subcutaneous infusion was started at 1
ml/hour.
Recovery from sedation
Whilst still on the ventilator, medetomidine sedation was reversed
by subcutaneous injection of 100 µg/kg atipamezole. Once signs
of conciousness began to appear (after 3-5min), the intubation
tube was removed and the animal recovered in individual housing
cages overnight before being returned to group housing.
4.2.3 Ventilation and side-stream capnography
The animals required artificial ventilation as the medetomidine
administration at the doses described suppressed spontaneous
breathing in our Sprague-Dawley rats.
Side stream sampling of a closed ventilation system introduces
challenges in maintaining adequate ventilation due to the rela-
tively large volumes sampled from the circuit compared to the
lung volume of the rat (minute volume 27ml/min/100g (Strohl
et al., 1997)) which reduces the ventilation pressure. As such, two
different ventilators were tested with an aim to determine which
one could accommodate the challenges that side-stream sampling
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brings.
Two capnographs were also assessed (details in Table 3 and below).
With each ventilator set up, end-tidal gases were sampled from
the expiration line, with an example shown in Figure 46.
1. Ugo-Basile Volume Cycling Ventilator (Harvard Apparatus):
A prescribed tidal volume is delivered via a cylinder-piston
assembly with the motor speed determining respiration rate.
2. SAR-830 Dual Volume/Pressure Cycling Ventilator (CWE
Instruments): Pressure driven ventilators offer more precise
control of in vivo ventilation by offering management of the
specified inspiration pressure (cm H2O), flow rate (cc/min),
inspiration time (Ti, ms) and rate (bpm). The ventilator will
inspire to a specific pressure at a specified flow and rate; the
latter is overridden if Ti is greater than the reciprocal of the
rate. Tidal volume can be calculated as the product of flow
and inspiration time or conversely, the required flow rate can
be calculated as twice the product of the tidal volume and
respiration rate. Expiration depends on the compliance of
the lungs.
Parameter CAPSTAR-100 microCAPSTAR
Measurement range (% CO2): 0− 10 0− 9.9
Accuracy (mmHg): n/a 1.1
Response Time (ms at 50ml/min): 130 150
Sample Flow Rate Range (ml/min): 10− 50 5− 20
Table 3: Specifications for the CAPSTAR-100 and microCAPSTAR (both CWE
Instruments).
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Figure 46: Photograph of the Three-way Luer connector (internal diameter
4.1mm) used for artificial ventilation and end-tidal sampling when ventilating
with the SAR-830 Pressure cycling system. (A) Male Luer connection to the
intubation tube; (B) inspiration line; (C) connector for airway pressure sensor;
(D) Luer-Y connector with capnograph sampling line attached; (E) expiration
line. The tubing for volume-cycling ventilation had a similar set up with the
exception of the use of a two-way Luer connector.
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4.2.4 Pulse Oximetry
Once the animal was secured within the cradle, the pulse oximeter
was attached to the hindpaw of the non-cannulated limb and
secured using tape (Leukoplast).
4.2.5 Data analysis
This study involved the sampling of physiological data at various
time points both within, and between groups. The data below are
summarised in two parts:
i The group means of the average physiological variable for
each animal were compared to assess whether there were any
large differences between ventilation-capnograph paradigms.
ii To determine which paradigm ensured the greatest stability
of each variable over the duration of experiment, the respec-
tive standard deviations of each experimental variable were
compared by one-way ANOVA, with Tukey’s test for multiple
comparisons.
To assess how well the End-tidal CO2 measurements agreed with
the arterial blood gas values, the data were assessed by the Bland-
Altman method (Bland and Altman, 1999) corrected for multiple
comparisons within each individual (Bland and Altman, 2007).
The term ’bias’ is used to define the mean difference between the
two measurement methods, which has its own variance. Ninety-
five per cent of the expected differences between measurements
can be expected to be found within the 95% Limits of agreement.
It is these limits which are corrected for multiple comparisons
within individuals by multiplying the variance by a factor which
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reflects the number of observations made (further details are in
the aforementioned reference).
The above method was chosen as it is inappropriate to assess
agreement between measurements using a correlation coeffiecient
as such values signify the strength of a relationship between two
independent variables, not their agreement. Correlation coeffi-
cients also have a high incidence of false positives and depend on
the range of the data (see Bland and Altman (1986)). End-tidal
carbon dioxide measurements were expected to be slightly lower
than arterial gas measurements due to alveolar dead space, as
such, one will expect a small bias which represents this physio-
logical constraint.
Statistical advice for this study was sought from Dr J. McClure,
Institute of Cardiovascular and Medical Sciences, University of
Glasgow.
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4.3 results
Three experimental set-ups were tested:
1. Volume-cycling ventilator with CAPSTAR-100 (n=4)
2. Pressure-cycling ventilator with CAPSTAR-100, (n=3)
3. Volume-cycling ventilator with Microcapstar, (n=6)
The mean durations of these experiments were 191, 168, and 189
minutes for each experimental group, respectively.
During the experimental period, changes of the tidal volumes
and percentages of inspired oxygen delivered to each animal to
maintain paCO2 and pO2 within normal ranges (35− 45mmHg),
and (min. 80mmHg) respectively. The accuracy and effect of side
stream-sampling of expired air by capnographs on arterial blood
gases were investigated.
4.3.1 The effect of medetomidine on heart rate and measurement accuracy of the
pulse oximeter.
Heart rates were monitored via the femoral artery cannula trans-
ducer (Section 2.3.3) and the pulse oximeter attached on the
opposite foot (Section 4.2.4).
The effect of medetomidine bolus on heart rate
Medetomidine is known to induce bradycardia. This was con-
firmed in 7 animals with measurements of heart rate before the
bolus (2.5% isoflurane) and after the start of the infusion (1%
isoflurane, 15 minutes later) via the arterial cannula. A subcuta-
neous bolus of 50µg/kg medetomidine caused a mean reduction
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in heart rate of 71± 41bpm (SD), (Figure 47).
Figure 47: Heart rates recorded via femoral artery cannula prior to
subcutaneous administration of medetomidine bolus (50µg/kg) and 15 min
later when the subcutaneous infusion (100µg/kg) was initiated.
Agreement between Pulse Oximeter and Arterial line on heart rate measurement
The use of a non-invasive MRI compatible pulse oximeter capable
of accurate heart rate measurements is obvious benefit for longitu-
dinal functional imaging studies. Simultaneous measurements of
heart rate from the arterial line transducer and the pulse oximeter
were compared.
As shown in Figure 48, the low bias and small limits of agree-
ment between measurements satisfied us that linear regression
with 95% prediction intervals between the two would confirm the
ability of the pulse oximeter to accurately measure heart rate.
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Figure 48: Bland-Altman plot of the bias and 95% limits of agreement between
simultaneous measurements of heart rate from a femoral arterial line and
pulse oximeter attached to the contralateral hindpaw. Bias = −0.48 and 95%
Limits of agreement (corrected) = −10.64 to 9.68
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4.3.2 Arterial pO2 changes and agreement between Arterial O2 saturation and
SpO2
Since the BOLD signal depends on deoxyhaemoglobin levels, ar-
terial partial pressures of oxygen are another variable essential to
maintain during functional imaging. Arterial oxygen pressures
must be maintained to at least 80 mmHg to avoid hypoxia. Hy-
peroxia does not perturb the BOLD signal until pressures of over
200 mmHg are reached, where paramagnetic free oxygen then
begins to dissolve in blood plasma (Tuunanen and Kauppinen,
2005).
Arterial oxygen levels in artificially ventilated animals depend
on the levels of oxygen in the inhaled gases as well as on tidal
volumes (Figures 49 50, 51& 62, and Table 4).
Figure 49: Changes in Arterial pO2 with respect to inspired O2 (right) while
ventilated using the Volume-cycling ventilator with CAPSTAR-100 sampling.
Animal 1(•); Animal 2 (); Animal 3(N); Animal 4(H).
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Figure 50: Changes in Arterial pO2 with respect to inspired O2 (right) while
ventilated with the Pressure-cycling ventilator with CAPSTAR-100 sampling.
Animal 7(◦); Animal 8 (); Animal 9(4).
Figure 51: Changes in Arterial pO2 with respect to inspired O2 (right) while
ventilated using the Volume-cycling ventilator with Microcapstar ET-CO2
sampling. Animal 12 (•); Animal 13 (•); Animal 14 (•); Animal 15 (•); Animal
16 (•); Animal 17 (•).
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Mean pO2 levels were maintained above 80mmHg for all exper-
iments (Figure 52). However, animals in the Volume-CAPSTAR
group (Figure 49) were frequently mildly hypoxic even with in-
creases in tidal volume. The percentage of inspired oxygen for
each group are summarised in Table 4.
Variable Vol-CAP Press-CAP Vol-microCAP
Inspired O2 (%) 27.0± 3.2 26.4± 3.0 27.5± 2.1
Tidal Volume (ml) 6.8± 1.1 7.2± 2.7 5.3± 0.5
Table 4: Ventilation parameters. Vol-CAP (n=4), Press-CAP (n=3),
Vol-microCAP (n=6). Data presented as mean±SD.
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In the experiments with the pressure cycled ventilator and the
Microcapstar (Figures 50 & 51), all animals began the experi-
ments with pO2 levels greater than 90mmHg despite similar lev-
els of inhaled oxygen. The pressure-ventilated paradigm caused
higher mean pO2 than the volume driven experiments with the
CAPSTAR-100 too. (Figure 52). The partial pressures of oxygen
throughout these experiments were all equally variable (Figure
53).
Figure 52: Summary graph of the Mean arterial pO2 over the duration of the
experiment for each animal. Animals in the Volume-CAPSTAR100 group had,
on average, lower arterial pO2 compared to the Pressure-cycling group,
p< 0.05 (One-way ANOVA with Tukey’s multiple comparisons test). Data
presented as mean±SD.
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Figure 53: Standard deviations of each animal’s pO2 throughout the course of
their respective experiment. The SD provides an indication of the variability of
the pO2 in response to changes in inspired oxygen. No statistically significant
differences were identified between groups (One-way ANOVA). Data
presented as mean±SD.
Figure 54: Bland-Altman plot assessing the agreement between blood oxygen
saturation measurements by non-invasive pulse oximeter measurements and
from arterial blood sampling from a femoral artery cannula.
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From Figure 54 it can be seen that the differences between oxygen
saturation measurement values vary according to the size of the
measurement, shown by the downward slope in the data: in other
words, the variance in the measurements increases as measured
values decrease. This would not be resolved by a logarithmic
transformation of the data. Bland and Altman (1999) recom-
mended ”modelling the variability in the SD of the [differences]
... based on absolute residuals from a fitted regression line”. This
means that the variability of the variances in measurements are
fitted to a regression line i.e. adjusting for the differences between
measurements, to establish a more robust measure of agreement.
The differences (D) between measurements were regressed against
the average (A) values of O2 saturation (Equation 4). To calcu-
late the limits of agreement of this relationship, ie, the variation
about the line of best fit, the residuals (R) of the differences are
then regressed against the average values (Equation 5). If the
relationship between R and A is not significant, the standard
deviation of the adjusted differences is the SD of the residuals. If
the relationship is significant, the SD of the residuals is multiplied
by
√
pi
2 and Equations 4 and 5 combined.
D = b0 + b1A (4)
R = c0 + c1A (5)
In the case of Figure 54, the resultant regression based on Equation
4 was:
D = 98.2− 0.98A (6)
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The residuals of Equation 6 were not significantly different from
the average measurements. As such, the 95% limits of agreement
for this regression were:
98.2− 0.98A± 1.96× 4.15 (7)
With this 95% agreement limit and a slope of approximately 1,
inference can be made of good agreement between measurement
options. As such, it was determined that the pulse oximeter
provided accurate measurements of blood oxygen saturation.
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4.3.3 Requirements to modify ventilation parameters to maintain paCO2
Arterial carbon dioxide levels are a fundamental variable in cere-
bral blood flow investigations due to its potent effect on cerebral
blood flow. Tidal volumes were adjusted throughout the experi-
mental periods with an aim to achieve normal, stable physiologi-
cal variables. Within-group changes are illustrated in Figures 56,
57, 58, and summarised in Figures 59, 60, 61, and 62. Group tidal
volumes are summarised in Table 4.
Experiments were conducted using the conventional volume cy-
cling ventilator with End-Tidal sampling with the CAPSTAR-100,
(Figure 56). All animals were acutely hypercapnic at the start
of the experiment with ventilation volumes gradually increased
to compensate. Volume changes were made slowly to avoid
over-inflation and damage of the pleural tissues. The return to
normocapnia proved challenging due to the side-stream sampling
by the capnograph, taking up to 120 min with tidal volumes of
up to 8.5ml required. The reduction in ventilation volume and
subsequent hypercapnia in Animal 1 was intentional in order to
acquire resting-state data under hypercapnia. The experiment
involving Animal 2 was terminated because the animal became
intolerant to the anaesthesia protocol.
CAPSTAR-100 side-stream sampling with pressure cycling ven-
tilation was evaluated to ascertain whether delivery at constant
peak inspiratory pressure would compensate for pressure loss
caused by the capnograph. However, responses to ventilation
were highly variable, (Figure 57). More frequent changes in tidal
volume were required to keep arterial blood gases within the
normal range compared to the constant volume ventilator (Figure
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62). This could have been due to our relative inexperience in
using this particular set-up.
The Microcapstar samples at smaller volumes compared to the
CAPSTAR-100 and was evaluated in 6 animals using the volume-
cycling ventilator. Any requirements to change tidal volumes
were far lower than with the other set-ups (Figures 58 & 62). This
did not limit difficulties in maintaining normocapnia. Mean arte-
rial pCO2 values (Figure 59) and mean tidal volumes (Figure 60)
were varied in each experiment. No differences were found in the
variability of paCO2 between the three experimental paradigms
(Figure 61) despite there being differences in the the tidal volume
variances (Figure 62).
4.3.4 Comparison of End-tidal CO2 measurements in relation to arterial pCO2
As described in Section 4.3.3 above, it was necessary to see
whether we could reliably measure end-tidal CO2 using side-
steam capnography as a non-invasive means of ascertaining pCO2.
At times of arterial blood sampling, we simultaneously recorded
the ET-CO2 for comparison. It is known that the end-tidal pCO2 is
3-5mmHg lower than the arterial pCO2 due to the alveolar dead-
space (Larson and Severinghause, 1962), so we expected a similar
bias in our measurements. The results of these comparisons are
summarised in Table 5 with individual group results described in
Figure 55.
All experiments showed substantial bias with both capnograph
set-ups consistently under-reading ET-CO2. Although the micro-
CAPSTAR showed the lowest measurement bias compared to the
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arterial pCO2, it had the widest limits of agreement (Figure 55C).
As Figure 55B shows, using a Pressure-cycling ventilation unit
caused a smaller bias in ET-CO2 readings with the CAPSTAR-100
compared to the conventional ventilator (Figure 55A), however
as discussed above (Figures 58 & 60) we experienced far greater
challenges in delivering a consistent tidal volume (Figure 62) to
maintain a normal range of arterial pCO2 with equal variance as
the other experimental paradigms (Figure 61).
Variable Bias ± SD 95% Limits of agreement (corrected)
Vol-CAP 38.00± 7.40 21.9− 54.0
Press-CAP 18.05± 4.01 10.15− 25.95
Vol-microCAP 14.24± 12.35 −11.20− 39.68
Table 5: Summary of the Bias and limits of agreement for arterial pCO2
measurements compared to ET-CO2. Limits of agreement were adjusted for
multiple comparisons.
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Figure 55: Bland-Altman plots comparing paCO2 measurements made via
arterial blood gases and side-stream capnography. Bias represented by the
central dashed line and 95% limits of agreement by the dotted lines. ’Vol-Cap’
group (A); ”Press-Cap’ group (B); and ’Vol-microCap’ (C).
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4.3.5 Arterial pCO2 changes
Figure 56: Arterial pCO2 changes using CAPSTAR-100 sampling (left) and
changes made to tidal volume (right) in response to paCO2 changes under
volume cycling ventilation. Animal 1(•); Animal 2 (); Animal 3(N); Animal
4(H).
Figure 57: Arterial pCO2 changes and changes made to tidal volume in
response (right) using CAPSTAR-100 sampling under Pressure-cycling
ventilation. Animal 7(◦); Animal 8 (); Animal 9(4).
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Figure 58: Arterial pCO2 changes and changes made to tidal volume in
response (right) using the Volume-cycling ventilator with Microcapstar
sampling. Animal 12 (•); Animal 13 (•); Animal 14 (•); Animal 15 (•); Animal
16 (•); Animal 17 (•).
Figure 59: Summary graph of the Mean arterial pCO2 of each animal for the
duration of the experiment. Vol-CAP (n=4), Press-CAP (n=3), Vol-microCAP
(n=6). Data presented as mean±SD.
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Figure 60: Summary graph of the Mean Tidal volumes delivered to each
animal for the duration of the experiment. Vol-CAP (n=4), Press-CAP (n=3),
Vol-microCAP (n=6). Data presented as mean±SD.
Figure 61: Standard deviations of each animal’s paCO2 throughout the course
of their respective experiment. The SD provides an indication of the variability
of the paCO2 throughout the individual experiment. No statistically
significant differences were identified between groups (One-way ANOVA).
Data presented as mean±SD.
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Figure 62: Standard deviations of each animal’s tidal volume throughout the
course of their respective experiment. The SD provides an indication of the
variability of the changes required to maintain normal paCO2 for each set-up.
Differences were seen when comparing the volume-cycling paradigms to the
pressure-cycling experiments (****, p< 0.0001) but not between volume cycling
setups (p> 0.05); One-way ANOVA with Tukey’s multiple comparisons test.
Data presented as mean±SD.
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4.3.6 Summary of Physiological variables
Table 6 below summarises the aforementioned and other physio-
logical variables measured during the experimental periods.
Variable Vol-CAP Press-CAP Vol-microCAP
Heart Rate (bpm) 306± 13 270± 13 264± 30
MABP (mmHg) 101± 21 94± 6 81± 12
Body Temperature (◦C) 37.4± 0.1 36.9± 0.1 37.3± 0.3
Arterial pCO2 (mmHg) 49.25± 5.31 38.47± 6.52 45.72± 6.3
Arterial pO2 (mmHg) 84.56± 3.43 112.1± 12.65 99.99± 10.65
pH 7.37± 0.05 7.48± 0.05 7.41± 0.05
Table 6: Average physiological variables collated from the start of the
medetomidine infusion to the end of the experiment. Vol-CAP (n=4);
Press-CAP (n=3); Vol-microCAP (n=6). Vol-CAP (n=4), Press-CAP (n=3),
Vol-microCAP (n= 6). Data presented as mean±SD.
4.4 discussion
We aimed to optimise methods of monitoring End-tidal CO2,
heart rate, and SpO2 in order to carry out longitudinal functional
imaging noninvasively. End-tidal capnography and pulse oxime-
try were compared against measurement of arterial blood gases
and blood pressure measurement via femoral artery transducer.
Methods for compensation of changes in ventilation pressure
caused by side-stream CO2 sampling were also investigated.
As previously shown, medetomidine exerted a pronounced brady-
cardic effect (Figure 47). However, mean arterial blood pressure
was maintained at homeostatic levels (Table 6).
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During the first series of experiments, substantial challenges were
encountered in maintaining normoxia and normocapnia (Figures
49, 52, 56, and 59). With the animal being in the prone position in
the cradle, collapse of the lungs (atelectasis) by artificial ventila-
tion caused hypoxia and hypercapnia. This was exacerbated by
the high volume of sampling by the CAPSTAR-100 (minimum 10
ml/min) reducing the overall pressure in the ventilation circuit.
The higher mean heart rates and lower blood pH of this group
are likely to be explained by the persistent hypercapnia (Table 6).
Attempts to maintain a constant tidal volume and a fixed peak
expiratory pressure during ventilation using the SAR-830 venti-
lator proved troublesome due to our inexperience with the unit
(Figures 57, 60, and 62). ET-CO2 sampling with this setup was no
more beneficial than using the volume-cycling ventilator (Figures
55b and Table 5). There was no time to further investigate the use
of this set-up. There were no challenges in maintaining sufficient
oxygenation (Figure 50).
Variations in pO2 (Figure 53), paCO2 (Figure 61) and tidal volumes
(Figure 62) during the course of each experiment, are largely at-
tributable to our attempts to maintain variables within normal
ranges. The large variances are mostly explained by challenges
caused by the lengths of the ventilation line, and the sample line
(described below).
Overall, none of the configurations tested measured ET-CO2 in
a manner which reliably represented the arterial pCO2 (Section
4.3.4). As such, predicting a change in measured ET-CO2 with
linear regression (and the relevent 95% prediction intervals) to a
reasonable degree of accuracy to true arterial pCO2 was impossi-
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ble.
ET CO2 is typically 3-5 mmHg less than arterial pCO2 due to
alveolar dead space (Larson and Severinghause, 1962). However,
the length of the sampling line from the ventilator expiration
line to the sensor (outside the MR bore) has a length of 7m; the
recorded sample is substantially lower than the expected ET CO2.
Aside from line-length, leakage and turbulence caused by the
additional sampling line and connectors will generate challenges
in ventilation and sampling. Compliance of ventilation tubing
may also have an effect on physiological maintenance, especially
with the lengths required to ventilate in the scanner. Softer, more
compliant tubing will be more elastic under ventilation pressure
changes, as such reducing flow through the system whereas more
resilient tubing will maintain a more consistent ventilation pres-
sure. Artificial ventilation is a closed circuit system with gases
delivered and extracted at specified volume and/or pressure. By
the addition of a side-stream sampling line, drawing expired
gases at a prescribed rate, overall pressure within the circuit de-
creases.
Based on the results of the experiments above, it was decided
that end-tidal capnography for MRI imaging required further op-
timisation to be able to be used effectively. Further optimisation
would need more time than what was available to complete the
longitudinal CTX cell investigation. We therefore chose to omit
the capnography and measure arterial pCO2 via femoral artery
blood sampling. Cannulation of the artery also permitted continu-
ous measurement of mean arterial blood pressure. Upon recovery
of the animal, we were able to seal the arteriotomy in the femoral
artery using diathermy forceps and successfully reperfuse the
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hind-limb . As the pulse oximeter demonstrated good agreement
in measurements of heart rate and SpO2, it was deemed suitable
for use in future studies.
The future work is now being carried out to continue to optimise
end-tidal capnography of rats using an MRI compatible set-up.
The details of the aforementioned results are being considered in
the design of these experiments.
5
M R I I N D I C E S O F F U N C T I O N A L R E C O V E RY
F O L L O W I N G C T X0E03 C E L L
T R A N S P L A N TAT I O N A F T E R I S C H A E M I C
S T R O K E
5.1 introduction
The brain is required to integrate and respond to a huge amount
of external and internal stimuli. It is commonly accepted that
distinct neural populations of the brain (nodes) interact with
each other in networks which coordinate in response to stimuli,
forming the basis of cognition and behaviour (Mis˘ic´ and Sporns,
2016). Ischaemic damage to the brain can disrupt these networks,
leading to functional and cognitive impairment.
With the failures to advance acute interventions beyond that of
thrombolytics or mechanical removal of emboli to limit the extent
of injury (Hacke et al., 2008; Kalra, 2010), attention has turned
towards the use of stem cells as a means of recovery and/or repair
of the post-stroke brain. Stem cells’ inherent multipotency, and
their proliferative capacity and trophism in response to injury
suggest that they may be suitable as a therapeutic in the later
stages of stroke (Sinden et al., 2012).
BOLD imaging (see Introduction Chapter) is the most popular
modality used to study brain network connectivity during ac-
tivation and rest (Fox and Raichle, 2007). As such, it provides
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a means in which to assess the functional network changes in
disease states as well as the brain’s responses to therapeutics.
5.1.1 Resting state fMRI and the post-stroke brain
Within the resting brain, there exist temporal correlations in low-
frequency BOLD signals between spatially distinct, but func-
tionally associated regions. This extended the well-established
stimulus-driven fMRI methodology into one where patients are
simply asked to remain motionless and ’at rest’ during imaging
(Biswal et al., 1995; Auer, 2008). Similar findings have been shown
using Positron Emission Tomography (PET) (Horwitz et al., 1984;
Friston et al., 1993) and electrophysiological methodologies such
as electrocorticography (He et al., 2006). Histological and neu-
roanatomical investigations (such as Diffusion Tensor Imaging)
have supported functional connectivity hypotheses with rele-
vant structural connectivities within the brain cytoarchitecture
(Bressler and Menon, 2010).
Recognition of the dynamic behaviour of the resting brain dur-
ing health and aberrations in disease have clinical potential in
both diagnosis and prognosis. The conservation of resting-state
networks among species including rodents (Pawela et al., 2008;
Lu et al., 2012), allows detailed in vivo experiments to probe the
direct mechanisms of brain connectivity in disease states.
Stroke is a sudden and focal injury to a region of the brain
with global consequences. Network changes post-stroke are not
restricted to the peri-infarct region. Whole brain changes in con-
nectivity have been identified in various regions of the brain (Kim
et al., 2015; Vallone et al., 2016) associated with the symptoms
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of diaschisis (dysfunction in areas remote from the infarct locus
(Seitz et al., 1999)).
Post-stroke disability can make task-based fMRI paradigms (such
as finger tapping) challenging for patients. Other issues regarding
task based functional imaging for stroke subjects are the limita-
tions of the task paradigm to a certain network within a specific
time frame, therefore neglecting the global and temporal changes
in the BOLD signal throughout the brain (Carter et al., 2012).
The absence of a stimulus paradigm in resting-state imaging can
improve the practicality of investigating disabled stroke patients.
By assessing post-stroke connectivity with resting state-fMRI
(rs-fMRI), it is hoped that it can become a useful methodology
for identifying the structural and functional correlates of stroke-
induced dysfunction, the resultant plasticity changes, as well as
predicting long-term clinical outcome and any improvements
following candidate therapies (He et al., 2007; Westlake and Na-
garajan, 2011).
Resting state fMRI & Stem cell therapy
With several cell-based therapies currently under trial for either
acute or chronic post-stroke interventions (Sinden et al., 2012),
there is a need for methodologies which complement functional
assessments in evaluating treatment effects. Non-invasive tech-
niques such as EEG, MEG, and rs-fMRI are therefore suitable
candidates for studying the local and global responses to cell
therapy. Successful integration of cellular therapeutics into ex-
isting brain structures requires, differentiation and integration
of the cell product into their respective lineages, for example:
functioning neurons, forming synapses within existing networks;
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angiogenesis of capillary beds with functionally relevant neu-
rovascular coupling; or myelination of new or existing damaged
neurons by oligodendrocytes. However, there is a growing con-
sensus that rather than integration into the host neural network,
cell therapies are more likely to provide a more trophic environ-
ment in which endogenous recovery mechanisms can act (Bliss
et al., 2007; Stroemer et al., 2009). Successful transplantation in-
tegration/trophism/endogenous recovery should therefore be
detectable by non-invasive modalities, potentially by changes in
BOLD signal behaviour during rest and activity. Invasive mecha-
nisms of investigation such as intracerebral electrophysiology are
restricted to in vivo models but are still pertinent in examining
the effects of cell-based therapies.
5.1.2 CTX0E03 cells in clinical trial
CTX0E03 cell treatment for chronic post-stroke disability is cur-
rently in clinical trials. The completed Phase I safety trial (PISCES,
NCT01151124), showed no deleterious clinical effects of varying
doses of CTX cell implantation into the peri-infarct basal ganglia
(Kalladka et al., 2016). The 11 male patients demonstrated a me-
dian NIHSS score improvement of 2, but with variable changes in
modified Rankin Scale (improvement in 3 patients, no change in
7 and worsened in 1 patient). However, the absence of blinding
and randomisation, small sample size, considerable clinical care
of the patients and lack of control subjects in this study, warrants
extreme caution in the interpretation of these results. The trial
found no cell-related adverse effects and a Phase II trial, (PISCES-
II, NCT02117635) is currently under way with a primary outcome
measure of an improvement in the ’Action Research Arm Test’
(ARAT, Yozbatiran et al. (2008)). The ARAT test will assess pa-
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tients who cannot retrieve and place a 25mm3 block with their
paretic arm prior to transplantation of 20 million cells, and again
6 months later.
Resting state fMRI in rodents
There are few investigations into chronic post-stroke changes
in rat resting-state networks measured by BOLD MRI (vanMeer
et al., 2010; van Meer et al., 2012) and no known studies where this
technique has been used to assess functional changes following a
stem cell treatment for stroke. Earlier in vivo studies found that
CTX0E03 cells improved functional recovery with some evidence
of angiogenesis and neurogenesis (Smith et al., 2012; Hicks et al.,
2013). Prior to this thesis, MRI had only been used in relation to
CTX cell therapy for infarct delination, volumetric changes and
Deformation-based morphometry (Smith et al., 2012). The use
of resting state-fMRI to study the post-stroke, stem cell-treated
rodent brain was therefore a novel opportunity to investigate
whether functional changes identified by behavioural assessments
correlated with MRI-derived metrics of brain functionality. These
could then determine whether such metrics would be applicable
to future stem-cell studies in both animal models and humans.
The study in this chapter was therefore a novel investigation
which complements previous and on-going clinical trials using
the same cell line.
5.2 aims
The aims of this study were as follows:
i To use resting state fMRI to characterise the effects of stroke
on resting-state networks
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ii To identify resting state fMRI indices of any functional re-
covery, identified by three functional assessments following
CTX0E03 transplantation into the peri-infarct brain.
iii To use the protocol from the previous studies (Stroemer et al.,
2009; Smith et al., 2012) in order to test the reproducibility of
the findings and apply rs-fMRI to investigate changes in the
post CTX0E03 cell treated ipsilesional caudate nucleus.
5.3 methods
5.3.1 Longitudinal study design
Three experimental groups were included in the study with an
intended n= 12 for each:
• Sham MCAO - HypoThermasol vehicle
• 90 min MCAO - HypoThermasol vehicle
• 90 min MCAO - CTX0E03 cells in HypoThermasol
Animals were randomised into experimental groups using ran-
domisation software (http://www.randomization.com) and re-
coded post-transplantation, blinding the experimenter during
subsequent functional assessments. Animals were recruited to
the study on a staggered basis with the whole study lasting 8
months. Previous studies identified the onset of functional recov-
ery from 6 weeks following CTX cell transplantation (Stroemer
et al., 2009; Smith et al., 2012). As such, the post-transplantation
imaging experiments were conducted 6 weeks after cell or vehicle
transplantation. Behavioural assessments were conducted prior
to MCAO/Sham and stereotaxic surgeries and fortnightly after.
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Details of all experiments, procedures, and their relevant timing
are described in Table 7 below.
Procedures Time point (weeks)
Functional test training −6 to −5
MCAO/Sham Surgery −4
Post-stroke MRI & Functional assessment −1
Immunosuppression −1 day +14 days
CTX cell/vehicle transplant 0
Post-transplant functional assessments 2, 4, 6, 8, 10, 12
Post-transplantation MRI 6
Perfusion fixation 12
Table 7: Longitudinal study design in chronological order based on weeks pre-
or post- Hypothermasol vehicle or CTX0E03 cell transplantation (Week 0).
5.3.2 Functional assessments
The functional assessments used were the Staircase, Adjusting
Steps, and Whiskers tests as piloted and detailed in Chapter 3.
5.3.3 Anaesthesia and sedation
Animals are artificially ventilated during MRI procedures and
anaesthetised via a nose cone for MCAO and Stereotaxic surgery.
The detailed protocols (and their optimisation) are described in
Chapters 3 & 4.
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5.3.4 Middle cerebral artery occlusion
The protocols for MCAO, analgesia, post-operative care are de-
scribed previously in the Methods chapter. All rats underwent
90min left tMCAO or Sham procedure.
Modification of the transient MCAO procedure
Following the incidence of five consecutive failed occlusions using
the Stroemer method described in Section (2.3.1), it was decided
not to recover the animals from anaesthesia with the filament
in situ. Instead, the incision was closed with Michel clips, and
the animal maintained under anaesthesia and monitored using
a Pulse Oximeter (Mouse OxPlus, Starr Life Sciences) attached
to the hindpaw. The instrument measured Heart Rate, Breath-
ing Rate, Pulse Distension, Breath Distension and SpO2. These
variables, including rectal temperature and percentage of inhaled
isoflurane were monitored continuously and recorded at 10 min
intervals following placement of the intraluminal filament. By
keeping the animal under anaesthesia for the entire duration of
the MCA occlusion, mean arterial pressure was lower than if the
animal were conscious, reducing the likelihood of collateral flow
into the occluded MCA territory.
5.3.5 Stereotaxic implantation of CTX0E03 cells
Delivery and Storage of CTX0E03 cells.
CTX cells in Hypothermasol (HTS) vehicle were delivered from
ReNeuron in 50µl cryovials (10x10x40 mm) at 50000 cells/µl, in a
cryobox (130x130x50 mm, Nalgene R©) via a liquid nitrogen cooled
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dry shipper. They were then transferred for long term storage
into a liquid nitrogen storage unit at −196 ◦C.
Determination of stereotaxic coordinates for implantation.
In previous rat studies (Stroemer et al., 2009; Hassani et al., 2012;
Smith et al., 2012), CTX0E03 cells were grafted into the ipsilesional
caudate putamen at the following two sites:
• AP −1.3 mm, L −3.5 mm, V +6.5 mm
• AP −1.8 mm, L −4.0 mm, V +6.0 mm
Antero-posterior (AP) and lateral (L) were relative to Bregma and
ventral (V) relative to the dura mater (Figure 63). It should be
noted that as the left middle cerebral artery was occluded, rather
than the right MCA as in the previous studies, the lateral coor-
dinates were switched to positive indices as per the convention
of coordinates on the left being positive. All other coordinates
remained the same.
Previous studies were conducted with no knowledge of the lo-
cation and volume of the ischaemic infarct. As such, it was not
known whether the CTX cells were grafted into the ischaemic
lesion until histological analysis was conducted. In this study, we
were able to quantify the volume and location of the ischaemic
infarct using T2 weighted magnetic resonance imaging (Section
5.3.8). By doing so, we could ascertain whether the ischaemic
infarct (T2 hyperintensities) had encroached the area of the stria-
tum where CTX cells would normally be grafted and modify their
implant location if necessary.
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Figure 63: Diagrams taken from the Paxinos Atlas (Paxinos and Watson, 2006)
with blue circles illustrating the stereotaxic implantation coordinates as
previously defined in Stroemer et al. (2009), Hassani et al. (2012), & Smith
et al. (2012). Both coordinates determined that the CTX cells were implanted
into the ipsilesional striatum.
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Using the methodology described in Bible et al. (2009), the loca-
tion of the default coordinates for implantation were located on
the respective image slices using a home-made MATLAB script.
The distance of the coordinates from the manually identified
mid-line on the dorsal surface of the brain (in millimetres) was
calculated (10 pixels/mm). Lines were then plotted onto the im-
age of a lateral width and ventral depth corresponding to the
implantation coordinates (Figure 64). When infarcts encroached
the predefined coordinates, the coordinates were altered by mov-
ing them to a more dorsal or caudal location but still aiming to
keep the implantation site within the striatum. The implantation
site was checked and recorded for all animals, including Sham
and MCAO-Vehicle groups.
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Figure 64: Example of determining whether the ischaemic infarct encroached
the pre-defined implantation coordinates. Lines were plotted over the T2
weighted RARE image lateral from the manually determined mid-line and
then ventral from that point at the two rostro-caudal levels for implantation.
Here infarcts (hyper-intensities) were present at the implantation site and for
transplantation, the coordinates would have been altered to a more
antero-dorsal location but still ensuring grafting into the ipsilesional striatum.
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Preparation of the intracerebral needle.
Cells were transplanted using a 50µl Hamilton syringe with nee-
dle attached. Prior to loading for transplantation, the syringe
barrel and needle were flushed with Medistel R©, left for 30 min,
and then flushed several times with sterile saline.
Handling and Preparation of CTX0E03 for Injection
Prior to transplantation, vials were removed from storage and
transferred on dry ice to the Wellcome Surgical Institute operating
theatre. Using gloves sprayed with 70% ethanol, the vials were
removed from dry ice and the suspension allowed to thaw at
room temperature. The 50 µl Hamilton syringe was secured in
the stereotaxic frame, placed within a motorised syringe pump
(KD Scientific), and loaded with HypoThermasol (HTS).
Cell Grafting
The rat was anaesthetised and prepared for surgery as described
in Sections 2.2.3 and 2.2.2. The tips of the disinfected ear bars were
dipped in local anaesthetic cream (EMLA, AstraZeneca), ocular
lubricant applied (Lacrilube, Allergan) and the animal placed into
the stereotaxic frame (Kopf 900 Series). Following administration
of analgesia, a midline incision was made and the fascia removed
using a bone scraper. The scalp was retracted by securing Spencer
Wells clips to long 4-0 suture threads at anterior and posterior
aspects of the scalp either side of the incision. The origin of the
left temporalis muscle was also partially retracted using the bone
scraper to improve access to the skull for the craniotomy. Any
bleeding from capillaries and pial vessels was stemmed using
pressure applied with sterile cotton buds. Stereotaxic coordinates
were derived using a digital frame reader (Stoelting, IL). Once
Bregma was located, the syringe needle was aligned with it and a
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zero point set. The needle was then positioned to the prescribed
coordinates (see above) and the location marked on the skull. The
syringe was then raised clear of the skull to provide room for the
craniotomies.
The craniotomies were performed using a dental drill (NSK) using
a 0.2 mm diameter drill bit under saline to prevent heat damage
to the underlying tissue. Once complete, the dura was punctured
to prevent impeding the needle’s passage. Approximately 15-20
µl of the CTX0E03 suspension was drawn up, the needle lowered
into the brain at the prescribed depth, raised 0.01 mm to provide
a space for the graft, and 4.5 µl injected at a rate of 1 µl/min.
Following grafting, the cannula was left in situ for three minutes
to allow permeation of the suspension, before slowly retracting
the needle.
Once grafting was complete, the scalp was sutured, 5 ml of
glucose/saline (two 2.5ml doses, Baxter Healthcare Ltd) admin-
istered subcutaneously, and immunosupression administered as
described in Section 5.3.6. The standard post-operative care pro-
tocols (Section 2.4) were also followed.
5.3.6 Immunosuppression
Immunosuppression was required due to the xenograft nature
of the cell transplants. The following drugs, and their concen-
trations, were prepared and administered subcutaneously post-
transplantation are described below. Both drugs were formu-
lated in a Category II hood in the Veterinary Research Facility.
The administration protocol matched that of all previous in vivo
CTX0E03 cell investigations.
5.3 methods 174
Methylprednisolone sodium succinate (SoluMedrol, Pfizer)
20 mg/kg subcutaneously on days -1, 0 (day of transplant), and
daily for 14 days. Stock solutions of 31.25mg/ml were prepared
with sterile water and refrigerated prior to use.
Cyclosporine A (CsA) (Sandimmune, Novartis)
Cyclosporine A (Sandimmune, Novartis) in Kolliphore EL (Sigma)
vehicle was formulated to a dose of 10mg/kg. Cyclosporine was
administered on days -1, 0 , and +1 post-transplantation and
three times a week subsequently for 14 days. Due to the viscous
nature of the CsA-Kolliphor solution, subcutaneous administra-
tion via a 21G, needle was required as the force pressure through
any smaller gauge needle caused the needle to detach from the
syringe. The flanks on either side of the rats were shaved; the
injection site alternated between doses, and the skin subsequently
monitored for lesions.
All immuno-compromised animals were kept in pairs (wherever
possible) in filter topped cages within the shared holding room
for the duration of the treatment.
5.3.7 Protocol for longitudinal MRI study
Due to time constraints in optimising end-tidal capnography to
provide reliable, non-invasive indication of arterial pCO2 (de-
tailed in Chapter 4), arterial cannulation and blood sampling was
used to ensure physiological variables remained within normal
ranges. Animals enrolled in the study were anaesthetised, intu-
bated, cannulated, sedated and prepared as described in earlier
Sections: 2.2.3, 2.3.2, 2.3.3, 2.7.1, 4.2.2, and 4.2.4 respectively. The
imaging sequences detailed below were conducted in order and
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arterial blood samples (80µl) were taken between a minimum
of three, and a maximum of six times during the experiment.
Ventilation parameters were modified, when necessary, to ensure
normal physiological variables. The anaesthesia protocol with 1%
isoflurane and medetomidine infusion is identical to the protocol
in Section 4.2.2.
The following variables were recorded throughout the experiment:
• Body temperature (via rectal probe maintained between 36.5
and 37.5 ◦C using a water heating blanket).
• Mean arterial blood pressure (via arterial line).
• Heart Rate (via arterial line and pulse oximeter).
• SpO2 (via pulse oximeter).
• Arterial O2 saturation (via arterial blood sample).
• Arterial pO2 (via arterial blood sample; normal range: 80-
100mmHg).
• Arterial pCO2 (via arterial blood sample; normal range: 35-
45mmHg).
• Breathing rate (via respiration sensor).
• Arterial blood pH (via arterial blood sample; normal range:
7.45-7.55.
• Ventilation volume (via an Ugo-Basille volume cycling venti-
lator, ml).
• Percentage inhaled oxygen (via a Viamed oxygen sensor) .
Time of samples and scans were recorded relative to the initiation
of the medetomidine infusion.
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5.3.8 Imaging sequences and specifications
Animals were reproducibly positioned and coil positioning veri-
fied using a FLASH sequence. Local shimming was conducted
using a fieldmap based algorithm (’MAPSHIM’). A fieldmap was
acquired after shimming to be able to apply distortion correction
(TR=30ms, TE=2 and 5.8ms at an isotropic resolution of 250µm).
A 20-minute DTI 4-shot diffusion weighted spin-echo EPI (SE-EPI)
sequence was also carried out, however due to time constraints,
its analysis is beyond the scope of this thesis (TR=4500ms, TE=
36ms, in-plane resolution of 200µm, and 15 slices of 1mm thick-
ness). Diffusion measurements were made in 36 directions with
b-factors of 0, 600 and 1000 s.mm2. T2-weighted RARE (Rapid
imaging with Refocused Echoes) imaging was used for high reso-
lution anatomical imaging for delineation of the ischaemic infarct
and for co-registration to the anatomical template (TR=5000ms,
TE=55ms, in-plane resolution of 100µm, 15 slices of 1mm thick-
ness). Resting BOLD fluctuation were measured using Single-shot
EPI (TR=1200ms, TE=16ms, in-plane resolution of 500µm and 15
slices of 1 mm thickness) experiments with 500 repetitions and 20
dummy scans, totalling 10minutes. Total scan duration, including
positioning times, took between approximately 70-90 minutes.
Post-imaging recovery from anaesthesia and sedation
Following completion of the imaging experiments the animal
was returned to the operating theatre. The arterial cannula was
removed and the arteriotomy sealed (to allow restoration of flow)
using diathermy forceps (Eschmann) - performed by Lindsay
Gallagher - and the wound sutured. Whilst still on the ventilator,
medetomidine sedation was reversed by intraperitoneal injection
of 100µg/kg atipamezol. Reversal typically took 3-5 minutes
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following administration. Once signs of consciousness began
to appear (e.g. resistance to intubation, hindpaw twitching and
restoration of pinch reflexes) the intubation tubing was removed
and the animals were recovered overnight in individual cages,
with fresh softened diet before being returned to group housing.
5.3.9 Data analysis
Serial behavioural performances were analysed via group com-
parisons of individual Area under the Curve (AUC) values as
described in Section (3.3.4). Group mean infarct volumes were
compared by Student’s two-tailed t-tests. Physiological data ac-
quired at the time of the resting-state imaging in all three groups
were compared by One-way Analysis of Variance (ANOVA) with
Bonferroni correction for multiple comparisons.
Graphs and their respective statistical analyses were generated
using Prism 5 software (GraphPad Software Inc). All data are
presented as mean±standard deviation unless stated otherwise.
Infarct volume measurements
Ischaemic infarcts were measured from the T2 weighted RARE
images taken at weeks −1 and +6 post-transplant. Composite im-
ages of mean infarct distribution were calculated using MATLAB
and MRICRO.
Resting state BOLD analysis
As described in Section 1.4.6, BOLD data requires several pre-
processing steps before statistical analysis can be performed.
These include: the detection and removal of artifacts, spatial nor-
malisation and smoothing of the data. Following pre-processing,
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statistical models can then be fitted to the data and networks
derived and quantified.
Before detailing the pre-processing pipeline, the co-registration
template used will be described below.
Schwarz MRI atlas in Paxinos Space & Regions of Interest
Seed-based region of interest (ROI) analysis was used to deter-
mine resting-state networks. Here, seed ROI voxels are are identi-
fied in a pre-determined region of functional and/or anatomical
interest. The mean signal time series from this ROI is then cor-
related with all other brain voxels across the whole time series.
Voxels with time-series correlations greater than the determined
statistical threshold (see 5.3.10) are then overlaid onto the already
coregistered anatomical template. The location of the seed ROI
will determine the resting-state network which is identified (see
Section 1.4.5).
The Paxinos & Watson Stereotaxic Rat brain atlas (Paxinos and
Watson, 2006), is a widely used standard atlas for in vivo neuro-
sciences. The atlas accurately details the anatomical structures of
the brain with coordinates based on distances from the midline,
bregma, and the interaural line. An MRI template, based on 97
structural scans of Sprague-Dawley rats aligned in Paxinos space,
has been developed by Schwarz et al. (2006). It is freely available
and was used for data coregistration and ROI determination. The
Schwarz atlas template dimensions were: Matrix, 96x96x30mm2,
and Resolution 0.19x0.19x0.8mm3.
Given that the PISCES II trial aims to investigate the efficacy
of CTX cells on the improvement of sensorimotor dysfunction
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post-stroke, seed-regions were focused on the S1 Forelimb (S1FL),
Barrel Field (S1BF) areas and the primary motor cortex (M1) in
both hemispheres (see Figure 65). The voxels from each internal
structure from the Paxinos atlas are assigned an integer value
allowing for derivation of structurally relevant unilateral and
bilateral regions of interest (ROIs) which were extracted using
homemade MATLAB scripts.
Figure 65: Location of the Regions of Interest (ROIs) used for seed-based
correlations of the resting state data. M1 (red), S1FL (green), and S1BF (blue).
The position of slices relative to Bregma in millimeters are noted below.
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Image pre-processing
Pre-processing and network identification of the MRI data was
conducted using SPM12 (Wellcome Department of Cognitive Neu-
rology, London, UK http://www.fil.ion.ucl.ac.uk/spm) and
the DBAPI toolbox as detailed below. MATLAB 2014a was used
in all cases.
Resting-state data were initially triaged for SNR and motion ar-
tifacts using the Aedes Toolbox (University of Eastern Finland)
for MATLAB (The MathWorks R©). Using this package, the signal
to noise ratio (SNR) of each dataset was assessed to determine if
the data were of satisfactory quality (over 50), and the time series
examined for motion artifacts.
All image header voxel dimensions were then augmented by a
factor of ten (thus, comparable with human brain dimensions),
to ensure compatibility with SPM12 using the DBAPI toolbox
(details in Section 5.3.9).
Prior to functional connectivity analysis, images were pre-processed
in the order detailed below and in Figure 66. By pre-processing
the data through multiple steps we ensured robust spatial locali-
sation of the functional data.
Coregistration and Normalisation to the Schwarz template:
With the Schwarz et al. (2006) atlas defining the image origin as
bregma, the origin of the Resting-state and T2 data sets were man-
ually changed to the same location. As demonstrated in Figure
66 the methods stated in Goense et al. (2008) were used. Coreg-
istrastion was performed as described in Collignon et al. (1995).
The coplanar T2 weighted RARE acquired at each experiment was
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co-registered to the Schwarz template. The resting-state EPI data
sets and magnitude images of the fieldmap were also coregistered
to the RARE, so by proxy, both the frequency component of the
fieldmap and the resting-state dataset were co-registered to the
Schwarz template.
Distortion Correction:
Prior to co-registration, the frequency and magnitude components
of the fieldmaps were manually extracted and rescaled using
homemade MATLAB scripts. A voxel displacement map (VDM)
of the phase distortion was then calculated using SPM (Jezzard
and Balaban, 1995; Jenkinson, 2003). Following co-reigstration,
the resting-state data were then unwarped in the phase direction
(Superior-Inferior).
Skull stripping:
The RARE data were skull stripped using the ’Brain extraction
toolbox, (bet) in (Smith, 2002). The fieldmaps were resliced to
match the RARE and then brain voxels extracted using the skull-
stripped RARE images as a mask. To extract the brain data from
the functional images, skull stripped RARE images were resliced
to match the EPI data, and all volumes skull stripped using a
homemade MATLAB script.
The ’Data Processing & Analysis of Brain Imaging (DPABI) Toolbox
The ’DPABI for Rat’ toolbox (which implements SPM functions
Yan and Zang (2010)), was used for final pre-processing steps
and network derivation. It is a semi-automated pipeline analysis
toolbox, allowing for batch processing of rs-fMRI data. Through
the toolbox, the following pre-processing steps were performed:
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Figure 66: Pre-processing pipeline of EPI data. Red arrows represent
coregistration. Purple arrows represent transformation processes.
Abbreviations: Mag (Magnitude), Hz (frequency), VDM (Voxel displacement
map).
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• Spatial filtering Smoothing was carried out using the default
Gaussian FWHM (Full-weight half-maximum) of [666] mm
defined in SPM12 .
• Temporal Filtering A bandpass filter of 0.01− 0.08 Hz was
applied to the data.
5.3.10 Statistical analysis of resting state data
Using the seed-regions defined above, global correlations were
derived. The correlation coefficients were then transformed via
Fisher’s transformation, automatically in DPABI (Z′, Equation 8),
to better fit the normal distribution.
Z′ =
1
2
ln
(1+ r)
(1− r) (8)
Global maps & Inter-ROI comparisons
Group mean global maps were generated by averaging group
correlations derived from the S1FL seed region across the time-
series. To generate the figures on MRICRO, voxels were overlaid
on the Schwarz template and a statistical significance threshold
of r ≥ 0.30; Z′ ≥ 0.310, (p < 0.00001) then applied. The group
mean time series between ROIs were also compared to each other
and then the aforementioned statistical threshold applied.
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5.4 results
5.4.1 Attrition
25 out of a total 49 animals either died or were excluded dur-
ing the study according to a priori criteria (Table 8). Following
5 consecutive failed MCA occlusions the surgical method was
modified as described above (Section 5.3.4). Two cases of infection
were found: One following CTX cell transplantation which was
complicated by severe bleeding from the skull; the other from
an infection acquired from the femoral cannula blood pressure
transducer. Following both incidents, aseptic standards were im-
proved and recurrence prevented. Miscellaneous deaths included
loss of spontaneous breathing during anaesthesia (x2) and one
termination during surgery due to an emergency evacuation of
the building.
A total of 8 animals were recruited for each group and successfully
completed the study.
Cause Number (% of total cases)
Failed MCAO 7(28)
Haemorrhage 7(28)
Exceeded licence severity 3(12)
Infection 2(8)
Death during intubation 2(8)
Failed baseline functional assessments 1(4)
Miscellaneous 3(12)
Table 8: Cause, and number of attrition cases during the study.
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5.4.2 Body weights and physiological variables
Body weights of all animals were recording regularly through out
the study (Table 9). During the MCAO procedure, animals were
monitored via a pulse oximeter (detailed in Section 5.3.4) above.
The following variables were maintained with their respective
ranges: Rectal temperature (37.0 − 37.4◦C), Heart Rate (355 −
375bpm) , Breathing Rate (46− 54br/min), SpO2 (98.6− 99.0%),
inhaled isoflurane (2.0− 2.4%).
Body weight at time point Sham-Vehicle MCAO-Vehicle MCAO-CTX cell
Pre-MCAO/Sham 325± 31 329± 19 327± 16
7 days post-MCAO 364± 35 314± 17 309± 36
Pre-Stereotaxic 387± 38 349± 28 334± 38
Post-immunosuppression 361± 26 342± 35 316± 26
Study end point (still diet restricted) 375± 49 335± 36 319± 31
Table 9: Body weights of study animals at different stages throughout the
longitudinal study. n=8 for each group. Data presented as mean±SD.
5.4.3 Infarct volumes of Vehicle and CTX cell groups
Ischaemic infarctions were measured manually from T2 weighted
RARE images acquired one week prior to, and six weeks following
CTX cell or vehicle transplantation (Figure 67). There were no
statistical differences between stroke groups at either time point.
Between time points there was a mean reduction in total infarct
volume of 7.1± 13.4 mm3 and 9.1± 6.1 mm3 in the MCAO-Vehicle
and MCAO-CTX groups, respectively (Figure 67C, p> 0.05).
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Figure 67: Ischaemic infarct volumes of both stroke groups, three weeks post
MCAO surgery (A), and six weeks following CTX cell or vehicle
transplantation. There was a mean decrease in infarct volume between time
points (C). No statistical differences were found between group means
(p> 0.05). Student’s two-tailed paired t-test. Data presented as mean± SD.
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5.4.4 Functional asssessments
All functional assessments were performed following a period of
training prior to MCAO; 3 weeks after MCAO; and at 2 week in-
tervals following CTX0E03/vehicle transplantation over 12 weeks.
The Staircase Test
Diet-restricted animals’ ability to reach, grasp, and retrieve sugar
pellets was assessed via The Staircase Test (Montoya et al., 1991),
and the number of pellets retrieved with each forepaw was
counted. Left hemisphere MCAO impaired pellet retrieval ability
of both forelimbs (Right p< 0.0001, Left p< 0.01, in both MCAO
groups, Figure 68). No recovery of function was seen during the
period of functional assessment. CTX-cell transplantation led to
no improvement in pellet retrieval using either forelimb. Sham
animals showed a mean, but not significant, decrease in right
forelimb pellet retrieval following stereotaxic injection compared
to the post-surgical test at week -1. There was no effect of stereo-
taxic injection on pellet retrieval with the left forelimb.
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Figure 68: The effect of CTX0E03 cell transplantation on pellet retrieval in The
Staircase Test. Baseline data were acquired prior to left tMCAO (dashed line)
and cell/vehicle transplantation (dotted line), and every two weeks
subsequently. (Left) the number of pellets retrieved with the right forelimb,
(Right) the number of pellets retrieved with the left forelimb.
Sham-Vehicle (n = 8, •); MCAO-Vehicle (n = 8, ); MCAO-CTX0E03 cell (n
= 8, N). Individual performance summarised using AUC analysis and group
Sham compared to MCAO-veh and MCAO-CTX groups. There were no
differences between the two MCAO groups. means compared with One-way
ANOVA, **** p< 0.0001, ** p< 0.01. Data presented as mean ±SD.
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The Adjusting Steps Test
The capability of animals to perform compensatory steps when
the contralesional (right) forelimb was dragged lateral, and me-
dial to the midline was evaluated (see Chapter 3 for details).
There was no effect of MCAO or CTX cell transplantation on step-
ping ability when the right forelimb was dragged lateral from the
midline, (p< 0.05, Figure 69). MCAO permanently impaired the
medial stepping ability of rats in both stroke groups (p< 0.0001)
with no evidence of functional improvement in the CTX cell trans-
plantation group, (p> 0.05). Ipsilesional forelimb data were not
acquired as pilot data showed no effect of MCAO on stepping
ability.
Figure 69: The effect of CTX0E03 cell transplantation on right forelimb
function in The Adjusting Steps Test. Baseline data were acquired prior to
MCAO (dashed line) and stem cell/vehicle transplantation (dotted line), and
every two weeks subsequently. (Left) the number of adjusting steps made in
the medial direction, (Right) the number of adjusting steps made in the lateral
direction.
Sham-Vehicle (n = 8, •); MCAO-Vehicle (n = 8, ); MCAO-CTX0E03 cell (n
= 8, N). Individual performance summarised using AUC analysis and group
means compared with One-way ANOVA, **** p< 0.0001 with Sham compared
to MCAO-veh and MCAO-CTX groups. There were no differences between
the two MCAO groups. Data presented as mean ±SD.
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The Whiskers Test
The ability of animals to reflexively place their forelimb following
upward homotopic vibrissae stimulation was evaluated. There
was no effect of MCAO or CTX cell transplantation on the per-
centage of failed reflexes on the left side (p> 0.05, Figure 70).
Transient MCAO caused a permanent failure in placing reflexes
of the right (contralesional) forelimb (p< 0.001) with no improve-
ment garnered by CTX cell transplantation, (p> 0.05, Figure 70).
Sham animals showed a mean, but not significant, increase in
reflex failures in weeks 2 to 10 following stereotaxic injection of
HypoThermasol.
Figure 70: The effect of CTX0E03 cell transplantation on right and left
forelimb placing failures, following stimulation of the homotopic vibrissae.
Baseline data acquired prior to MCAO (dashed line) and stem cell/vehicle
transplant (dotted line), and every two weeks subsequently. Sham-Vehicle (n
= 8, •); MCAO-Vehicle (n = 8, ); MCAO-CTX0E03 cell (n = 8, N).
Individual performance summarised using AUC analysis and group means
compared with One-way ANOVA and Bonferroni’s correction for multiple
comparisons. **** p< 0.0001. Data presented as mean ±SD.
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5.4.5 CTX0E03 transplantation and resting-state networks
Sham, MCAO-Vehicle and MCAO-CTX cell treated groups all
underwent resting-state fMRI under medetomidine anaesthesia
at 3 weeks following MCAO or Sham surgery, and again at 6
weeks following implantation of Hypothermasol vehicle or CTX
cells. Resting-state data were assessed for quality, unwarped,
pre-processed as described earlier, and global sensorimotor maps
and inter-ROI correlations derived via seed-based analysis.
Exclusions
Three data sets from the pre-transplant Sham-Vehicle and one
from the pre-transplant MCAO-Veh group were excluded due
to surface coil failure leading to poor SNR. One animal from
the MCAO-CTX group had an infarct so large that the resulting
structural deformations were too large to correct and allow for
accurate coregistration and as a result, the entire data set was
removed. A technical error in the rectal thermometer caused
an under-reading of body temperature and overheating of one
animal in the post-transplant Sham-Vehicle group; the data set
was consequently excluded.
Physiological variables during functional imaging
Physiological variables were acquired during imaging to ensure
that at the time of the resting-state imaging, variables were within
normal ranges appropriate for detection of the BOLD signal (Ta-
bles 10 & 11). The cannula in one pre-transplantation and in one
post-transplantation MCAO-Veh group animal failed at the pre-
resting state sampling time point. Ventilation parameters were
maintained and resting-state network quality control of both data
sets indicated no deleterious issues. There were some statistical
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differences between mean variable values between groups. How-
ever the data range was within physiological norms and was no
cause for concern. Post-transplant weights of the MCAO groups
were lower than their Sham counterparts.
Variable Sham-Vehicle MCAO-Vehicle MCAO-CTX cell
Time from infusion start (min) 73± 16 79± 15 78± 20
Body weight (g) 377± 36 342± 24 331± 32∗
Temperature ◦C 36.9± 0.6 37.1± 0.3 37.5± 0.3∗
Heart Rate (bpm) 235± 12 246± 14 258± 21
MABP (mmHg) 100± 8 91± 3∗ 89± 7∗
PaCO2 (mmHg) 45.6± 5.0 42.8± 2.8 42.7± 3.5
PaO2 (mmHg) 99.1± 12.6 89.5± 15.5 103.3± 13.9
pH 7.421± 0.03 7.439± 0.03 7.417± 0.01
Inspired O2 (%) 27.4± 1.8 27.7± 1.3 26.5± 0.9
Table 10: Physiological variables at the time of Resting state fMRI (minutes
after the start of medetomidine infusion). Imaging protocol carried out 3
weeks after MCAO/Sham surgery and 1 week before stem cell transplantation.
∗ represents statistical differences compared to the Sham-Vehicle Group
(p< 0.05, One-way ANOVA with Bonferroni correction for multiple
comparisons). Sham-Vehicle (n= 5), MCAO-Vehicle (n= 6), MCAO-CTX
(n= 7). Data expressed as the mean±SD.
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Variable Sham-Vehicle MCAO-Vehicle MCAO-CTX cell
Time from infusion start (min) 84± 21 81± 14 91± 34
Body weight (g) 402± 37 349± 40∗ 335± 29∗∗
Temperature ◦C 37.0± 0.3 37.1± 0.4 37.3± 0.2
Heart Rate (bpm) 225± 10 228± 28 234± 22
MABP (mmHg) 93± 10 88± 7 87± 8
PaCO2 (mmHg) 42.2± 4.0 42.9± 4.4 39.5± 2.3
PaO2 (mmHg) 106.8± 20.3 99.5± 11.1 106.9± 15.5
pH 7.483± 0.04† 7.443± 0.05 7.473± 0.05†
Inspired O2 (%) 27.4± 2.13 29.3± 3.9 28.3± 2.4
Table 11: Physiological variables at the time of Resting state fMRI (minutes
after the start of medetomidine infusion). Imaging protocol carried out 6 week
following stem cell transplantation. ∗ p< 0.05, ∗∗ p< 0.001, statistical
differences compared to the Sham-Vehicle Group; (One-way ANOVA with
Bonferroni correction for multiple comparisons). † p< 0.05, statistical
difference between the Pre-transplant variable of the same group
Sham-Vehicle (n= 7), MCAO-Vehicle (n= 7), MCAO-CTX (n= 7). Data
expressed as the mean±SD.
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Naı¨ve networks and thresholding
During optimisation of the resting state sequence and anaesthesia,
naı¨ve rats were placed under medetomidine-isourane anaesthesia
and resting state fMRI data were acquired as described above.
All physiological variables were in range and SNR was over 50.
The same pre-processing and analysis pipeline was used, apart
from unwarping. As seen in Figure 71, animals had a complete
bilateral sensorimotor network across the whole cortex.
As stated above, a correlation coefficient threshold of 0.3 (0.31,
after Z’ transform) was chosen for network identification. Figure
71 demonstrates the effecting of varying statistical thresholds on
sensorimotor network identification. Low statistical thresholds
(ρ = 0.1, 0.2) increase the false positive rate (Type I error) with
noise voxels identified as statistically significant. Alternatively,
high thresholds (ρ = 0.4) increase the false negative rate (Type
II error), often negating voxels contralateral to the seed region
limiting significant voxels to the ipsilateral hemisphere.
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Figure 71: Mean global maps of the cortical resting-state sensorimotor
networks of two naı¨ve rats at varying correlation coefficient thresholds (left).
The choice of correlation coefficient threshold determines ratio of voxel Type I
and II errors.
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Challenges with the ischaemic hemisphere
During the analysis process it became clear that despite robust
coregistration, in animals where the infarct involved the dorso-
lateral cortex, contamination of any seed ROIs voxels with CSF
from within the ischaemic infarct and/or expanded ventricles
would lead to maps with spurious correlations with other areas
of high CSF (Figure 72). The high T∗2 signal of CSF within the
infarct caused falsely high correlations between bilateral homol-
ogous ROIs. Infarct volumes in both stroke groups were highly
variable (Figure 67) and as such, seed ROIs were either clear, par-
tially, or fully contaminated by CSF in a non-consistent manner.
Masking of the ischaemic infarct from the resting-state data was
unsuccessful due to partial volume effects and smoothing. As a
result, attention was focused on the intact contralesional (right)
hemisphere, as detailed below.
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Figure 72: Global resting state map demonstrating the effect of brain
deformation with white matter entering into the left S1FL seed ROI (red, right
hand side). Brain distortion causes contamination of the ROI with white
matter/CSF leading to correlations between the infarct, white matter, and the
ventricles. Global comparisons based on the left S1FL thresholded at Fisher
transformed correlation coefficient of 0.31 (left), the respective T2 weighted
RARE slices with S1FL seed ROI overlaid in red (right). Data from one animal.
Colourbar represents the normalised correlation coefficient (Z’) of the
resting-state voxels.
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The effects of CTX0E03 transplantation on resting state sensorimotor networks
Animals were transplanted with CTX0E03 cells or HypoThermsol
vehicle (Sham, and MCAO controls) in the peri-infarct region as
described earlier. Resting-state fMRI was conducted 1 week prior
to, and 6 weeks following, transplantation.
Resting-state sensorimotor networks were derived using the right
S1FL region as a seed for global correlations. Sham-Vehicle ani-
mals showed bilateral correlations of the sensorimotor cortex sim-
ilar to a healthy/naı¨ve sensorimotor network, 3 weeks following
surgery (Figure 73). 6 weeks following CTX cell transplantation,
the bilateral sensorimotor network was disrupted, likely due to
the stereotaxic injection of Hypothermasol vehicle. This disrup-
tion was not reflected in the animal’s functional ability with no
significant effect on performance in behavioural tests (Figures 68,
69, and 70).
3 weeks following 90 min left tMCAO, the sensorimotor network
was largely intact in the MCAO-Vehicle group (Figure 74) but not
so in the MCAO-CTX group (Figure 75). There was some restora-
tion of contralateral connectivity post-CTX cell transplantation
and a small increase in connectivity around the seed following
transplantation (Figure 75). As seen in the Sham group, stereo-
taxic implantation of Hypothermasol caused disruption of the
resting network with a loss of left-hemisphere connectivity in
both groups (Figures 74 and 75). However, as stated earlier, there
was no detected functional improvement in behavioural tests fol-
lowing CTX cell transplantation.
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Resting-state sensorimotor networks and infarct location
With previous studies reporting post-stroke sensorimotor network
recovery being dependent on the size of the ischaemic infarct (We-
ber et al., 2006; vanMeer et al., 2010) and with no evidence of
behavioural or network recovery in the above results, the effect of
infarct distribution on network connectivity was investigated.
Therefore, MCAO-Vehicle and MCAO- CTX animals were pooled
and then re-grouped according to whether the ischaemic infarct
encompassed the subcortical tissue or entorhinal cortex area only,
or was more extensive and involving areas of the sensorimotor
cortex (Figure 76). Four animals from the vehicle treated and one
from the CTX cell treated group had large infarcts which involved
the sensorimotor cortex (141± 48mm3, mean±SD). Four animals
from the vehicle treated and six from the CTX cell treated group
had infarcts contained within the striatum and entorhinal cortex
only (42± 30mm3, mean±SD).
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Three weeks post-stroke, animals with infarcts confined to the
left striatum and entorhinal cortex had a partial bilateral senso-
rimotor network and strong correlations with the whole right
sensorimotor cortex (Figure 77). In animals with large infarcts,
correlations were mostly restricted to the contralesional cortex
around the seed with some contralateral correlations(Figure 78).
As mentioned earlier, it was seen in all treatment groups that
stereotaxic injection appeared to disrupt bilateral connectivity
of the resting sensorimotor network. When grouping based in
infarct location, stereotaxic injection caused small changes in
post-stroke networks in both groups with a loss of remaining
contralateral networks which previously existed. This was more
pronounced in the group with large infarcts involving the sen-
soirmotor cortex (Figure 78). There was also an increase in the
ipsilesional intrahemispheric correlations in this group.
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Connectivity correlations with the left S1FL
In Sham-vehicle treated animals, the absence of stroke and the
challenges it caused (described in Figure 72) were not present. As
such the left S1FL region of the cortex could be used as as seed
region. Here the bilateral sensoriomotor network was detectable
prior to the Hypothermasol vehicle transplantation (Figure 79).
Following stereotaxic implantation of HypoThermasol (Figure
79) scarring and bleeding generated by the procedure caused
susceptibility artefacts and distorions near the seed region. As
such, spurious correlations were generated.
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Intra-hemispheric connectivity of the contralesional hemisphere
Intrahemispheric connectivity between different regions of the
sensorimotor cortex was evaluated to determine whether resting-
state fluctuations in the non-infarcted hemisphere change in re-
sponse to stroke in the long-term. Correlations were assessed
as previously described, by treatment group and pooled infarct
location. Correlations between M1 (Figure 80) and S1BF (Figure
81) regions and the homotopic S1FL were compared. No differ-
ences were found between any groups at any time points with no
effect of infarct size or CTX-cell treatment on intra-hemisphere
connectivity.
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Figure 80: Intrahemispheric connectivity (Fisher transformed correlation
coefficients Z’) of the contralesional M1 and S1FL regions of the sensorimotor
cortex. Pre- and post-transplantation data displayed by treatment group (A)
and pooled stroke volume location (B). There were no statistical differences
between any groups and any time points (One-way ANOVA with Bonferroni
correction for multiple comparisons, p> 0.05). Data are displayed for
individual animals along with the mean and SD. Error bars: mean±SD.
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Figure 81: Intrahemispheric connectivity (Fisher transformed correlation
coefficients Z’) of the contralesional S1BF and S1FL regions of the
sensorimotor cortex. Pre- and post-transplantation data displayed by
treatment group (A) and pooled stroke volume location (B). There were no
statistical differences between any groups and any time points (One-way
ANOVA with Bonferroni correction for multiple comparisons, p> 0.05). Data
are displayed for individual animals along with the mean and SD. Error bars:
mean±SD.
5.4 results 212
The sensorimotor network of an animal with a failed MCAO
One animal was excluded from the longitudinal study due to a
failed-MCAO and used for a terminal optimisation study un-
der the same anaesthesia protocol, gradients, sequence, pre-
processing, and analysis pipeline detailed above. The failed
MCAO surgery had occurred 3 weeks earlier, as such, the an-
imal was scanned at an analogous time as all animals recruited
into the longitudinal study. Functional assessments showed no
evidence of stroke-induced functional deficits, i.e. preserved vib-
rissae evoked forelimb function, which were confirmed by the
absence of an ischaemic infarct on the T2 weighted RARE. Figure
82 shows that there was an absence of the bilateral sensorimotor
resting-state network similar to the animals that had undergone
MCAO.
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Figure 82: Mean global maps of the cortical resting-state sensorimotor
networks of an animal with failed MCAO, with no evidence of functional
deficits or ischaemic infarction on T2 weighted MRI. Global comparisons
based on ROI in left S1FL thresholded at Fisher transformed correlation
coefficient of 0.324.
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5.5 discussion
5.5.1 The lack of functional improvement following CTX-cell treatment
There was no evidence of sensorimotor functional improvement
(Figures 68, 69 & 70) or changes in the resting-state sensorimotor
network following CTX0E03 transplantation (Figure 75). This
is contrary to previous studies using the same model of stroke
and same stem cell line (Pollock et al., 2006; Stroemer et al., 2009;
Smith et al., 2012) for which there are many potential causes.
Firstly, the stem cells may not have been successfully transplanted.
This can be confirmed by histological analysis to identify any
surviving cells or markers of differentiation as used in previous
work. Secondly, damage caused by the needle tract may have
offset any potential therapeutic effect of the stem cell placement
(details below). In comparison to previous studies, functional MRI
using medetomidine was used. Dexmedetomidine been reported
to be neuroprotective at the acute stage via intravenous infusion
(Jolkkonen et al., 1999), and there is no evidence on the effects
of multiple medetomidine administrations over a long period of
time. However the effect of multiple surgeries throughout the
study cannot be discounted. One potential issue is the study
design. By randomisation of treatment groups with small n
numbers, there is a risk of an unequal distribution of small and
large strokes. This was the case in this longitudinal study (Figure
67). Randomisation was not carried out in earlier CTX-cell studies.
This increases the inter-group variability, potentially generating
noise which may obscure any stem cell related effect. Allocating
animals to treatment groups based on infarct volume to ensure
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equal variance between groups could be considered for future
studies.
5.5.2 Functional assessments and the absence of spontaneous recovery
Left transient MCAO induced sustained right forelimb impair-
ment identified via the Staircase, Adjusting Steps, and Whiskers
tests (Figures 68, 69, & 70). The main finding is that CTX cell
transplantation generated no improvement in MCAO induced
sensorimotor dysfunction in all three behavioural assessments
used. In this longitudinal study there was no evidence of sponta-
neous recovery in either stroke group, despite evidence of this in
the earlier pilot study (Chapter 3). Caleo (2015) also showed no
spontaneous recovery in animals with ischaemic stroke induced
by intracerebral endothelin-1. The MCAO-control group in Stroe-
mer et al. (2009) also showed no spontaneous recovery. Blinding
and randomisation of study animals reduces experimenter bias.
As such, the spontaneous recovery seen in the pilot study may
be attributable to bias, as the study was not blinded. Where
infarctions are restricted to small volumes of tissue (such as in
the 12-week pilot study), it is possible that the greater volume of
surviving tissue has a greater capacity for repair of damaged cir-
cuits compared to large infarctions encompassing large structures
and nuclei.
The absence of spontaneous recovery may also be attributable to
the stereotaxic injection of CTX cells or HypoThermasol (HTS) ve-
hicle. Following stereotaxic injection of HTS in the sham animals,
there was an observed (but not statistically significant) reduction
in right pellet retrieval (Figure 68) coupled with a loss of bilat-
eral functional connectivity in the area of the cortex approximate
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to the site of transplantation (Figure 73). When seeded in the
left S1FL, some bilateral connectivity seems apparent (Figure 79)
however this may be due to contamination of the ROI with the
needle tract (containing blood/glial scarring/distorted white mat-
ter/ventricles), leading to spurious correlations. Differences in
the implantation site due to the varied infarct volumes may have
also contributed to these differences.
Inserting the injection needle in the brain causes an injury. Cor-
tical stab injuries, biopsies, and electrode placements have been
shown to cause microglial and macrophage recruitment and as-
trocytic scarring for up to 8 weeks, with a subsequent reduction
in the counts of both cell types (Potter et al., 2012; Hampton
et al., 2004). There is limited published research on the functional
and anatomical consequences of stab injury. Stereotaxic injection
into the caudate nucelus will damage both the overlying cortex,
overlying vasculature, and the corpus callosum.
With the corpus callosum having a role in interhemispheric com-
munication, it is unsurprising that damage caused by a stereotaxic
procedure, may disrupt interhemispheric bilateral correlations in
the BOLD signal. There is some qualitative evidence that correla-
tions around the right S1FL seed region increased after stereotaxic
needle insertion through the left hemisphere (Figures 75 & 78).
Potter et al. (2012) showed that beyond 8 weeks post-stab injury,
astrocytes and microglial cell counts decreased. It may be that at
the time of the post-transplant scan (6 weeks after surgery), in-
flammation and scarring was still present, impeding connectivity
and functional outcome. However the plateau in the Sham-vehicle
pellet retrieval numbers beyond 4 weeks post-surgery (Figure 68)
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suggests otherwise.
It is possible that the damage caused by stereotaxic implanta-
tion of CTX0E03 cells or HTS vehicle generated an additional
source of noise in the behavioural data, clouding any functional
improvements generated by the stem cells, although this was not
seen in the Bilateral Assymetry test in previous work (Stroemer
et al., 2009; Smith et al., 2012). Histological staining and immuno-
cytochemistry of the implantation site and needle tract would
confirm the presence of scarring, inflammation, and damage to
the cortex and corpus callosum. The study by Frost et al. (2006)
on the capsular endothelin-1 infarct model showed no functional
impairments of saline injection into the posterior limb of the in-
ternal capsule compared to baseline performance.
Previous in vivo studies involving CTX cell transplantation (Stroe-
mer et al. (2009) & Smith et al. (2012)) all used the Bilateral
Asymmetry and Rotameter tests to assess post-transplantation
functional recovery. The Bilateral Asymmetry test did not detect
any long-term sensorimotor dysfunction in our hands (Chapter
3) and there were no facilities for Rotarod assessments. The
Staircase, Adjusting Steps, and Whiskers test were piloted and
selected for longitudinal assessment of post-stroke function, and
deemed sensitive enough to detect functional recovery following
CTX cell transplantation.
The Staircase test (Montoya et al., 1991) is a sensitive assessment
of post-stroke dysfunction in rodent models due its ability to
assess forelimb function independently with limited assessor bias.
However, the gross summation of pellets retrieved that are used
as a metric of performance, lack sensitivity in the fine aspects of
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motor control. It was common to observe rats attempting pellet
retrieval but failing to and displacing them to other steps. Colour
coding of the pellets relative to their original step has shown to
increase the sensitivity of the staircase test to impairments in dex-
terity in focal ischaemia and Parkinsonian models (Kloth et al.,
2006). In the single pellet reaching task the animal is trained
to reach forward for a single pellet and retrieve it. Although
this assessment can be subject to the same rudimentary assess-
ments as the Staircase test, detailed biometric assessments have
been developed to fully elucidate the changes in all the compo-
nents of the reaching act (lifting, reaching, pronation, grasping,
supination and single digit movements), (Gharbawie et al., 2006;
Alaverdashvili et al., 2008; Alaverdashvili and Whishaw, 2008).
Such analyses further expand the data available from a simple
task, but also allow investigations into compensatory mechanisms
following injury.
Chronically diet-restricted rats performing the Staircase test often
exhibited rushed and frantic behaviour when retrieving the pel-
lets. It is therefore likely that this behaviour may have decreased
the number of pellets the rats were able to retrieve had they been
calmer. Because the Staircase limits the task retrieval to the in-
dividual forelimb, compensatory mechanisms such as increased
use of the unimpaired forelimb or dexterous modification were
undetectable. The Vermicelli test (Allred et al., 2008) or single
pellet reaching task (see above) with additional biometric anal-
yses could be more sensitive methods for detecting functional
improvements following CTX0E03 cell transplantation which are
likely to be more subtle than more gross assessments like the
Staircase test. Where a range of tests are employed, the fewer that
demonstrate a positive effect of therapy, the less likely the therapy
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will translate to induce benefit in patients. Therefore tests such as
the single pellet reaching task or Staircase test should be sufficient
to determine whether a candidate therapy will translate.
5.5.3 The ischaemic infarct
CTX0E03 cells implanted into the peri-infarct region did not affect
infarct volume (Figure 67). Conventional thought is that stem
cell transplantation/administration does not replace volumes of
dead tissue but instead provides a greater trophic environment
for endogenous repair mechanisms to function (Bliss et al., 2007;
Stroemer et al., 2009). As such, the current results are unsurpris-
ing. Small reductions in infarct volume over time are expected
due the loss of the structural integrity of the infarcted hemisphere
and the intraventricular pressure induced expansion of the ventri-
cles into the territory. Mean infarct volumes in this study were
markedly larger compared to volumes observed in pilot studies
(Chapter 3). This is likely due to differences in the method of
MCAO used, with the Stroemer method (conscious assessments
of MCAO with the filament in situ), and the modified method
used for this longitudinal study (Section 5.3.4). The mean ar-
terial blood pressure (MABP) of awake rats is higher than in
those under isoflurane anaesthesia (Bun˜ag and Butterfield, 1982;
Masamoto et al., 2009a). As such, recovery of the animal with
the filament in situ is likely to lead to an increase in collateral
flow to the occluded territory, maintaining penumbra viability,
and reducing the volume of infarcted tissue. Lower MABP under
anaesthesia will limit collateral flow to the occluded territory,
leading to a larger infarct volume.
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Animal models of ischaemic stroke allow for greater control in
infarct location and volume compared to the highly variable hu-
man population. However they are not without their caveats.
Intraluminal filament occlusion of the MCA at its origin is highly
variable due to the risk of partial occlusion and perfusion into
the MCA territory by Heubner pial anastomoses and other ves-
sels (Heubner, 1874) makes the probability of cortical infarction
difficult to predict (Brozici et al., 2003). The distribution of the
ischaemic infarcts is often bimodal, between restriction to subcor-
tical structures and those involving the sensorimotor cortex, as
seen in the results in this Chapter. This has previously predicted
the degree of spontaneous recovery with larger infarcts impairing
recovery (Weber et al., 2008) & (vanMeer et al., 2010).
The location of an MCA territory infarct is therefore an important
variable which can in part be determined by the model used. The
vast majority of optical and electrophysiological studies inves-
tigating spontaneous recovery focus on cortical remapping and
plasticity due to limitations of the techniques (Nudo, 1999). It is
important to recognise that plasticity mechanisms in the cortex are
likely to be different compared to the basal ganglia and thalamus
(both of which contain a higher percentage of white matter com-
pared to the cortex) because of the different respective functional
roles. Models of ischaemic stroke such as the distal diathermy,
topical endothelin, or photocoagulation methods (Macrae, 2011)
generate focal cortical infarcts capable of generating long-term
sensorimotor deficits. Although not without their own respective
caveats, generation of lesions specific to the cortex reduce intra-
group variability, allowing for greater sensitivity in both imaging
and functional assessments.
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The contralesional hemisphere is known to have increased com-
pensatory activity in the acute and sub-acute period post-stroke
(Weiller et al., 1993; Pineiro et al., 2001; Ward et al., 2003b). Inter-
ROI connectivity between sensorimotor regions was compared
between treatment & vehicle groups and pooled stroke groups
(Figures 81 & 80) to assess whether changes in intrahemispheric
connectivity occurred as a result of the loss of bilateral connectiv-
ity. No differences were found between any groups. The variances
in correlations observed are likely to be due the complexities of
the BOLD signal discussed below.
5.5.4 Considerations when analysing the chronic post-stroke brain
The process by which focal ischaemic insults result in the de-
struction, loss of brain tissue and the subsequent neurological
impairments are well understood (Dirnagl et al., 1999; Woodruff
et al., 2011). However, the loss of brain tissue also has conse-
quences for imaging methodologies that assess structural and
functional changes longitudinally. When the primary inflamma-
tory responses are resolved and the dead tissue cleared by the
microglia and macrophages, the global architecture of the brain
is permanently altered. Compromises in the structural integrity
of the brain will cause deformation of primarily the ipsilesional
hemisphere, caused by the replacement of the infarct with a fluid-
filled cyst and by the IVP pressure gradient (Dereski et al., 1993).
Despite this, there is little literature available that has investigated
longitudinal changes in the post-stroke brain, likely due to the
cost and duration of such studies. The literature available is vari-
able with many papers focusing on atrophic changes in the cortex
and striatum Hara et al. (1993), Fujie et al. (1990) respectively, and
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the substantia nigra (Abe et al., 2003) as detailed earlier in this
thesis.
These changes are dynamic and occur over several months subse-
quent to the ischaemic insult. This generates a particular challenge
in longitudinal imaging studies, in particular, functional based
assessments. Seed-based functional analyses often depend on
fitting the data set to normalised structural templates. By not
taking into account structural distortions that occur post-stroke,
templates (and seed-regions) may incorrectly coregister with the
functional data, or the functional area e.g. forelimb area of S1
may either be infarcted, or plastic compensatory mechanisms
have remapped the remaining cortical projections (Nudo, 1999).
This is an issue in both pre-clinical and clinical investigations and
requires further investigation (van den Heuvel and Pol, 2010).
In this study, anatomical MRI data was not analysed for gross
structural distortions of the ipsilesional cortex. Analysis tech-
niques such as Voxel Based Morphometry (VBM), Tensor Based
Morphometry (TBM) and Voxel Lesion Symptom Mapping (VLSM)
allow for additional semi-automated measurements of structure-
function relationships in post-stroke brain changes (Crum et al.,
2013).
5.5.5 ROI based analyses for post-stroke resting-state fMRI
The size and location of the seed ROI has an impact on the corre-
lations derived. The larger the number of voxels within a ROI, the
greater the SNR and the smaller the signal variance within, and
as such, a larger number of voxels will be significantly correlated
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to it. Using a surface coil means that the SNR decreases as a func-
tion of distance away from the coil. Subcortical regions therefore
have lower SNR compared to cortical areas and cortical seed ROIs
will correlate more highly with other cortical regions. Although
cortico-cortical connectivity is more prevalent than cortico-striatal
connections, it is important to note that SNR challenges may
mean that existing networks are not detected.
The global signal is the average of signal fluctuations across
the entire brain. Many resting-state MRI studies, where ROI
based analyses have been used, have employed global signal re-
gression as a means of nuisance regression of physiological and
other sources of noise that are assumed to be uncorrelated to
the seed voxel (Desjardins et al., 2001). In van Meer et al. (2010)
and van Meer et al. (2012) global signal regression was utilised
and both positive and negative resting-state correlations were
identified with a seed region in the sensorimotor cortex. One
of the outcomes of global signal regression is the generation of
anti-correlated networks i.e. ρ < 0. Murphy et al. (2009) have
comprehensively demonstrated that by regressing out the global
signal, the sum of the voxel-wise correlations across the whole
brain will by less than or equal to zero. It is therefore purely a
mathematical consequence of the regression that anti-correlated
networks arise. The size of the ROI used also determines the
extent to which noise will become negatively correlated with a
larger ROI causing a greater negative correlation (Murphy et al.,
2009). By not using global signal regression in the analyses of this
thesis, negative BOLD signal correlations were not identified.
Challenges were identified using seed regions within the is-
chaemic hemisphere and the effect of cortical atrophy several
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weeks post stroke (Section 5.4.5). Contamination of the corti-
cal seed ROIs with CSF or white matter in data sets with large
ischaemic infarcts delivered challenges in robust group-wise anal-
ysis (Figure 72). Both vanMeer et al. (2010) and van Meer et al.
(2012) segmented the lesion out of the functional data as well as
performing global signal regression to remove the confounds of
infarct infiltration into the S1FL ROI used. However, by doing
so, two situations arose. Firstly, any ROIs which contained in-
farcted tissues were truncated, and as such, their SNR reduced,
directly affecting any correlations derived. Secondly, the negative
connectivity found in both studies is a mathematical consequence
of the regression procedure as detailed above. ROI truncation
or modification to accommodate the infarcted hemisphere have
also been used in human investigations (Rehme et al., 2011; Siegel
et al., 2015).
Another challenge with ROI-based analysis in the post-stroke
cortex is that the surviving tissue is likely to have remapped its
functional representations (Rossini et al., 2003; Lim et al., 2014).
Therefore, what represents an intact barrel field or forelimb region
in a healthy animal, may not have the same functional represen-
tation post-stroke. However the area is still likely to represent
the somatosensory region of the cortex as remapping is likely to
occur within the volume represented by a single voxel (500µm
and more so after spatial filtering). Increases in resolution would
reduce the partial volume and infarct contamination effects that
were encountered with the 500µm resolution used. However this
comes at a cost of a reduction in SNR and increased imaging
time. Regression of the CSF signal alone may limit the deleterious
effects of the infarct when using ipsilesional or peri-infarct seed
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regions.
ROI-based analyses involve a large number of a priori assumptions
and present several challenged as mentioned above. Independent
component analysis (ICA) is a popular method of resting state net-
work analysis which can identify statistically significant networks
within a data set (Beckmann et al., 2005). However, networks
identified by ICA will still be affected by the infarcts so distin-
guishing functionally relevant networks from noise is still subject
to user interpretation. Graph theory is another method of evalu-
ating brain connectivity whereby the interactions between nodes
(representing anatomical brain regions) are evaluated by metrics
such as clustering, and small-worldness (Power et al., 2011). Such
methods advance ways of understanding intrinsic connectivity
changes in the brain and may prove useful in understanding
post-stroke recovery mechanisms.
An overall assumption with BOLD imaging of the post stroke
brain is that neurovascular coupling and the haemodynamic re-
sponse function (HRF) are analogous to that of the healthy brain.
However there is human evidence of delays in the HRF after
stroke (Pineiro et al., 2002; Bonakdarpour et al., 2007). Post-
stroke neuronal plasticity is accompanied by haemodynamic and
reduced functional hyperaemic response compared to healthy
counterparts (Girouard and Iadecola, 2006). A decrease in CBF
responses to activation as well a loss of a group mean BOLD
signal change but with consistent cerebral blood volume and CBF
weighted responses has also been found in chronic post stroke
patients (Blicher et al., 2012). This evidence suggests that there
exists a dissonance in post-stroke neurovacular coupling.
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Although implantation of CTX0E03 stem cells into the peri-infarct
region failed to generate any functional recovery, this study was
the first to utilise resting-state BOLD imaging for a cellular ther-
apeutic in post-stroke rats. A point of interest is the apparent
sensitivity of the resting state BOLD to stab injury via stereo-
taxic injection. However, as the resting-state was only acquired
at one time-point 6 weeks post-transplantation it is difficult to
ascertain whether these network impairment were a transient or
permanent phenomenon and it is possible that the injury impeded
spontaneous recovery.
6
G E N E R A L D I S C U S S I O N
Stem cell therapy for ischaemic stroke may reduce the burden of
disability 50% of survivors experience (Muir, 2010). Clinical trials
of exogenous or autologous stem cells to treat ischaemic stroke
are growing in number. However, population heterogeneity and
small patient numbers make it difficult to determine the potential
of such treatments. Resting-state fMRI may provide a means to
assess functional changes following cell transplantation. This
thesis detailed a novel attempt at using resting-state fMRI in a
pre-clinical model of stroke with transplantation of a GMP cell
line, CTX0E03, currently in a Phase 2 clinical trial.
This thesis reports the selection of appropriate longitudinal func-
tional assessments for post-stroke disability, work to develop
non-invasive physiological monitoring within a high-field MRI
scanner, and a longitudinal study investigation of resting-state
network changes both following stroke, and CTX-cell transplan-
tation. In this longitudinal study, no functional improvement
was seen with implantation of CTX-cells, in contrast to earlier
work (Stroemer et al., 2009; Hassani et al., 2012; Smith et al., 2012)
in the same rodent model of stroke. This study confirmed the
previous work of van Meer et al. 2010a, 2010b, showing loss of bi-
lateral sensorimotor network connectivity following MCAO. The
study also showed that the resting-state sensorimotor network is
sensitive to cortical damage caused by stereotaxic injection.
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6.1 comments on the longitudinal study
The longitudinal study detailed in Chapter 5 investigated resting
state fMRI as a tool to identify functional recovery following a
neural stem cell therapy for ischaemic stroke. Despite the lack of
functional improvement following stem cell injection, changes in
the resting state sensorimotor network were evident after stereo-
taxic injection into the caudate nucleus. Damage to the cortex and
corpus callosum might impede post-stroke functional recovery
and perturb bilateral connectivity or the implantation procedure
itself generates an additional co-founder which may outweigh
any functional improvements.
The intraluminal filament method is a popular method for MCAO
due to its relative ease to perform, and since it generates subcorti-
cal infarcts with sensorimotor disability. However, the volumes
and distribution of infarcts generated by this method are highly
variable. MCAO methods such as distal coagulation, photothrom-
botic, and topical application of endothelin, can generate small
focal lesions in the cortex with lower variability compared to the
filament method. By destroying discrete regions of the cortex, e.g.
S1FL, specific functional deficits can be observed (Schallert et al.,
2000). When using small numbers of animals, such as around
n=8 per group as in this study, limiting the inter-subject variance
allows for a more robust assessment of a therapeutic agent. It
may be the case, that the bimodal and unequal distribution of
infarcts across both the MCAO vehicle and CTX-cell treatment
groups generated variability greater than the effects of CTX-cell
transplantation.
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The intra-striatal implantation procedure caused a degree of dam-
age to the brain which may have masked the effect of the cellular
therapy. Scarring and bleeding caused by the implantation pro-
cedure is likely to have affecting resting-state networks. Further
investigations into the effect of stereotaxic injury on resting-state
networks would help evaluate the sensitivity of networks to injury.
Earlier pilot work indicated that the behavioural tests used (in-
trinsic to behavioural and functional data) were sensitive enough
to detect post-stroke functional recovery and group sizes for the
longitudinal study were largely selected on a pragmatic basis
and in relation to earlier work. However the sensitivity of the
resting-state networks and the tests used (which were not applied
in previous studies) suggests that a greater number of animals
should be used to identify the effects of CTX-cell transplantation.
6.2 challenges regarding stem cell therapy for is-
chaemic stroke
There are several possibilities as to why the CTX0E03 transplan-
tation conducted in Chapter 5 did not demonstrate the same
functional benefits as in previous studies conducted by Stroemer
et al. (2009) and Smith et al. (2012). One possibility is that the
cells were unsuccessfully transplanted. Although few cells sur-
vive post-transplant (Pollock et al., 2006; Stroemer et al., 2009),
immunocytochemical staining for the human nuclear antigen
(HuNuc) near the transplantation site should demonstrate the
presence of any surviving cells to confirm successful transplanta-
tion.
Goldman (2016) recently reviewed the prospects of stem cell ther-
apies for a plethora of neurological diseases. The pathological
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consequences following an ischaemic insult are multifaceted, in-
volving inammatory, necrotic, and oedematous processes in the
acute stage with continued inflammation, and degeneration of
neural pathways in the chronic phases (Figure 3, Tamura et al.
(1991)). All cell types of the brain are affected by ischaemic stroke.
As such, for the intention of cellular replacement, implanted stem
cells would be required to not only differentiate into functioning
neurons but into all other cells types within the CNS as well.
The mechanisms by which neural progenitor cells are driven to
their fates are also complex involving numerous molecular sig-
nals within a finely controlled environment (Harris et al., 2016).
Furthermore, human stroke survivors often suffer from various
co-morbidities such as hypertension and Type II Diabetes, which
have deleterious effects on neurovascular coupling and function
(Simpson et al., 1990; Girouard and Iadecola, 2006). Aside from
cellular replacement, there is growing evidence of cellular treat-
ments exerting a beneficial paracrine effect in the host brain,
enhancing endogenous repair mechanisms (Carmichael, 2016).
CTX0E03 cells are believed to operate by this mechanism (Stroe-
mer et al., 2009; Hicks et al., 2013). Either way, implanted cells
must survive for a reasonable amount of time within a deleterious
post-stroke brain environment to exert a beneficial effect. This and
the frequency of co-morbidities in stroke patients must be taken
into account when undertaking BOLD imaging experiments.
Beyond cell replacement, exogenous transplantation of neural
stem cells may also have a role in immunomodulation, which
in turn influences neurogenesis (Kokaia et al., 2012). Although
the mechanisms by which neural stem cells and the immune
system interact are well established, it is yet to be elucidated
as to whether this can be translated into a clinical environment.
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Enhancement of the grafting environment may also improve cell
viability. Various scaffolds and matrices for transplanted stem
cells (often containing growth factors) have been investigated to
improve graft survival and function (Bible et al., 2009; Skop et al.,
2014). Scaffold design is complex due to the requirement for sub-
strates to be produced in a sterile envionment and be non-toxic,
injectable, biodegradable, and porous for cell and blood vessel
integration. Candidate substrates include various gels (Jin et al.,
2010), hyaluronic acid (Liang et al., 2013), and microparticles
(Aliabadi and Lavasanifar, 2006).
Clinical trials of exogenous or autologous stem cells to treat is-
chaemic stroke are growing in number. However, the cell type
and time of transplantation post-stroke varies greatly among trials
(Sinden et al., 2012). Autologous mesenchymal stem cells appear
to be the most popular cell type for transplantation (due to astro-
cytic fate (Kopen et al., 1999), and greater ethical acceptance com-
pared to foetal cells). These are often administered intra-arterially
or intravenously in the acute post-stroke period with an aim of
neuroprotection. Human bone marrow stromal cells (hBMSCs)
administered intra-arterially 60 days post-stroke accumulated in
the spleen, reduced systemic inflammation and MHC-II positive
cells in the brain (Acosta et al., 2015). The recent clinical trial
data from Steinberg et al. (2016) and (Kalladka et al., 2016), both
of which involved intracerebral transplantation of bone marrow
derived MSCs and neural stem cells respectively, found improve-
ments in functional outcome in small patient groups. However
as these studies were open labelled and non-randomised safety
trials, the interpretation of the secondary functional assessments
should be treated with caution. A large (120 patient) multi-center
trial of intravenous bone marrow stem cell treatment delivered in
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the sub-acute stages post-stroke conducted by Prasad et al. (2014)
showed no beneficial effects on functional outcome.
Although the outlook for stem cell therapy for stroke remains
uncertain, there are other neurological diseases which are likely
to benefit from cellular therapies. These include myelin specific
diseases such as multiple sclerosis where injection of highly mi-
gratory glial progenitor cells have been shown to improve myeli-
nation (Windrem et al., 2004). Macular degeneration and other
ocular diseases are good candidates for stem cell therapy due
to the relative ease of being able to observe post-transplantation
changes within the eye. These are currently in trial (Song et al.,
2015; Schwartz et al., 2015).
6.3 approaches to resting state functional mri in stroke
Resting State fMRI is increasingly used as a clinical investigation
due to the absence of task based assessments and the relative ease
of acquisition. Pre-clinical work is more challenging due to the
requirement to train conscious animals to remain stationary or
to develop and optimise anaesthetic regimes which do not cause
changes in the BOLD response. In rodents, medetomidine with
or without isoflurane is now an accepted method for rs-fMRI
imaging experiments with recovery (Weber et al., 2006; Zhao
et al., 2008; Kalthoff et al., 2013). Alpha-chloralose and urethane
are useful anaesthetics for non-recovery experiments (Hsu and
Hedlund, 1998; Williams et al., 2010).
Analysis methods for resting state imaging are seed based, use
Independent Component Analysis (ICA) or frequency based anal-
yses such as Partial Directed Coherence (PDC). As described
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earlier in this thesis, inter-ROI correlation coefficients are deter-
mined, not only by the low frequency BOLD fluctuations, but are
also influenced by the SNR and partial volume effects. This is a
particular challenge for ischaemic stroke data sets where contami-
nation of the ROIs by the infarction or tissue distortion can cause
erroneous network derivation. There appear to be limited solu-
tions for this issue, primarily due to the heterogeneous size and
location of ischaemic infarcts and the extent of the subsequent
disability, making it difficult to ascertain standard post-stroke
network changes. Possible approaches include a standardised
method of nuissance regression against infarcts and CSF as well
as agreement on ROI usage within the ischaemic hemisphere.
Non-invasive physiological control remains a significant challenge
for rodent functional imaging. Although the use of end-tidal
and subcutaneous capnography devices is commonly reported
(Silva and Koretsky, 2002; Weber et al., 2006; Masamoto et al.,
2009b), there tends to be little detail given on the details of the
set up (Mirsattari et al., 2005). As demonstrated in Chapter
4, accurate end-tidal capnography within an MRI scanner is
challenging due to the long sampling line lengths required. As
such, a careful balance between sampling rate, ventilation volume,
and respiration rate is required. A standardised methodology
with optimal species/strain specific ventilation parameters would
be of great benefit to the in vivo functional imaging field.
6.4 other uses of mri in assessing stem cell thera-
pies
Other MR techniques may provide insight into cell fate and/or
host responses to stem cell transplantation. Incorporation of
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super-paramagnetic iron oxide particles (SPIOs) into exogenous
cells allows for their identification in vivo due to the particles
generating strong susceptibility gradients in T∗2 weighted im-
ages (Bulte et al., 2002; Sykova and Jendelova, 2007). However,
the specificity of the ferrous signal to the grafts decreases over
time due to the clearance of cells by microglia as well as chal-
lenges in identifying SPIO labelled cells from petichial blood
post-ischaemia.
ASL uses a 180◦ inversion pulse to label intra-arterial water and
determine CBF by measuring the net magnetisation of tissue after
a pre-determined transit time (Detre et al., 1992). With some
stem cell lineages reported to be pro-angiogenic (Jiang et al.,
2005; Thored et al., 2007; Zhang et al., 2011) including CTX0E03
cells (Hicks et al., 2013), ASL (Arterial Spin Labelling) may be
able to detect flow changes or improvements following treatment
(Seevinck et al., 2010).
Magnetic resonance spectroscopy imaging (MRSI) measures the
levels of metabolites such as lactate and N-acetyl-aspartate (NAA,
believed to be a marker of neurons (Simmons et al., 1991)). This
technique has been used to examine the post stroke brain (Weber
et al., 2005). With stem cells purported to have largely neu-
rotrophic actions (Burns and Steinberg, 2011), MRSI may provide
evidence for the metabolic responses of the brain to stem cell
treatment. However the technique is limited in in vivo models
due to the large voxel sizes require limiting spatial specificity.
Diffusion tensor imaging (DTI) data was acquired during the
longitudinal study (Chapter 5) to assess changes in anatomical
connectivity but was not analysed for this thesis. DTI-derived
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indices such as Fractional Anisotropy and Mean Diffusivity, allow
for inferences on tissue structure via directional biases in tissue
water diffusion (Beaulieu, 2002). Successful grafting of neural or
oligodendrocyte precursors cells has previously been reported to
change the diffusion properties within the brain after transplanta-
tion (Gupta et al., 2012), due to remyelination and differentiation
into astrocytes and oligodendrocytes. Similar results have been
reported in rodent stroke models (Jiang et al., 2006). Novel analy-
sis techniques such as segmentation via k-means clustering (Jones
et al., 2015) may provide a greater understanding of the post-
stroke brain, especially in the peri-infarct region. Jones et al. (2015)
have demonstrated that such methods have shown greater sensi-
tivity to brain tumour infiltration and structural properties at a
greater sensitivity compared to conventional anatomical methods.
This technique may provide a detailed insight into the structural
changes within the peri-infarct region and the transplantation site.
6.4.1 Other imaging modalities
The radiotracers 18F-Fludeoxyglucose (FDG) and 15O are highly
sensitive markers of brain metabolism frequently used in brain
research. The specificity of PET ligands make them a useful
investigative tools to understand stem cell fate and responses.
Prasad et al. (2014) used FDG PET to identify new regions of
FDG uptake following intravenous cell transplantation. Although
highly sensitive, the suitability of PET imaging is hindered by
limitations in the number of widely available radioligands and
the safe number of scans a patient can undertake.
6.5 conclusions 236
Optical techniques allow for high resolution visualisation of the
microvascular and cellular environment within the retina or cor-
tex. Optical Coherence Tomography (OCT), (Huang et al., 1991)
and Autoflourescence imaging provide a high resolution assess-
ment suitable for the retina (or cortical layers in vivo). These
techniques therefore would be preferable in the assessment of
stem cell therapeutic efficacy for retinal diseases in humans (Ja-
cobson et al., 2016). Bioluminescene imaging (where cells are
labelled with luciferase) allows for longitudinal imaging of cell
grafts and their fate and is a useful adjunct with optical imaging
techniques (Love et al., 2007).
6.5 conclusions
Overall, this thesis has illustrated the challenges and opportu-
nities which arise from longitudinal investigations using post-
stroke rodent models. From the selection of appropriate func-
tional assessments; the continuing challenges of non-invasive
physiological monitoring; the absence of functional improvement
following CTX0E03 transplantation; and the unexpected sensi-
tivity of resting-state fMRI to injury. The former finding opens
up a discussion on how resting-state fMRI can be used to assess
functional outcomes in post-surgical models and patients. This
technique is a powerful and exciting tool to the neuroimaging
field and used cautiously in combination with other advanced
techniques, will continue to enlighten us into the workings of the
brain.
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